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Many organisms possess a non-heme, mononuclear iron enzyme termed cysteine 
dioxygenase (CDO) that aids in homeostasis. This enzyme irreversibly adds molecular 
oxygen to the thiol group of the N-terminal cysteine residue of proteins in plants, acting 
as an oxygen sensor. Plant CDO targets are transcription factors which permit 
transcription of enzymes required for anaerobic metabolism. Under hypoxic conditions, 
the molecular oxygen co-substrate is not present at a high concentration therefore these 
transcription factors cannot be dioxidised and remain able to elicit an anoxic response. 
In normoxia, plant CDO dioxidises the N-terminal cysteine of these transcription factors, 
tagging them for degradation. This study evaluated recombinant expression and 
purification of CDO from a three plant species. CDO from Arabidopsis thaliana and Zea 
mays were then characterised both structurally and kinetically.  
 
Plant CDO’s were expressed in Escherichia coli cells and purified using Strep-tag® 
affinity chromatography. Plant cysteine oxidase 1 (PCO1) and plant cysteine oxidase 2 
(PCO2) isoforms from Arabidopsis thaliana co-purified with chaperones, and DNA. 
Two shortened variants of PCO1 were designed to abolish these interactions and improve 
homogeneity. A variant, ΔN, had residues 2-51 removed and produced contaminant-free 
product. When residues 2-52 and 247-293 were removed in the variant termed ΔNΔC, 
more co-purifying contaminants were present than with full-length PCO1. Plant CDO 
from Zea mays was expressed and purified both as a full length construct and a variant 
missing the first 32 residues. The full length Z. mays construct co-purified with a range 
of contaminants, and removal of the N-terminal did not improve protein homogeneity. A 
PCO2 isoform from Orzya sativa was attempted to be produced, resulting in no 
expression. 
 
Homology models of PCO1 were produced to assess structural characteristics. Surface 
charge distribution, disulfide bonding and accessibility of the active site was explored in 
these models. Mass spectrometry (MS) showed that disulfide bonding was present in 
PCO1. PCO1, PCO2, ΔN, ΔNΔC and both maize constructs were subjected to a range of 
high-throughput crystallography screens. Promising conditions were optimised, but no 
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diffracting crystals were produced. Metal ion binding to plant CDO was assessed using 
intact MS, and showed that the protein may also bind zinc in vitro. Nuclear magnetic 
resonance showed that plant CDO is not able to dioxidise free cysteine. Other 
colorimetric kinetic assays were performed to show that plant CDO is able to act on N-
terminal cysteine as part of a di-, tri- or penta-peptide having the N-terminal of target 
molecules. Plant CDO has greater affinity for longer peptides.  
 
DNA binding is predicted to be via an electrostatic interaction with N-terminal, which 
also appears to also contain a nuclear localisation signal. Nuclear localisation, followed 
by DNA binding could permit localisation to targets in vivo. This would allow plant CDO 
to quickly bind transcription factor targets as they are also DNA binding proteins. 
Disulfide bonding may also play a role in modulating protein activity. As disulfide 
bonding relates to cell oxidation state, this could permit conformational changes that 
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1.1 Cysteine Dioxygenase 
Almost any living organism to survive, must be capable of adapting to a range of 
environments. Many organisms possess a non-heme, mononuclear-iron enzyme termed 
cysteine dioxygenase (CDO- E.C 1.13.11.20) that aids in homeostasis. This enzyme is 
responsible for the irreversible addition of molecular oxygen to the thiol group of 
cysteine residues. This reaction leads to the incorporation of both oxygen atoms to 







Figure 1.1 Reaction catalysed by CDO. Cysteine is dioxidised to form cysteine sulfinic 
acid. Note the requirement for molecular oxygen as a co-substrate (red). Figure taken 
from Davies (2016). 
 
This enzyme was first described in 1966 by Ewetz and Sorbo, who determined that it 
functioned as a general oxidase (Ewetz and Sörbo, 1966). Lombardini and colleagues 
showed that CDO was in fact a dioxygenase, and that it did not require external redox 
cofactors as originally anticipated (Lombardini et al., 1969). Upon purification from rat 
liver in the 1970s by Yamaguchi, the first major steps in mammalian CDO 
characterisation were performed (Yamaguchi et al., 1978). This showed that mammalian 
CDO was a dioxygenase that was important for cysteine metabolism (see 1.2). Since 
then, many other researchers have produced experimental data for both the activity and 
structure of mammalian CDO. The role of CDO in plants was not elucidated until 
recently. Weits et al. showed that plant CDO dioxidised targets like mammalian CDO 
and permitted a response to low oxygen levels (see 1.3) (Weits et al., 2014). CDO was 
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identified in bacteria in 2006 by sequence alignment, however the physiological role has 
not yet been elucidated (see 1.4). Although many studies have been conducted to derive 
the general mechanism of CDO, it remains elusive (Ye et al., 2007; Kumar et al., 2011). 
It is currently best understood in mammalian CDO.  
 
1.2 Mammalian CDO 
Within mammals, CDO is involved in the initial steps of cysteine catabolism (Stipanuk, 
2004). After free cysteine is dioxidised to cysteine sulfinate (CSA), the reaction can 
branch in two directions. Decarboxylation of CSA leads to the production of hypotaurine, 
which is then able to be further oxidised in order to produce an important amino acid, 
taurine (Stipanuk et al., 2011). The second branch enables the production of free sulfate 
groups and pyruvate by a transamination reaction (Figure 1.2). 
 
 
Figure 1.2. Metabolic pathway of Mammalian CDO catalytic activity. Cysteine 
sulfinate produced by CDO is metabolised either to taurine or pyruvate and sulfate. Taken 
from Stipanuk (2015).  
 
Mammalian CDO regulation is cysteine mediated and is solely post-translational (Bella 
et al., 2002; Joseph and Maroney, 2007). Degradation is rapid, and ubiquitin facilitated 
as the 26S proteasome is responsible for its breakdown. This mechanism has been shown 
to have remarkable responsiveness, and CDO activity is determined primarily by dietary 
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intake of cysteine (Stipanuk et al., 2006). Such responsiveness indicates that homeostasis 
of cysteine is important for cell viability. This is further highlighted by the cytotoxic and 
neurotoxic effects of increased cysteine levels (Stipanuk et al., 2009). A decrease in CDO 
activity has also been observed in many types of cancer (Heafield et al., 1990; Brait et 
al., 2012; Prabhu et al., 2014). A CDO knockout mouse model resulted in excess 
production of toxic hydrogen sulfide (H2S) and build-up of cysteine. This product was 
excreted in urine and affected mouse growth substantially. The long term effects were 
not elucidated, as these mice were fed hypotaurine and taurine 6-weeks post birth (Roman 
et al., 2013).   
 
1.3 Plant CDO  
Controlling oxygen usage in plants is crucial to different growth stages such as seed 
development and maturation. During these various growth stages oxygen diffusion is 
limited, therefore a means of oxygen sensing is critical for plant survival. Oxygen sensing 
is also required during submergence-tolerance and waterlogging, a factor essential for 
the cultivation of food such as rice (Xu et al., 2006). Tolerance to submergence is also 
important in flooding, where timely adaptation to this hypoxic environment permits 
survival (Bailey-Serres and Voesenek, 2008). The activity of CDO within plants permits 
a response to molecular oxygen concentration. This is because CDO activity is only 
possible in the presence of molecular oxygen, as it is a co-substrate. This has been 
demonstrated in rice, Arabidopsis and barley (Kosmacz et al., 2015; Mendiondo et al., 
2016).  
 
More specifically, plant CDO catalyses the N-terminal dioxidation of penultimate 
cysteine residues to form cysteine sulfinic acid under normoxia (>1% v/v O2)(White and 
Flashman, 2016).  This dioxidation leads to arginylation by arginyl transferases (ATE1/2) 
which decreases target protein stability by the pathway that executes the N-end rule 
(Bachmair et al., 1986; Weits et al., 2014). A single subunit E3 ligase, PROTEOLYSIS 
6 (PRT6), recognises the N-terminal arginine and polyubiquitylates the protein. Target 
degradation then occurs via the 26S proteasome (Licausi et al., 2011; Bailey-Serres et 
al., 2012). For this to occur, methionine aminopeptidase (MetAP) is required to remove 
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the N-terminal methionine residue of the nascent target to expose the N-terminal cysteine 
(Figure 1.3).  
 
 
Figure 1.3. Plant CDO activity scheme. Depicted is the process plant CDO is involved 
in to permit target degradation. Green oval represents target transcription factor 
RAP2.12, single letters before the green oval are N-terminal amino acids, and PCO1/2 
are plant CDO isoforms from Arabidopsis. Subscript ‘ox’ refers to the cysteine being 
dioxidised. RAP2.12: Related to Apetala 2.12, MetAP: methionine aminopeptidase, 
ATE1/2: arginyl transferase 1/2, PRT6: PROTEOLYSIS 6. Figure taken from Weits et 
al. (2014).  
 
White et al. conducted a range of experiments to explore the specifics of plant CDO’s 
activity. Using mass spectrometry and NMR, it was demonstrated that plant CDO 
catalyses the formation of species from 10mer peptides (with an N-terminal cysteine) 
that are consistent with the addition of an extra 2 or 3 oxygen atoms. It was deduced that 
both oxygen atoms from molecular oxygen were incorporated into the product by using 
isotopically labelled molecular oxygen (18O2). It was later shown that trioxygenation was 
an artefact of their experimental procedure and was a result of laser exposure during 
Matrix assisted laser desorbation/ionisation mass spectrometry (MALDI-MS) (White et 
al., 2017). 
 
Studies were conducted to evaluate whether plant CDO was not active on targets, but 
instead enhanced activity of ATE1/2 or PRT6. It was also hypothesised that the response 
could be as a result of plant CDO acting as a transcriptional repressor. Neither of these 
hypotheses were proven to be true, and evidence instead supported the idea of the protein 
acting as a dioxygenase (Weits et al., 2014).  
 
1.3.1 Target proteins 
Although there are almost 200 proteins in Arabidopsis that contain a cysteine at position 
2 (Licausi et al., 2011), as yet plant CDO has been shown to act only on group VII 
ethylene response factor (ERF-VII) transcription factors (Weits et al., 2014; White et al., 
2017). Arabidopsis has 5 transcription factors within this group, Hypoxia Responsive1 
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(HRE1), Hypoxia Responsive2 (HRE2) and the constitutively expressed Related to 
Apetala 2.12 (RAP2.12), RAP2.2 and RAP2.3.  
 
Target protein activities 
These transcription factors are characterised by a single conserved ethylene response 
factor (ERF) domain which binds cis-elements in DNA. They are involved in up-
regulating approximately 25 hypoxia associated genes, including the transcription of 
enzymes that utilise anaerobic fermentation to produce energy such as alcohol 
dehydrogenase 1 (ADH1), lactate dehydrogenase (LDH) and pyruvate decarboxylase 1 
(PDC1) (Figure 1.4) (Gasch et al., 2016). They also permit transcription of enzymes 
required for enhancing carbohydrate mobilisation and glycolysis for fermentation such 
as sucrose synthase 4 (SUS4) (Liu et al., 2005; Gibbs et al., 2011). These processes 
prevent excessive oxygen usage during metabolism, permitting oxygen conservation 
(Weits et al., 2014). This switch in metabolism is essential for plant survival during 
anoxia, but limits plant growth (Paul et al., 2016).  
 
 
Figure 1.4. Scheme of RAP2.12 mediated response. Figure taken from Paul et al. 
(2016). Red indicates inhibition, green indicates activation and the dotted arrow indicates 
an uncharacterised interaction. RAP2.12: Related to Apetala 2.12, ADH: alcohol 
dehydrogenase, PDC: Pyruvate decarboxylase, LDH: Lactose Dehydrogenase, AlaAT: 
Alanine Aminotransferase, TCA: Tricarboxylic acid cycle.  
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During hypoxia, the enzyme alanine aminotransferase (alaAT) is also upregulated (Klok 
et al., 2002)(Figure 1.4). It is proposed that this upregulation is related to the enhanced 
stability of the RAP proteins, although this interaction has not been characterised. Under 
hypoxic conditions, this alaAT converts pyruvate into alanine.  This presents an 
alternative to the lactate and ethanol fermentation pathways. This reaction does not 
provide cofactor reduction such as with other pathways, thus the exact role of this 
upregulation is not clear. Alanine does however provide a non-toxic molecule into which 
excess pyruvate can be converted to for the removal of glycolytic products. It has been 
suggested that this aids in maintaining cellular pH and permits a balance between carbon 
and nitrogen during hypoxia (Miyashita et al., 2007). This also allows for downregulation 
of the TCA cycle as it is not required to utilise pyruvate from glycolysis. The 
downregulation of the TCA cycle then reduces the need for oxygen utilisation during 
cofactor recycling by the electron transport chain. 
 
ERF-VII proteins contain a short (approximately 10 amino acid) conserved N-terminal 
sequence (Figure 1.5). The presence of an N-terminal cysteine is crucial for catalysis. 
Mutating this residue to alanine slowed oxygen consumption substantially, suggesting 
that dioxidation by plant CDO was no longer occurring (Weits et al., 2014). Licausi et 
al. showed that by removing the first 13 amino acids of RAP2.12 (termed Δ12RAP2.12), 
it was no longer degraded under normoxic conditions (21% v/v oxygen) (Licausi et al., 
2011). This is because Δ13RAP2.12 is not recognised by plant CDO due to the absence 
of the N-terminal recognition sequence. Over expression of Δ13RAP2.12 during 
normoxia led to large changes in the plant metabolome. In particular, there was an 
accumulation of fermentation products which slowed plant development. Interestingly, 





Figure 1.5. ERFVII N-terminal consensus sequence. Black represents polar residues, 
green non-polar residues and red negatively charged residues. Size of single amino acid 
code dictates likelihood of the residue at that position, with 1.5 bits being full 
conservation. Created used software developed by Schneider and Stephens (1990), and 
Crooks et al. (2004). Sequences of all 5 predicted CDO targets were used (RAP2.2, 
RAP2.3, RAP2.12, HRE1 and HRE2). Sequences were taken from Uniprot. 
 
1.3.2 RAP proteins  
Transcriptome studies show that RAP2.2, 2.3 and 2.12 elicit the strongest response 
during anoxia, and therefore are important transcription factors in the ERF-VII group. 
All three are constitutively expressed, and exhibit similar expression profiles. RAP2.2 
and RAP2.12 are close homologues with 62% percent identity (Appendix 1). They are 
thought to be functionally redundant, acting on the same target genes (Bui et al., 2015). 
 
Whilst RAP2.2 appears to be a solely nuclear protein, fluorescent labelling showed that 
RAP2.12 and RAP2.3 can be translocated to the plasma membrane. RAP2.12 and 
RAP2.3 are translocated in complex with an acyl-CoA binding domain containing 
protein 1 (ACBP1). This prevents transcription factor degradation as plant CDO is not 
found near the cell membrane. Although the transcription factors are present, it does not 
permit the hypoxic response as they must be interacting with DNA in the nucleus to elicit 
a transcriptional response. As the transcription factor is readily available for translocation 
back into the nucleus when oxygen levels deplete (below 10% v/v oxygen), this permits 
timely adaption to hypoxic conditions (Licausi et al., 2011; Kosmacz et al., 2015).  
 
1.3.3 HRE proteins 
In contrast to RAP proteins, these transcription factors are expressed in low levels during 
normoxia, and are upregulated during anoxia. Licausi et al. showed that over expression 
of these proteins enhanced survival during anoxia, yet decreased plant survival during 
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normoxic conditions. Micro-arrays suggest HRE1 is the main HRE protein responsible 
for the anaerobic response in vivo, as more anoxic genes were upregulated by over 
expression of HRE1 than HRE2. However, knockouts showed that HRE2 is able to 
compensate for the loss of HRE1 as loss of only HRE1 had no effect on plant survival, 
only influencing a small number of non-lethal factors (Licausi et al., 2010). This suggests 
that HRE1 and HRE2 are partially redundant. Experiments show regulation of HRE1 is 
at the expression level, whilst regulation of HRE2 is post-transcriptional. As HRE1 is 
regulated at the expression level, this means that plant CDO is only required post-anoxia 
to remove excess HRE1 proteins. HRE2 however appears to be regulated by plant CDO 
under normal conditions.  
 
1.3.4 Localisation and expression 
There are 5 different plant CDO isoforms within Arabidopsis. These isoforms were 
termed plant cysteine oxidase (PCO) 1-5 by Weits et al. The activities of PCO1 and 
PCO2 are predicted to be redundant, as are the activities of PCO3, PCO4 and PCO5. This 
was demonstrated by single double gene knockouts whereby removal of either PCO1 or 
PCO2 had little to no impact, but removal of both led to a decrease in plant survival under 
normoxia. Analysis of the genes transcribed as a result of these knockouts showed that 
the same genes were being over-expressed in the absence of PCO1 or PCO2 during 
normoxia. Using fluorescent labelling, PCO1 and PCO2 were shown to localise 
exclusively to the nucleus, whereas PCO3, PCO4 and PCO5 are cytosolic proteins (Weits 
et al., 2014).  
 
Weits et al. analysed the expression profile of all PCOs and found that all genes were 
expressed during development. PCO1 and PCO2 expression was greatly upregulated 
during growth stages, such as seed development, which are characterised by low oxygen 
levels. Over-expression of PCO1/2 by Weits et al. (2014) unsurprisingly led to impaired 
tolerance during submergence and negatively impacted plant growth.  
 
Plant CDO upregulation during anoxia is due the increased presence of RAP proteins. 
The upstream promoter region of PCO1 and PCO2 comprises a hypoxia-responsive 
promoter element (HRPE) 5′-AAACCA(G/C)(G/C)(G/C)GC-3′ which contains a highly 
conserved AC-rich start, loosely conserved linker and GC end. This element was shown 
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to be important for transcriptional transactivation by RAP2.12 and RAP2.2 as they can 
directly bind to this element. As these CDO targets have been shown to upregulate 
transcription of the PCO genes themselves, this creates a negative feedback loop that 
primes the anoxic cell for target degradation on return to normoxia (Weits et al., 2014; 
Gasch et al., 2016).  
 
1.4 Bacterial CDO 
With the aid of crystallographic data and alignment tool searches, Dominy et al. 
identified four potential CDO enzymes within Bacillis and Streptomyces genera. Overall 
identity was low (12-21%), yet active site residue conservation indicated similar 
function. Enzyme kinetic data showed that the four proteins tested exhibited a strong 
substrate preference for cysteine. These data confirmed that these enzymes were in fact 
bonda fide CDOs of prokaryotic origin. Further phylogenetic analyses indicate that CDO 
is also found within many other eubacteria phyla. The use of these enzymes within 
bacteria is proposed to be for the production of elemental sulfur. It may also play a role 
in regulation of disulfide bonds and formation of endospores (Dominy et al., 2006).  
 
Sequence alignment by Tchesnokov et al. also showed a CDO homologue from 
Pseudomonas aeruginosa (Tchesnokov et al., 2015). This enzyme was shown to be 
expressed under basal conditions using mass spectrometry. Assays showed the protein 
was able to oxidise cysteine in vivo, but showed a preference for 3-mercaptopropionic 
acid (3-MPA). Mössbauer spectroscopy suggested that substrate binding via the thiol 
group and crystallography showed similar active site geometry to mammalian CDO. The 
role of 3-MPA oxidation was suggested to provide a means of substrate assimilation. 
This would permit removal and subsequent utilisation of the elemental sulfur of the thiol 
group. As this enzyme prefers 3-MPA as opposed to cysteine, it is a thiol dioxygenase 





1.5 Structure of CDO 
Crystal structures of CDO have been analysed from mammalian and bacterial sources. 
These crystal structures, alongside sequence homology, show that CDO is a member of 
the very diverse cupin superfamily (Dunwell et al., 2001). As a member of this 
superfamily, CDO contains two short characteristic cupin motifs (GX5HXHX3-6EX6G 
and GX5-7PXGX2HX3N) which are separated by a variable linker region of 15-20 amino 
acids (Chad R Simmons et al., 2006). These conserved sequence motifs are responsible 
for providing ligands for metal binding. These ligands are the side chains of histidine 
residues, which explains the histidine residue conservation for the cupin motif. The 
central structure of CDO consists of a canonical six-stranded β-barrel, comprised of β-
sheets. This core is where Fe2+ is coordinated by three histidine residues (Figure 1.6) 
(Joseph and Maroney, 2007; Stipanuk et al., 2011). As seen in Figure 1.6, only three α-







Figure 1.6. Structure of Mammalian CDO. Blue is used to colour α-helices, whereas 
β-strands are tan. Iron is shown as an orange sphere bound to the active site histidine 
residues, which are depicted as sticks with nitrogen atoms coloured blue. PDB accession: 
2B5H.  
 
When superimposing bacterial and mammalian CDO structures, no secondary structure 
elements vary between the two structures by more than ~0.5 Å. This suggest that although 
mammalian and bacterial CDO exhibit low sequence similarity (12-21%), they maintain 
similar structural characteristics (Figure 1.7). Thus these structures likely reflect that of 
plant CDO with significant homology, even though plant CDO also shares low sequence 
similarity with mammalian CDO. Structural characteristics of plant CDO have yet to be 
confirmed due to the absence of a crystal structure. The production of homology models 




Figure 1.7. Comparison of bacterial and mammalian crystal structures. Iron co-
ordinating histidine residues are shown. Tan represents bacterial thiol dioxygenase (from 
Pseudomonas aeruginosa), blue represents mammalian CDO (Rattus norvegicus). 
Bacterial CDO accession: 3USS.  
 
1.5.1 Active site structure 
The active site of CDO differs from many other non-heme, mono-iron enzymes. The 
archetype is a 2-His-1-carboxylate triad of iron ligands. CDO lacks this configuration, 
and instead contains a neutrally charged 3-His facial triad that coordinates the central 
iron. The change may be related to the fact that many similar non-haeme mono-iron 
enzymes catalyse reactions with non-thiol substrates. The coordinating histidine residues 
are present at positions 86, 88 and 140 in mammalian CDO, as shown in Figure 1.8.   
 
To understand why such a variation is present, de Visser and Stragnaz conducted 
computation modelling where they replaced the 3-His coordination with a 2-His/1-Asp 
triad within mammalian CDO (de Visser and Straganz, 2009). The results of this indicate 
that although the reaction was able to proceed, a larger energy barrier was present. 
Therefore, the rare coordination was not required for activity but aided in optimal 
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cysteine dioxidation (Tchesnokov et al., 2012). This is likely due to a stronger interaction 
between the iron and thiol group, as well as the variation influencing the iron spin state. 
This in turn affects dioxygen activation (Souness et al., 2013).  
 
 
Figure 1.8. Fitted electron density map for the key active site features of 
Mammalian CDO. Taken from Simmons et al. (2006). Water is portrayed as red 
spheres, whereas iron is portrayed with a larger orange sphere. A crosslink is present 
between Tyr-157 and Cys-93, which is shown in orange. All residues and their positions 
are labelled. Nitrogen coloured blue, oxygen red, orange sulfur and carbon is grey.  
 
Other important features of the active site include the residues Tyr-157, Cys-93 and His-
155 (Figure 1.8). The hydrogen bonding networks of these residues aid in stabilising 
catalysis (Aluri and de Visser, 2007). It has also been proposed that Tyr-157 is a catalytic 
acid/base due to its hydroxyl group (Dominy et al., 2006; Davies et al., 2014).  
 
Sequence alignment suggests that the 3-His triad is present in plant CDO, yet indicates 
that other core stabilising amino acids are not conserved (Figure 1.9). This includes Tyr-
157, Cys-93 and His-155. Due to such difference in the active site, an overall sequence 
identity of 24% between mammalian and plant CDO is not surprising (not shown, 
comparison done using BLAST). Comparison of plant CDO and bacterial CDO shows 
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even less sequence similarity with little more than only the iron co-ordinating histidine 
residues being conserved. The production of crystal data would enable the active site 
configuration to be determined.   
 
Arabidopsis      MGFEMKPEKEVLELISSKNQCKSNPNSVKKKNKNKNKKMMMTWRRKKIDSPADGITAVRR 60 
Bacillus         ----------------------------------------------------------ME 2 
Rattus           ------------------------------------------MERTELLKPR----TLAD 14 
Mus              ------------------------------------------MERTELLKPR----TLAD 14 
Pan              ------------------------------------------MEQTEVLKPR----TLAD 14 
Homo             ------------------------------------------MEQTEVLKPR----TLAD 14 
                                                                              
 
Arabidopsis      LFNTCKEVFSNGGPGVIPSEDKIQQLREILDDMKPEDVGLTPTMPYFRPNSGVEARSSPP 120 
Bacillus         LYECIQDIFGGLK---NPSVKDLATSLKQIPNAAKL------SQPYIKEPDQYA-----Y 48 
Rattus           LIRILHELFAGDE---VN-VEEVQAVLEAYE-SNPA------EWALYAKFDQYR-----Y 58 
Mus              LIRILHELFAGDE---VN-VEEVQAVLEAYE-SNPA------EWALYAKFDQYR-----Y 58 
Pan              LIRILHQLFAGDE---VN-VEEVQAIMEAYE-SDPT------EWAMYAKFDQYR-----Y 58 
Homo             LIRILHQLFAGDE---VN-VEEVQAIMEAYE-SDPT------EWAMYAKFDQYR-----Y 58 
                 * .  :::*.          ..:    :                      .          
 
Arabidopsis      ITYLHLHQCDQFSIGIFCLPPSGVIPLHNHPGMTVFSKLLFGTMHIKSYDWVVDAPMRDS 180 
Bacillus         GRNAIYRNN-ELEIIVINIPPNKETTVHDHGQSIGCAMVLEGKLLNSIYRSTGEHAEL-- 105 
Rattus           TRNLVDQGNGKFNLMILCWGEGHGSSIHDHTDSHCFLKLLQGNLKETLFDWPDKKSNEMI 118 
Mus              TRNLVDQGNGKFNLMILCWGEGHGSSIHDHTDSHCFLKLLQGNLKETLFDWPDKKSNEMI 118 
Pan              TRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMV 118 
Homo             TRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMV 118 
                       :   ::.: ::         :*:*        :* *.:  . :    .       
 
Arabidopsis      KTRLAKLKVDSTFTAPCNASILYPEDGGNMHRFTAI---TACAVLDVLGPPYCNPEGRHC 237 
Bacillus         -SN-------S-YFVH-EGECLIS—TKGL-HKMSNPTSERMVS-LHVYSPPLE-----DM 148 
Rattus           KKS-------E-RTLR-ENQCAYINDSIGLHRVENVSHTEPAVSLHLYSPPFD-----TC 164 
Mus              KKS-------E-RTLR-ENQCAYINDSIGLHRVENVSHTEPAVSLHLYSPPFD-----TC 164 
Pan              KKS-------E-RVLR-ENQCAYINDSIGLHRVENISHTEPAVSLHLYSPPFD-----TC 164 
Homo             KKS-------E-RVLR-ENQCAYINDSIGLHRVENISHTEPAVSLHLYSPPFD-----TC 164 
                  .        .      : .         :*:          . *.: .**          
 
Arabidopsis      TYFLEFPLDKLSSEDDDVLSSEEEKEGYAWLQERDDNPEDHTNVVGALYRGPKVED 293 
Bacillus         TVFEEQKEVL-----ENS-------------------------------------- 161 
Rattus           HAFDQRTGHK-----NKVTMTFHSKFGIRTPF----------TTSGSLENN----- 200 
Mus              HAFDQRTGHK-----NKVTMTFHSKFGIRTPF----------TTSGSLENN----- 200 
Pan              HAFDQRTGHK-----NKVTMTFHSKFGIRTPN----------ATSGSLENN----- 200 
Homo             HAFDQRTGHK-----NKVTMTFHSKFGIRTPN----------ATSGSLENN----- 200 
 
 
Figure 1.9. Multiple sequence alignment of CDO from various origins. Arabidopsis 
thaliana (thale cress or mouse-ear cress), Bacillus subtilis (non-pathogenic, soil dwelling, 
gram positive bacterium), Rattus norvegicus (brown rat), Mus musculus (house mouse), 
Pan trogolodytes (common chimpanzee) and Homo sapien (modern human). Blue 
indicates histidines in the iron coordination sphere and green the proposed catalytic 
tyrosine (not present in PCO1. One dot indicates similar amino acid, two dots very similar 
amino acids and a star indicates identical amino acids. Alignment generated on Clustal 





Metal iron centre 
Tchesnokov et al. revealed that exceptionally tight, stoichiometric binding was present 
between the central iron and 3-His imidazole groups. This iron contains a four-coordinate 
pseudo-tetrahedral geometry (Tchesnokov et al., 2012). As three of the iron coordination 
sites are occupied by histidine, this leaves the fourth coordination site vacant to a water 
molecule (pictured as Wat4 in Figure 1.8) (Souness et al., 2013). A second water 
molecule then interacts via H-bonding with the first.   
 
The active site Fe2+ of CDO is crucial for enzymatic activity (Joseph and Maroney, 2007). 
The necessity for iron was shown experimentally by Tchesnokov et al. by use of an 
oxygen electrode to follow oxygen consumption. Results disclosed that the amount of 
iron binding was proportional to enzymatic activity (Tchesnokov et al., 2012). White et 
al. was able to co-purify plant CDO with 0.3 ± 0.12 atoms of Fe2+ per CDO suggesting 
that plant CDO also contains a metal iron centre (White and Flashman, 2016). Iron 
occupancy of ~30% may be as a result of in vitro purification, as free iron availability is 
likely to be different in plant cells. Mammalian CDO is able to be purified with ~20% 
iron occupancy, and this can be increased to greater than 90% by loading purified protein 
with iron (Tchesnokov et al., 2012). Attempts to increase plant CDO iron binding post-
purification could be achieved by iron addition such as with mammalian CDO.  
 
Crosslink formation 
Another key feature of the mammalian CDO is a crosslink which provides a structural 
variant. This crosslink can be formed between Tyr-157 and Cys-93, both residues which 
are buried deep in the active site. This thioether bond (depicted in orange within Figure 
1.8) crosslinks two β-strands which are present within the active site. This crosslink is 
not a ligand for iron binding as the distance is too large (4.16 Å) (Joseph and Maroney, 
2007). Crosslinking was proposed to facilitate enhanced catalysis due to the constant 
orientation of the tyrosine aromatic ring within the active site (de Visser and Straganz, 
2009). More recently it has been shown by enzyme kinetics and crystallography that the 
increase in catalysis is instead due to the removal of the thiol of Cys-93 out of the active 
site (Davies et al., 2014). Model chemistry also suggests that it is important for increased 
catalysis as it decreases both the redox potential and pKa of the tyrosine (Shinobu Itoh et 




Covalent crosslinking was only able to be achieved in the presence of oxygen, and as 
such this is a condition in which CDO enzyme maturation is important. Among naturally 
occurring CDO, crosslinking has only been experimentally demonstrated in mammalian 
CDO. Crystal structure analysis shows that variant prokaryotic sources are also able to 
form a crosslink (Siakkou et al., 2011; Fellner et al., 2016). Sequence alignment suggests 
that both Cys-93 and Tyr-157 are not present within plant CDO, therefore the likelihood 
of an active site crosslink is low. Crystal structure determination would aid in verifying 
if this assumption is true.  
 
Bioinformatic based analysis has shown that although the tyrosine present in the 
mammalian crosslink is found within bacterial CDOs, Cys-93 is substituted for glycine 
(Joseph and Maroney, 2007). Most bacteria contain a glycine residue in this position, 
which does not support the formation of a crosslink.  Some bacteria have a cysteine close 
to this position, therefore it has been speculated that this could permit formation of the 
crosslink. Solved bacterial CDO crystal structures did not contain a cross link, so it was 
suggested that this hypothesis is not correct (Driggers et al., 2015). However, bacterial 
CDO has not been crystallised in the presence of substrate, so this has not been 
extensively tested.  
 
1.6 Substrate binding  
Mammalian and bacterial CDO dioxidise free cysteine whereas plant CDO dioxidises 
cysteine as part of a peptide. Changes to the substrate will have large influences on 
substrate co-ordination and order of substrate entry into the active site. It was determined 
by Dominy et al. that cysteine-CDO binding is highly specific, thus no alternate 
substrates react or compete with native substrate (Dominy et al., 2006). This specificity 
is a characteristic of all known CDOs, and is contrasting to other known non-heme 
mononuclear iron enzymes (Tchesnokov et al., 2015). Electron paramagnetic resonance 
(EPR) showed that binding of the dioxygen substrate occurs after cysteine is bound 
(Stipanuk et al., 2011; Souness et al., 2013). This ordered binding occurs in both 
mammalian and bacterial CDO. However, it is not known if this binding order applies to 
plant CDO as it has not been experimentally tested. It seems likely that oxygen will enter 
the active site before the target peptide as the peptide is large, and may block co-substrate 
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entry. Multiple spectroscopic approaches could be harnessed to test this, such as EPR as 
mentioned above.  
 
Cysteine binds to mammalian CDO in a bidentate fashion via both the amide and sulfide 
groups (Souness et al., 2013). The cysteine carboxyl interacts with the Arg-60 
guanidinium group via a salt bridge. This interaction allows further orientation 
stabilisation and substrate specificity (Aluri and de Visser, 2007; Kumar et al., 2011; 
Tchesnokov et al., 2012). This was demonstrated experimentally by Fellner et al. (Fellner 
et al., 2016). This reaction is not possible in plant CDO as the carboxylate is contained 
within the amide bond within the peptide. The formation of a substrate-bound crystal 
would enable affirmation of how peptide binds in the active site.   
 
1.6.1 Proposed Mammalian CDO Mechanism 
Most of what is known of the potential mechanism of mammalian CDO is derived 
computationally. This is because the reaction proceeds very quickly, therefore 
intermediates are exceptionally hard to trap and characterise. Stopped-flow 
spectrophotometry by Davies (unpublished) shows that the reaction proceeds to 
completion within 30 ms. However, using isotopically labelled molecular oxygen it was 
shown that both of the dioxygen atoms are integrated to form the sulfinate (Aluri and de 
Visser, 2007). This gives some indication as to how the mechanism proceeds. There are 
currently two favoured models for the mechanism of mammalian CDO.   
 
Mechanism I 
With the aid of both quantum mechanics/molecular mechanics (QM/MM) and density 
function theory (DFT), de Visser and Straganz were able to predict a potential CDO 
mechanism (Mechanism I of Figure 1.10)(de Visser and Straganz, 2009). After cysteine 
binding, the initial step of the reaction is proposed to be dioxygen activation. Upon 
coordination of dioxygen, the Fe2+ is oxidised to Fe3+ and a superoxide is formed (Figure 
1.10, A). This activation leads to radical addition on the distal oxygen atom to the 
cysteine sulfur. This forms a 4 membered heterocycle where a new O-S bond is present 
and the sulfur become a radical cation (Figure 1.10, B). This structure weakens the O-O 
bond, causing bond cleavage (Figure 1.10, C). An iron(IV)-oxo complex is then formed 
with a cis-bound sulfoxide. A rotation of the sulfoxide oxygen enables the proximal 
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oxygen atom to be transferred whereby cysteine sulfinate is formed. The iron is then 
reduced back to the +2 oxidation state (Figure 1.10, D). Modelling conducted by Aluri 
and de Visser concluded that the rate limiting step of the reaction was that preceding the 
sulfoxyl radical formation (Aluri and de Visser, 2007).  
 
 
Figure 1.10. Proposed mechanisms for the production of cysteinesulfinate by 
mammalian CDO. Taken from Scheme 2 of Kumar et al. (2011). Blue is the distal 
oxygen, whereas the proximal oxygen is coloured red.  
 
Mechanism II 
The second proposed mechanism was described by Kumar et al. (Kumar et al., 2011). It 
was projected that the initial step involves the radical addition of the proximal oxygen 
atom to the cysteine sulfur to form a persulfinate (Mechanism II of Figure 1.10, E). 
Through atomic rearrangement, the distal oxygen inserts into the persulfinate forming a 
4-membered, heterocycle (Figure 1.10, F). This ring structure permits a break in the 
dioxygen bond, enabling a sulfoxide intermediate to form (Figure 1.10, G). The last step 
involves transfer of an oxygen atom to yield cysteine sulfinate (Figure 1.10, D). This 
mechanism has been predicted to have higher activation energies and is therefore not the 
most likely mechanism. Instead, it was proposed that this mechanism may present a 
means of enzymatic inhibition as it blocks the active site. 
 
Although there has been significant research into the mechanism of mammalian CDO, 
the reaction proceeds too quickly for intermediates to be determined. Given this, the true 
mechanism of mammalian, bacterial or plant CDO is still not known. As there is a current 
plateau in formulating the correct mammalian CDO mechanism, analysing the active site 
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of plant CDO may offer some benefit. As many active site residues are lacking in plant 
CDO, yet the same thiol dioxidation reactions takes place, characterisation of plant CDO 
shows what features are essential for the reaction.  
 
1.7 CDO kinetics  
Several studies have been conducted to characterise kinetic properties of thiol 
dioxygenases. To do this, a multitude of different methodologies have been employed. 
These include the use of oxygen electrodes to measure co-substrate usage (Njeri and 
Ellis, 2014), whereas HPLC (Weits et al., 2014) and mass spectrometry (MS) measure 
product formation (White et al., 2017). NMR has also been used to look at both substrate 
depletion, and product formation (Bruland et al., 2009). Unfortunately, all of the methods 
described have deficiencies. Although oxygen electrodes are highly specific for oxygen, 
data does show what product is being formed during oxygen consumption. HPLC and 
MS allow end point analysis but do not easily allow kinetic parameters to be assessed. 
Much like HPLC and MS, NMR provides means to specifically assess product formation 
but does not permit routine kinetic measurements.  
 
A number of kinetic parameters have been reported for mammalian CDO. Fellner et al. 
(2014) used the Ellman’s assay to suggest a Km of 2.8 mM for cysteine in presence of 
saturating O2 and kcat of 0.63 s
-1 (Fellner et al., 2014). Simmons et al. (2006) used HPLC 
to determine a Km of 0.45 mM for cysteine in presence of saturating O2 and kcat of 0.72 
s- 1 (Chad R. Simmons et al., 2006). Although many kinetic values have been determined 
there are inconsistences in results. This may be due to variation in assay pH and 
temperature as well as heterogeneity of protein samples due to the crosslink and/or iron 
occupancy  (Davies et al., 2014). Differing kinetic values may also be due to the use of 
different assay methods.  
 
Kinetic parameters from bacterial thiol dioxygenases have also been explored. 
Tchnesnekov et al. (2015) used HPLC to determine kinetic properties of Pseuodmonas 
aeruginosa thiol dioxygenase under the presence of saturating O2. This study suggested 
a Km of 1.0 ± 0.4 mM and kcat of 0.11 ± 0.002 s
-1 (Tchesnokov et al., 2015). Dominy et 
al. (2006) also used HPLC under the presence of saturating O2 and reported Km of 3.0 mM 
and kcat of 0.39 s
-1 for Bacillus subtilis thiol dioxygenase. Dominy et al. also determined 
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a Km of 5.7 mM and kcat of 2.0 s
-1 for Bacillus cereus (Dominy et al., 2006). Again, 
although many kinetic values have been determined there are inconsistences in results. 
These changes may appear due to factors mentioned above.  
 
A colorimetric assay that measures substrate usage have also been used to study thiol 
dioxygenase kinetics (Davies et al., 2014). This method presents a means of 
standardising thiol dioxygenase kinetic studies. This assay uses Ellman’s reagent to 
measure free thiol groups, and as all substrates contain a thiol prior to dioxidation, one 
can follow substrate depletion. As this assay can be conducted in a 96-well plate, data 
can be obtained in a high-throughput manner. As data points can be obtained at short 
time intervals, it is suitable for determining kinetic parameters. This method presents 
only one issue- that substrate depletion is measured as opposed to product formation. 
This can be accounted for by the use of other more specific techniques such as NMR and 
MS to assess if the correct product is being formed. This method was utilised in research 
conducted for this thesis. 
 
Little is known of plant CDO’s kinetic properties. Weits et al. (2014) used HPLC to 
determine that plant CDO is able to able to catalyse the formation of CSA from free 
cysteine. However, the no enzyme control appeared to produce almost as much CSA as 
samples that contained enzyme and this result is contradicted by a later study (White et 
al., 2017). These authors also used an oxygen electrode to show that plant CDO is active 
with peptides that contain an N-terminal cysteine residue. However, data in this paper 
suggested that plant CDO shows some activity with peptides that do not have an N-
terminal cysteine which is thought to be extremely unlikely (Weits et al., 2014).  White 
et al. (2017) used MS to show specifically that plant CDO is able to dioxidise short 
peptides (10 amino acids) that have an N-terminal cysteine residue. The data produced 
also suggested that the product peptides included CSA. No kinetic parameters were 
reported in either of these studies. Kinetic properties of plant CDO will be further 






1.8 Project significance 
This research presents both agricultural significance, and aids mammalian CDO research 
which may have clinical relevance. Characterisation of plant CDO could aid in 
determining the mechanism of mammalian CDO. As the substrate differs greatly to that 
of both mammalian and bacterial CDO, it is intriguing that the same dioxidation reaction 
takes place. It therefore offers a unique perspective on the minimal requirements for CDO 
activity. As mammalian CDO is involved in the metabolism of a cytotoxic amino acid, 
the determination of its mechanistic activity has clinical relevance. This could then 
permit the production of treatments for some cysteine related disorders involving 
cysteine accumulation, including Alzheimer’s and Parkinson’s disease.  
 
Agricultural applications arise when considering the effect of CDO on plant survival. As 
CDO facilitates both submergence-tolerance and seed development in plants, 
manipulation may reap benefits in terms of crop yield. This is of vital importance when 
considering increasing food scarcity and population size. Climate change is also 
impacting weather conditions, and severe weather events such as flooding are becoming 
increasingly common (Lesk et al., 2016). Strategies to address the survival of crops in 
such adverse conditions is vital for maintaining the economy of countries reliant on 
agriculture, and to ensure enough crops are cultivated for food.  
 
1.9 Project aims 
It is clear that little research has been conducted to characterise plant CDO. This project 
aimed to establish expression and purification conditions for different CDO isoforms 
from a range of plant species. Extensive crystallographic based research was attempted, 
with a range of variation screens and optimisation of selected conditions. Four 
Arabidopsis thaliana, two Zea mays and one Orzya sativa CDO protein/s were employed 
to aid in crystallisation. Homology models were also employed to assess structural 
features. Parameters of enzymatic activity and metal binding properties were also 
explored. The use of different substrate peptides allowed probing of substrate recognition 
and catalytic efficiency. Characterisation will give not only insight into plant CDO, but 
may aid in determining the mechanism of mammalian and bacterial CDO. 
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Chapter Two  
Materials and Methods 
2.1 Materials 
All water (unless stated otherwise) is sourced from a Milli-Q® filtration system produced 
by Merck. Water from this system results in Type 1 ultrapure water with a resistivity of 
18.2 MΩ·cm at 25 °C. For a list of all chemicals used and the supplier, see Table 2.1. A 
list of all enzymes and associated buffers can be found in Table 2.2.  
 
Table 2.1 Chemical suppliers.  
Chemical Supplier 
Acetic acid, glacial Merck 
Acrylamide, 30% acrylamide/bis solution 
37:5:1 
Bio-Rad 
Agar Bacteriology grade Lab Supply 
Agarose low endoelectrosmosis (EEO) Lab Supply 
Antifoam A concentrate Sigma 
Ampicillin (amp) Goldbio 
Ammonium acetate Scharlau Chemie 
Ammonium iron (II) sulfate Thermofisher  
Ammonium persulfate (APS) Bio-Rad 
L-Arginine  Sigma 
L-Ascorbic acid Thermofisher 
Adenosine triphosphate (ATP) Sigma 
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β-mercaptoethanol (BME) Sigma 
Bromophenol blue VWR 
 Calcium chloride VWR 
Calcium acetate Sigma 
Charcoal, activated Riedel-deHaen 
Chloramphenicol Goldbio 
Citric acid Thermofisher  
Cobalt Chloride Sigma 
Coomassie blue G250 VWR 
L-Cysteine  Sigma 




Diethylenediamine penta-acetic acid 
(DTPA) 
Thermofisher 






Ethanol, bulk and analytical grade Scharlau Chemie 
Ethylenediaminetetraacetic acid (EDTA) VWR 
Ferrozine Sigma 
Glutathione, reduced (GSH) Sigma 





piperazineethanesulfonic acid (HEPES) 
Sigma  
Hydrochloric acid (HCl) VWR 




Iron (III) chloride Sigma 
Kanamycin (KAN) Goldbio 
Magnesium chloride VWR 
Molecular weight marker, broad range Bio-Rad 






Peptone from casein, tryptone Merck 
Potassium chloride Sigma  
Polyethylene glycol (PEG) 8,000 Sigma 
PEG Mono-Methyl Ether (MME) 5000 Molecular Dimensions 
Propan-2-ol Scharlau Chemie 
Protease inhibitor cocktail (cOmplete, 
EDTA free) 
Roche 
Sodium acetate Merck 
 Sodium cacodylate Scharlau Chemie 
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Sodium chloride Merck 
Sodium citrate Scharlau Chemie 
Sodium dodecyl sulfate (SDS) Merck 
Di-sodium hydrogen phosphate Scharlau Chemie 
 Sodium di-hydrogen phosphate Scharlau Chemie 
Sodium hydroxide pellets Scharlau Chemie 
D-Sucrose Lab Supply 
Sulphuric acid VWR 
Trichloroacetic acid (TCA) VWR 
Tetramethylethylenediamine (TEMED) VWR 
Trisaminomethane (Tris) Lab Supply 
TWEEN® 20 Sigma 
Xylene cyanol FF Sigma 
Yeast extract, granulated Merck 
 
All chemicals used were analytical grade unless otherwise specified.  
 
Table 2.2 Enzymes and associated buffers. 
Enzyme Supplier 
Type II restriction enzyme BamHI NEB 
BspHI NEB 
DnaseI, bovine pancreas Roche 




Proteinase K Sigma 
RNase A, bovine pancreas  Roche 
Shrimp alkaline phosphatase (SAP) Roche 
T4 DNA ligase Roche 
T4 DNA ligase buffer Roche 
NEB buffer 4 NEB 
 
Table 2.3 Chromatography columns, resins and commercial eluent.  
Product Supplier 
Chelex® 100 resin, styrene 
divinylbenzene copolymer  
Bio-Rad 
Sulfopropyl (SP) high performance (HP) 
5 mL cation exchange column, HiTrap® 
GE Healthcare 
Strep-Tactin® Superflow High Capacity 
resin, streptavidin  
IBA 






StrepTrap™ HP, HiTrap®,strepavidin 
resin 
Roche 
Superdex 75, HiLoad 16/60, sepharose 
resin 
GE Healthcare 
Superdex 200, HiLoad 26/600, sepharose 
resin 
GE Healthcare 
All columns mentioned in Table 2.3 were stored in 20% ethanol, and were washed with 




Table 2.4 General consumables. 
Material Supplier 
Dialysis cassette, Slide-A-Lyzer™, 10K 
molecular weight cut off (MWCO) 
 
Thermofisher 
Dialysis tubing, Snakeskin® pleated, 
10K MWCO 
Thermofisher 
E.Z.N.A® plasmid extraction kit VWR 
Filters, circular 47 mm diameter, 
cellulose acetate 0.2 μm 
Lab Supply 
Plate, clear, 96-well flat bottom Corning 
Co-star® 
Sigma 
Syringe filter, ReliaPrep™ 0.2 and 
0.45 μm, 30 mm diameter 
Lab Supply 
T7 bacteriophage promoter forward and 
reverse primers  
Sigma 
Amicon® concentrator, 10K MWCO 
(0.5, 6 and 15 mL) 
Merck 
 
Table 2.5 Crystallography consumables. 
Material Supplier 
Bases, copper (with vials) Mitegen 









MiTeGen® loops Mitegen 
Screens 
Crystal screen HT 
JCSG plus™ 













Mosquito micro-reservoir strips TTP LabTech 
Plates 





Plate seals (96-well), 
clear ViEWSEAL SEALER  
Lab Supply 
 
Table 2.6 Equipment. 
Equipment Supplier 
Centrifuges 
Avanti J-25 (standing) 
Avanti JXN-26 (standing) 
Microfuge® 16 (bench-top) 






Dynamic light scattering (DLS), 
Dynapro-99-E-50 









Fermenter, Microgen New Brunswick Scientific 
Fast protein liquid chromatography 




Hoefer Mighty Small II SE250 Multiple 
gel  castor (4 8x7 cm gels) 
Horizontal DNA gel castor, Mini-Sub® 






Gel Doc™ XR+ (with Image Lab™ 
Software) 






Hoefer SE250 Mighty Small II mini 























pH meter  
Orion 3 star 
Thermofisher 
Shakers 
New Brunswick Innova™ 2300 
(platform) 






Sonics vibra cell™ CV33 
Sonifier® Branson 
 
Sonics and Materials 
Thermofisher 
Spectrophotometers 
Pharmacia ultrospec II 
Multiskan™ GO plate reader 





UV light platform, Hoefer Mighty Bright GE Healthcare 
Vortex, MS1 minishaker IKA 
Water purification, Milli-Q® Merck 
X-ray crystallography equipment  
Liquid handler, Mosquito (v 3.4.1 43716) 
Rock Imager® R1-1000 with Rock 
Maker® Software 
X-ray detector, Rigaku R-Axis IV ++ 
X-ray generator, MicroMax-007 HF with 







For sources of general consumables see Table 2.4 and crystallography consumables see 





Table 2.7 E. coli strains used. 
Strain Antibiotic resistance Supplier 
BL21(DE3) None Invitrogen 
BL21(DE3) pLysS Chlormaphenicol Invitrogen  
DH5α None Invitrogen 




Almost all E. coli cell lines from Table 2.7 were sourced from Invitrogen, a subsidiary 
of Thermofisher. Origami™ (DE3) was sourced from the Day Lab of the Biochemistry 
Department at the University of Otago.  
 




pET-21a+ with A. thaliana PCO1 Ampicillin GenScript 
pET-21a+ with A. thaliana PCO2 Ampicillin GenScript 
pET-21a+ with A. thaliana Δ2-51 PCO1  Ampicillin GenScript 
pET-21a+ with A. thaliana Δ2-51, Δ247-293 
PCO1 
Ampicillin GenScript 
pET-21a+ with Z. mays PCO2 Ampicillin GenScript 
pET-21a+ with Z. mays Δ1-32 PCO2 Ampicillin GenScript 
pET-21a+ with O. sativa Δ1-34 PCO2 Ampicillin GenScript 
pET-24d+ Kanamycin Poulter Lab  
 
All constructs were purchased in pET-21a+ plasmids (Table 2.8). Plant origin and 
isoform is stated for each construct. All constructs were optimised for E. coli codon 
usage. Proteins with ΔX-X denotes what residues were removed for shortened constructs. 
The plasmid pET-24d+ (Table 2.8) was sourced from the Poulter Lab of the 





Table 2.9 Antibiotic stocks. 
Antibiotic Preparation (1000 ×) Working concentration 
Ampicillin (amp) 1 g of amp powder 
10 mL of water 
100 µg/mL 
Chloramphenicol  0.5 g of chloramphenicol 
powder 
10 mL of 100 % ethanol 
50 µg/mL 
Kanamycin (KAN) 0.5g of KAN powder 
10 mL of water 
50 µg/mL 
 
Details on antibiotic stock preparation can be found in Table 2.9.  
 
Supplier details 


























New England BioLabs, Inc. (NEB) 
USA. 
NZ Distributor: Genesearch Pty Ltd 
Website: www.genesearch.co.nz 
Email: orders@genesearch.co.nz 
GE Healthcare Ltd. USA. 
Website: www.GEhealthcare.com 
Email: sales.nz@ge.com 
Rigaku Corporation, Japan. 
Website: www.rigaku.com/en 
Email: info@rigaku.com 
Genscript Biotech, USA. 
Website: www.genscript.com 
Email: info@genscript.com 
Roche Ltd. NZ. 
Website: www.roche.co.nz 
Email: nz.info@roche.com 
Gold Biotechnology, Inc. USA. 
Website: www.goldbio.com 
Email: contactgoldbio86@goldbio.com 
Scharlau Chemie, Spain. 
Website: www.scharlab.com 
NZ Distributor: Chem-Supply 
Email: sales@chemsupply.com.au 







Hoefer Inc. USA. 
Website: www.hoeferinc.com 
Email: sales@hoeferinc.com 





Honeywell Riedel-deHaën. Germany. 
Website: www.riedeldehaen.com 
Email: RCC@honeywell.com 
Thermofisher Scientific. NZ Ltd. NZ. 
Website: www.thermofisher.co.nz 
E-mail: NZinfo@thermofisher.com 
IBA Lifesciences, Germany.  
Website: www.iba-lifesciences.com 
Email: info@iba-lifesciences.com 
TTP LabTech, UK. 
Website: www.ttplabtech.com 
Email: discover@ttplabtech.com 
Lab Supply, NZ. 
Website: www.labsupply.co.nz 
Email: info@labsupply.co.nz 
VWR International. USA. 
NZ Distributor: Global Science 
Website: www.bio-strategy.com 
E-mail: sales@globalscience.co.nz 
Wyatt Technology, USA. 




2.2 DNA work 
All DNA sequencing was performed by Genetic Analysis Services, based at the 
University of Otago. Primers used were purchased T7 forward and reverse primers. Much 
of the work within this section uses methods adapted from Sambrook et al., (1989). 
 
  DNA buffers 
Tris Acetate-EDTA (TAE) buffer (50×) 
242 g tris base 
57.1 mL acetic acid 
100 mL of 0.5 M EDTA (pH 8) 




This buffer was used in the preparation of agarose gels, as well as the gel running buffer. 
 
Agarose gel (1%) 
0.5 g agarose  
50 mL 1× TAE buffer 
 
DNA gel sample buffer (6×) 
25 mg bromophenol blue 
25 mg xylene cyanol FF 
2.5 g sucrose  
7 mL water 
 
  Plasmid design 
Synthetic plant CDO genes were purchased from GenScript with a C-terminal Strep-
Tag® II within expression plasmid, pET-21a+. Strep-Tag® II is a synthetic octapeptide 
(Trp-Ser-His-Pro-Gln-Phe-Glu-Lys) with an intrinsic affinity toward Strep-tactin® resin, 
which contains an active group consisting of engineered streptavidin (refer to 2.4.2). 
 
Constructs ordered consisted of full length PCO1 (At5g1512) and PCO2 (At5g3989) 
from A. thaliana. Shortened constructs of A. thaliana PCO1 were ordered which had 
residues 2-51 removed for one construct, and these residues alongside residues 247-293 
removed for the second construct. A predicted PCO2 isoform from Zea mays (maize) 
was ordered as a full length construct. Shortened constructs from maize and Oryza sativa 
(rice) were ordered with residues 1-32 and 1-34 removed respectively. These constructs 
also had restriction sites which could permit the removal of the Strep-Tag®, and 
subsequent addition of a hexa-histidine tag.  
 
As plasmids arrived lyophilised, tubes were centrifuged at 6000 g for 1 min at room 
temperature. Subsequently 20 μL of Tris-EDTA (TE) buffer was then added and the 




  Plasmid purification  
All plasmids were amplified and purified following transformation into DH5α cells. In a 
growth tube, 5 mL of 1× LB was inoculated with a single colony from the transformation 
using a wire loop, and the appropriate stock antibiotics were added. This was incubated 
overnight (16-20 h) at 37°C on a shaker at 200 rpm. Three millilitres of overnight culture 
was centrifuged down 1 mL at a time, and preparation was carried out using an Omega 
bio-tek ENZA® plasmid mini kit I as per the kit instructions. The wash step was repeated, 
and 40 μL of elution buffer was added. This was left to incubate for 30-40 min before 
the final elution. 
 
  Horizontal TAE agarose gels   
Agarose was prepared by heating the solution in the microwave for around 1 min (until 
bubbling), then 2.5 μL of 10 mg/mL ethidium bromide was added. The solution was 
swirled and let to cool for approximately 5 minutes before being poured in the Bio-Rad® 
gel caster. The comb was added once it was poured, and any bubbles were removed using 
a sterile pipette tip. Once set, (around 20 min later) the comb was removed, running 
buffer was added and samples were loaded.  Gels were run at 100 V for 45 min, and 
imaged on a BioRad® Gel Doc system. The ladder used was BioRad® 1 kb plus, which 
was prepared as per the manufacturer’s instructions. 
 
2.3 Bacterial Growth  
  Bacterial work reagents 
Lysogeny broth (LB) (1×)  
1% (w/v) peptone 
1% (w/v) sodium chloride  
0.5% (w/v) yeast 
 
This was dissolved in water, and autoclaved before use. 
 
Agar plates 




Stock antibiotics were added to plates once the liquid agar had cooled to a temperature 
of 45-50°C. Plates without antibiotics could be poured without the need for cooling. 
Plates were poured under flame for sterility. 
 
  Competent cell preparation 
In a growth tube, 5 mL of 1× LB was inoculated using either glycerol stocks which were 
scraped with a sterile toothpick whilst still frozen, or inoculated using 50 μL of thawed 
competent cells. The appropriate antibiotics for each bacterial strain were added. This 
was left overnight at 37°C on a 200 rpm shaker.  
 
A 250 mL flask containing 50 mL of 1× LB was inoculated with 500 μL of the overnight 
culture, and again, the appropriate antibiotics were added. This was incubated at 37°C on 
a 200 rpm shaker until an optical density (OD) reading at 600 nm had an absorbance 
value of approximately 0.5-0.6. The culture was removed from the shaker and 
immediately transferred to an ice bath. 
 
The culture was poured into a pre-chilled 50 mL Falcon tube and centrifuged at 4°C, and 
3220 g for 5 min. The supernatant was discarded and the pellet resuspended in 25 mL of 
ice cold 0.1 M calcium chloride. This was incubated in an ice slurry for 30 min, then 
centrifuged again (4°C, 3220 g for 5 min). Supernatant was again discarded and the pellet 
was resuspended in 2 mL of 0.1 M calcium chloride 20% glycerol. Two-hundred 
microlitres of cells were dispensed into 1.7 mL microcentrifuge tubes before being snap 
frozen using methanol and dry ice. Cells were stored at -80°C until required. The method 
was derived from Dagert and Ehrlich (1979). 
 
  Transformation 




Transformation begun with adding 0.5 or 1 μL of stock plasmid to 1.7 mL 
microcentrifuge tubes, followed by the addition of between 50 and 100 μL of competent 
BL21 (DE3) E. coli cells. DH5α, BL21(DE3) pLysS and BL21(DE3) origami strain 
38 
 
E. coli cells were also used for certain preparations. This was then incubated on ice for 
30 min. Samples were subjected to a 42°C heat block for 45 s before being put back on 
ice for 2 min.  LB was added (500 μL of 1×) and all tubes were again incubated, this time 
on a 200 rpm shaker at 37°C for 60 min. Samples (100 μL of each) were then spread on 
agar plates with the appropriate antibiotics, using a sterilised spreader. Plates were 
inverted then left at 37°C overnight. All work was conducted under flame for sterility, 
and used aseptic technique. Positive controls were produced by plating stock cells on 
antibiotic free agar to confirm cell viability. Negative controls were produced by plating 
stock cells on agar that contained the selective antibiotic. This insured that all colonies 
on the selective media contained the plasmid of interest.  
 
Electro-competent  
Once the competent cells (prepared by Malcolm Rutledge) had thawed on ice, 0.5 μL of 
plasmid was combined with 50 μL of competent cells. This was incubated on ice for 15 
min, then the cells were transferred to cuvette and electroporated. One mL of 1× LB was 
added immediately, and the cells were transferred to a microcentrifuge tube for a 60 min 
incubation on a 200 rpm shaker at 37°C. Samples were spread as per chemical 
transformation. Again, both positive and negative control plates were produced, and all 
work was conducted under a flame where possible.  
 
  Induction of protein expression 
An overnight culture (generally 50 mL of 1× LB media with 50 μL of the appropriate 
antibiotic) was inoculated with a single colony from a recent transformation. The newly 
inoculated media was then left to incubate overnight shaking at 200 rpm at 37°C. 
Inoculation was performed aseptically.  
 
Large scale expression was then conducted using one of two platforms, either a fermenter 
(10 L) or in 2 L baffled flasks (each flask contained 1 L of culture). Smaller scale 
expressions were used for expression trials. Flask volumes here were 100-125 mL in 250 
mL flasks and volumes of culture, were scaled appropriately, concentration of antibiotics 
and IPTG kept constant. During expression trials, expression was conducted at 18, 28 or 




The New Brunswick SF-116 Microgen fermenter was heat sterilised while containing 8 
L of distilled water. Once sterilised, the temperature was dropped to 37°C and 2 L of 
sterile 5× LB was added to the 8 L of sterilised distilled water to make 10 L of 1× LB. 
For this volume, and when using pET-21+ expression vectors with BL21(DE3) cells, 
amp was added followed by 100 mL of overnight culture. One millilitre of sterile 
Antifoam A concentrate was then pipetted into the fermenter. This was left at 37°C with 
the sparger set at 1-2 L/min aeration, and the agitator at 400 rpm until an OD600 of 0.6-
0.7 was reached. The culture was cooled to 18 or 28°C before 1 mL of 1 M IPTG was 
added to a final concentration of 100 μM. The culture was left stirring at 400 rpm, and 
the sparger was set at 1-2 L/min aeration for 6 h.  
 
To express in flasks, 1 L of 1× LB was sterilised in baffled 2 L flasks. Flasks were stored 
at 37°C overnight before use to bring the broth to temperature for bacterial growth. Ten 
millilitres of overnight culture was used to inoculate each flask, alongside the addition of 
the appropriate antibiotics for selectivity. Flasks were left at 37°C on a 200 rpm shaker 
until an OD600 of 0.6-0.7 was reached. Flasks were moved to the expression temperature 
(either 18, 28 or 37°C depending on the protein), induced with 1 mL of 1 M IPTG and 
incubated for 6 h. 
 
Cells were pelleted using 1 L centrifuge bottles in the Beckman-Coulter standing 
centrifuge with the JLA-8.1 rotor. The samples were centrifuged at 4°C and 6000 g for 
15 min. The pellet was stored in a plastic bag at -20 °C until required.  
 
Expression with iron  
In an attempt to increase iron bound to the protein post-purification, changes were made 
to the expression protocol. Here, four 2 L flasks containing 400 mL of 1× LB were 
prepared. An iron (III) chloride stock (80 mM) was prepared, and used at a final 
concentration of 200 μM. The iron supplement was added immediately before 
incubation, and this flask was induced with 100 μM IPTG. The other 3 cultures were 
used to test varying IPTG concentrations, inducing with 100, 1 and 0.1 μM once an OD600 
of ~0.6-0.7 was reached. All cultures were left to express for 6h at 18°C before being 
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pelleted by centrifugation. Expression levels were analysed via SDS-PAGE. Each pellet 
was subsequently subjected to protein purification and assessment of iron occupancy.  
 
2.4 Protein work  
  Protein work buffers 
All purification buffers for use with the ÄKTA™ pure were filtered through 0.2 μM 
cellulose acetate membranes and degassed before use.  
 
Cell lysis buffer (1×) 
4.1 mL 10× strep wash buffer 
203 μL TWEEN® 20  
660 μL 300 mM DTPA 
22.7 mL water  
1 × cOmplete™, Mini, EDTA free Protease Inhibitor Cocktail  
 
Strep-Tactin® wash buffer (1×) 
100 mM tris pH 8 
150 mM sodium chloride 
1 mM EDTA 
 
High salt Strep-Tactin® wash buffer (1×) 
400 mM tris pH 8 
150 mM sodium chloride 
1 mM EDTA 
 
Strep-Tactin® elution buffer (10×) 
1 M tris  
1.5 M sodium chloride 
10 mM EDTA  
20 mM biotin 
 




Bench top regeneration buffer (1×) 
HABA was mixed from a 10 × stock purchased from IBA.  
 
ÄKTA™ regeneration buffer (1×) 
0.5 M sodium hydroxide 
 
Refolding buffer (2×) 
40 mM tris pH 8  
1 cOmplete EDTA free protease inhibitor tablet  
200 μM ammonium iron (II) acetate 
0.8 M L-arginine  
 
This buffer should be prepared immediately before use to prevent iron (III) formation, 
and to ensure optimal activity of protease inhibitors.  
 
SDS-PAGE buffers  




1.25 mL 0.5 M tris pH 6.8 
0.667 mL 30% acrylamide/Bis solution 37:5:1 
50 μL 10% (w/v) SDS 
3.033 mL water 
50 μL 10% (w/v) APS 
5 μL TEMED 
 
Stacking gel 
2.5 mL 1.5 M tris pH 8.8 
4 mL 30% acrylamide/Bis solution 37:5:1 
100 μL 10% (w/v) SDS 
3.4 mL water 
100 μL 10% (w/v) APS 




SDS-PAGE running buffer (1×) 
195 mM glycine 
50 mM tris 
1% (w/v) SDS 
 
SDS-PAGE sample buffer (5×) 
60 mM tris pH 6.8 
2% (w/v) SDS 
0.1% (w/v) bromophenol blue 
32.5% (v/v) glycerol 
5% (v/v) BME 
 
SDS-PAGE marker preparation (1×) 
5 μL of stock Bio-Rad® broad range molecular weight marker 
20 μL 5× sample buffer 
75 μL sterile water 
 
After combining materials, samples were boiled at 95 °C for 15 min and centrifuged at 
13000 g for 1 min. Aliquots (5.2 μL) were prepared and frozen at -20 °C for later use.  
 
Coomassie Blue stain (1×) 
250 mL propan-2-ol 
100 mL acetic acid 
0.5 g Coomassie Brilliant Blue R250 
 
This was made up to 1 L using water, and filtered through 0.2 μm Whatman paper.  
 
Destain (1×) 
100 mL propan-2-ol 
140 mL acetic acid 
50 mL glycerol 




  Homogenisation and lysis 
A cell pellet was resuspended in 1× cell lysis buffer before being homogenised using a 
glass homogeniser (30 mL of lysis buffer was used per 10 g of pellet). This was followed 
by sonication to disrupt cell membranes using a Sonifier® at 40% amplitude; 1 s interval 
pulsing for 30 s to 5 min. This was followed by centrifugation at 4°C and 6000 g for 10-
45 min. Purification then continued on one of two platforms, a bench top method that 
uses gravity flow or using FPLC on an ÄKTA™ pure.  
 
  Syringe purification  
Purification harnesses the Strep-Tag® present on the protein as it binds to Strep-Tactin® 
Sepharose® resin with high affinity (Figure 2.1). For further details on Strep-Tag® 
purification see (Skerra and Schmidt, 2000; Schmidt and Skerra, 2007). After 
homogenate centrifugation, supernatant was bound to Strep-Tactin® Sepharose® resin 
(new resin was washed with 1× Strep-Tag® wash buffer before use). The supernatant 
was incubated with the resin on a rotating wheel  at 30 rpm, 4°C for 30 minutes. This 
was then washed twice using 1× Strep-Tag® wash buffer. Protein was eluted using 1× 
Strep-Tag® elution buffer, the active component of which is desthiobiotin. As the resin 
has a higher affinity for desthiobiotin than the Strep-Tag®, protein was eluted from the 
column. 1× HABA was used to regenerate the column by removing anything still bound 
to the resin, as the resin has an even higher affinity for this compound. HABA is removed 
by washing the resin with 1.5 M Tris pH 10.5 as the high pH interferes with the HABA-
resin interaction. Flow-through can then be reapplied to the column if necessary. This 





Figure 2.1. Schematic of Strep-affinity method. Recombinant proteins (green sphere) 
with the Strep-tag® bind Strep-Tactin resin (purple spheres) whilst host proteins are 
washed out. Desthiobiotin (black tear drop) permits elution of the protein of interest as it 
has a higher affinity for the resin than the Strep-Tag®. HABA (4'-hydroxyazobenzene-
2-carboxylic acid, orange/red square) is then used to regenerate the resin as it disrupts 
desthiobitin. HABA is removed by increasing the pH of the wash buffer. Taken from 
Schmidt and Skerra (2007). 
 
  FPLC purification  
Once centrifugation of homogenate was complete, the supernatant was filtered using 
0.45 μM ReliaPrep™ syringe filters. This was then applied to a 5 mL StrepTrap™ 
HiTrap™ column. At all times the flow rate was set at 5 mL/min. 
 
The column was prepared by washing with at least 5 column volumes (CV) of water until 
the conductivity and UV absorption stabilised. The column was then equilibrated with 
5 CV of 1× Strep-Tactin® wash buffer. Sample application occurred either with a sample 
pump (volumes of greater than 4 mL) or using a static loop. Once the sample had been 
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applied, 10 CV of 1× Strep-Tactin® wash buffer was run through the column. Protein 
was eluted using 1× Strep-Tactin® Elution buffer for 6 CV. Fraction sizes were generally 
2 mL.  
 
Column regeneration begun by washing the column with 5 CV of water, followed by 5 
CV of 0.5 M sodium hydroxide. This was washed again with 5 CV of water, or until the 
conductivity and UV absorption stabilised. The column was often then used for further 
purification. If the column was to be stored, it was washed with 20% ethanol until the 
conductivity and UV absorption stabilised. The column was stored in 20% ethanol at 
4°C. The method was derived from GE Healthcare Life Sciences Recombinant Protein 
Purification Principles and Methods handbook. 
 
  Dialysis and concentrating  
Once protein was eluted from bench top columns, or in fractions from the FPLC, it was 
dialysed using SnakeSkin 10,000 molecular weight cut off (MWCO) 22 mm inner 
diameter dialysis tubing. Dialysis was against 20 mM Tris and 50 mM NaCl at pH 8 in a 
3 L container with a stirring flea. Approximately 3 buffer changes occurred, at least 2 
hours apart but at times overnight. The method was adapted from Bollag et al. (1996). 
 
Dialysed protein was concentrated using 10 kDa Amicon® Ultra spin filters of various 
volumes (0.5, 6 and 15 mL). Membranes were first wet by running a small volume of 
water through the filter. The sample was then applied, and centrifuged at 4°C until the 
desired final volume was met. Purified and concentrated protein samples were snap 
frozen in liquid nitrogen and stored at -80°C. Protein concentration was determined using 
the NanoDrop spectrophotometer which scanned wavelengths between 220 and 360 nm. 
The absorbance value at 280 nm was recorded and used with the predicted extinction co-
efficient for each protein as determined by Expasy (see 2.8.3). Results from the 




  Gel filtration chromatography 
This type of chromatography separates proteins based on size. The column matrix 
consists of hollow beads with varying channel sizes that act as a ‘molecular sieve’. For 
further detail about this technique see Hagel (2001).  
 
Superdex 75 
In an attempt to separate CDO and the co-purifying chaperones, gel filtration was used. 
Two millimolar adenosine triphosphate (ATP) was added to the protein sample, and this 
was incubated on ice for 15 min. This sample was then applied to a HiLoad 16/60 
Superdex 75 column which had been equilibrated with filtered and degassed 50 mM 
sodium chloride, 20 mM tris-HCl pH 8 buffer. The gel filtration was also conducted with 
this buffer with a flow rate of 1 mL/min.  
 
A second gel filtration was conducted with varying sample preparation. In this instance, 
the protein was prepared by dialysing overnight using a Slide-A-Lyzer in 3 mM EDTA, 
50 mM NaCl and 20 mM Tris-HCl pH 8. A single buffer change occurred as the same 
volume was only 3 mL and the dialysis buffer volume was 3 L. A charcoal slug was 
present during dialysis to remove excess ions chelated by EDTA or nucleotides. This 
sample was then loaded on the Superdex 75 with the same buffer and flow rate as the 
previous protocol.   
 
Superdex 200 
This was run to determine if purified protein was forming larger complexes or 
aggregating. The column was run in 20 mM Tris pH 8 and 50 mM sodium chloride with 
a flow rate of 1 mL/min. Once equilibrated with this buffer, 1 mL of purified PCO1 
protein was added to the column. Fractionation volume was 2 mL and samples were run 
on a gel once eluted.  
 
  Cation exchange chromatography 
First, a Dnase I digestion was conducted using 1 μL of a 1 mg/mL Dnase I stock and 20 
mM magnesium chloride. This was left to incubate at room temperature (RT) for 1h. The 
cation exchange column employed was an SP HP 5 mL HiTrap. The high salt buffer 
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consisted of 50 mM HEPES pH 7, 1 M sodium chloride, whilst the low salt buffer 
consisted of 50 mM HEPES pH 7, 10 mM sodium chloride. The flow rate was 1 mL/min. 
 
The column was washed with water, followed by low salt buffer. The gradient of high 
salt buffer was then increased until the column was completely in the high salt buffer. A 
blank run was conducted to ensure the column was clean and establish the population of 
counter ions on the resin. After this, the protein sample was loaded onto the column and 
the same protocol run again. Peak fractionation was selected, and fractions were 1.8 mL 
in size.   
 
  SDS-PAGE  
Protein gels were traditional Laemmli-style which were cast and run using a Hoefer 
electrophoresis system. APS and TEMED were added immediately before pouring the 
resolving and stacking gel. Approximately 1 mL of propan-2-ol was pipetted on the top 
of the freshly poured resolving gel. The isopropanol was washed out with water once the 
gel was set and excess water was blotted with paper towels before the stacking gel was 
then poured. Combs were then added. Gels were stored at 4°C for up to 2 weeks before 
use. This method is derived from Bollag et al. (1996).  
 
All samples were prepared with a 1 in 5 addition of 5× loading dye and boiled at 95°C 
for at least 5 min prior to loading (unless stated otherwise). Gels were run in 1× SDS-
PAGE running buffer at 100 V until the dye front had run through the stacking gel, and 
at 200 V thereafter for approximately 45 min. Once the dye front had run off, gels were 
stopped and transferred to Coomassie Blue stain. After 2 hours, the Coomassie Blue stain 
was removed, the gel was washed with water and destain was added. Destain was 
removed once bands were visible and background stain was no longer present. Gel 
pictures were taken using LabScan.  
 
  Solubility testing  
Before large scale expression and purification occurred, smaller scale trials were 
performed. Once samples were produced (2.2.2 and 2.2.3), and expression levels were 
evaluated using SDS-PAGE (2.4.8), conditions with promising results were subjected to 
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solubility testing. This was to ensure that the resulting protein was soluble in those 
conditions. 
 
Testing begun by centrifuging 1 mL samples at 13000 g for 5 min at 4°C. Supernatant 
was discarded, and the pellet was resuspended using a micropestle in 500 μL of 100 mM 
sodium phosphate buffer pH 7.2. Cells were lysed using sonication for 30 secs, 30% 
amplitude, pulsing at 1 sec intervals, using a Sonics VibraCell with a microtip. A 30 μL 
sample of each homogenate was kept for SDS-PAGE analysis, and the rest of the samples 
were spun at 13000 g for 5 min at 4°C. A 30 μL sample was taken of each supernatant, 
and pellets were resuspended in 440 μL of 100 mM sodium phosphate buffer pH 7.2. A 
20 μL sample was taken of all pellets, and samples were run on SDS-PAGE to analyse 
results. Gel samples were prepared by combining 30 μL of each sample with 7 μL of 
loading dye, and 15 μL of this was loaded onto the gel.  
 
  Improving protein solubility during lysis  
For the N-terminal truncation of the maize PCO2, six additional lysis conditions were 
trialled for effect on solubility of expressed protein: regular lysis buffer (2.4.1), regular 
lysis buffer with 400 mM sodium chloride or 125 mM L-arginine, 100 mM sodium citrate 
pH 4 and 5 or 100 mM Tris pH 7.1 all with 300 mM sodium chloride and 0.7% TWEEN® 
20. Five-hundred microlitres of each buffer was used to resuspend 6 samples of ΔN 
Maize pellet. Samples were then prepared as stated in 2.4.9.   
 
 Improving protein solubility post-purification   
Six tubes were prepared with 60 μL of freshly purified protein, and a range of reagents 
were added at varying concentrations. They are as follows (final concentration listed): 
ammonium iron (II) acetate 200 μM, sodium chloride 0.4 M, TWEEN® 20 0.7%, BME 
100 μM, magnesium chloride 200 mM and DTPA 2 mM. Each sample was left to 
incubate on ice for 15 min before being centrifuged at 10000 g and 4°C for 5 min. The 




  Refolding assay  
Stock protein was prepared by combining 70 μL of 150 μM PCO1 with 98 μL of 2× 
refolding buffer. The stock solution was then split by adding 40 μL to 4 microcentrifuge 
tubes. Different ratios of oxidised to reduced glutathione were then employed (stock 
GSSG and GSH concentrations were 50 mM). Tube 1 add: 5 mM GSSG, 0.5 mM GSH, 
tube 2: 5 mM GSH, 0.5 mM GSSG, tube 3: 2 mM GSSG, 2 mM GSH and tube 4: no 
glutathione control. Potassium chloride was added to all tubes for a final concentration 
of 62.5 mM. Samples were incubated at 4°C overnight on a vortex with low speed 
shaking.  
 
  TCA precipitation  
Inducing protein precipitation helps one determine if protein is present within a sample, 
even if the amount of protein present is very low.  This is because the protein can be 
pelleted and resuspended in a smaller volume for analysis. To begin, samples were 
brought up to a volume of 1 mL. One hundred microlitres of 100% TCA was added to 
each tube and the samples were vortexed. The samples were incubated at -20°C for 20 
min, then spun at 10000 g for 5 min. The supernatant of each sample was removed, and 
all pellets were resuspended in 20 μL of 0.1 N sodium hydroxide. The resuspension was 
run on a gel.  
 
When the protein concentration is predicted to be below 5 μg/mL (the sensitivity of the 
TCA precipitation), but greater than 1 μg/mL a variation of the TCA precipitation can be 
employed. Once the sample was brought up to 1 mL, 100 μL of 0.15% DOC was added 
and the tube vortexed. Incubation occurred at RT for 10 min, then 50 μL of 100 % TCA 
was added, the tube was vortexed and the instructions were followed from the TCA 
addition as specified above. Both methods were taken from Bollag et al. (1996). 
 
  Dynamic light scattering (DLS) 
DLS instruments are used to determine particle size and distribution in solution. One 
hundred microlitres of 2 mg/mL protein solution was prepared. Protein concentration was 
judged by absorbance at 280 nm, and SDS-PAGE gels. Protein was centrifuged at 
13000 g and 4°C for 30 min. Water used as a control was spun down in the same way. 
50 
 
The cuvette used in the machine was cleaned thoroughly with 20% ethanol followed by 
water. Once rinsed, 80 μL was added to the cuvette, the cuvette exterior was wiped clean 
with lint free tissues and data were recorded for 4 min at RT. Results were then assessed 
and recorded.  
 
2.5 Crystallisation  
  High throughput screening 
Before high throughput screening, pre-screens were conducted. This is used to evaluate 
whether or not large scale screening would be worthwhile with the protein preparation. 
The PCT™ Pre-Crystallization Test produced by Hampton Research was used, and the 
manufacturer’s instructions were used to perform the test.  
 
Many high-throughput screens were used for initial crystal screening. This includes: 
Hampton Research HT, PEG/ion HT, PEGRx HT, JCSG Plus and PACT Premier 
screens. Protein preparation for crystallography varied. Stock protein concentration was 
using 5 mg/mL and a range of different metals including nickel, cobalt and iron were 
added to the stocks with varying stoichiometry. Peptide substrate was also included in 
some of the protein stocks used for setting up plates.  
 
To set up screens, 25 μL of each solution was added to the reservoirs of a Swissci MRC 
3 drop 96 well plate. TTP Labtech’s Mosquito® liquid handling robot was used for 
protein and solute addition. Generally, the drop sizes were approximately 600 nL and 
each of the three drops had varying ratios of well solution and protein.  All drops prepared 
using the Mosquito® were sitting drops and employed vapour diffusion. Drops were 
imaged using the daily/weekly/nightly schedule of the Rock Imager® software. Images 
were taken using visible light, UV light and under cross polarised conditions.  
 
  Varying condition plates 
Any drops that showed interesting results with commercial screens were attempted to be 
reproduced using lab reagents. Conditions of interest were not only copied but varied in 
an attempt to form crystals or try improve crystallisation. Factors that were varied were 
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generally buffer pH range, and concentration of precipitant. A Morpheus® additive 
screen was also used by adding it to a condition of interest at a concentration of 10% v/v.  
 
Both 24- and 96-well plate formats were used. Twenty-four well plates were prepared 
manually and the drop size was 1 μL of protein mixed with 1 μL of the solute of interest. 
The Mosquito was used to set up 96-well plates with conditions of interest. The 24-well 
varying plate solutions were prepared on the plate, whist 96-well plates were prepared 
on a separate 96-well plate so excess could be prepared. Twenty-four well plates used a 
hanging drop vapour diffusion technique, whilst the 96-well plate format used sitting 
drop vapour diffusion.  
 
  Mounting crystals 
Any crystals that were formed and were of a large enough size were attempted to be 
mounted. A range of loop sizes were used, but generally those smaller than 100 μm. 
MiTeGen MicroLoops™ were the preferred style. Both RT and frozen crystals were 
prepared for assessment on the Otago University Biochemistry Department home source. 
At room temperature, plastic sleeves (Mitogen) were used to minimize evaporation. 
Crystals were frozen by plunging into liquid nitrogen immediately after mounting in 
loops. All crystals that were taken to the Australian synchrotron were frozen. Addition 
of cryoprotectant was always considered, with 10-20% glycerol generally being used 
when required.  
 
  X-ray diffraction 
At the University of Otago Biochemistry department, crystals were manually placed on 
the goniometer and aligned. Single-crystal diffraction data was collected using Cu Kα 
radiation at the University of Otago (see Table 2.6 for details of equipment). At 93 K 
and a wavelength of 1.542 Å, 140 images were collected at an exposure time of ten 
minutes, using a detector distance of 250 mm.  
 
At the Australian Synchrotron the MX2 beam-line was used for crystal screening. MX2 
featured a silicon double-crystal monochromator and an Eiger direct detector. Radiation 
of wavelength 0.9537 Å (13 keV), usual exposure, 1 second/degree of oscillation and 
beam attenuation of 80%.  The detector was set 250 mm from the crystal. A crystal 
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mounting robot placed bases with mounted crystals on the goniometer. Blu-Ice software 
was used to direct a crystal mounting robot orientate the crystal and direct data collection.  
 
2.6 Assays 
  Ellman’s assay 
Ellman's reagent  
23.1 mg DTNB 
2.9 mg EDTA 
50 mL of 100 mM sodium phosphate at pH 7.5 
 
The substrate of plant CDO contains an N-terminal cysteine, which is characterised by a 
thiol group. This thiol group becomes dioxidised during catalysis, forming a sulfonyl 
group. Ellman’s assay measures free thiol groups which react with DTNB to form a 
coloured product (Figure 2.2). As the substrate of CDO contains a free thiol group, this 
assay reports substrate depletion. A standard curve is employed to determine unknown 
free thiol concentrations at a given absorbance (Figure 2.3). 
 
 In a 96 well plate, 97.5 μL of reagent was added to each well. Sample volume added to 
each well for varying time points was 2.5 μL. Sample addition to the Ellman’s reagent 
quenched the reaction. Assays were conducted in a dark box and samples taken every 2 
minutes for between 12 and 48 minutes. Samples were read at 412 and 750 nm on a 
MultiSkan GO 96-well plate spectrophotometer. Ellman’s reagent absorbs maximally at 
412 nm and 750 nm can show if there any air bubbles or other inconsistences in the 
samples. Data were analysed using Microscoft Excel and GraphPad prism. For further 
details of this assay, see Fellner et al. (2014). 
 
 
Figure 2.2. Ellman’s reaction. The presence of a free thiol (A) breaks the colourless 
DTNB (B) compound into a mixed disulfide (C) and yellow coloured 2-nitro-5-
thiobenzoate (TNB) product (D). Adapted from Nieri et al. (2017).  





Figure 2.3. L-cysteine standard curve. Line slope 0.0817 ± 0.0002. Graphed are three 
technical replicates, error bars representing standard error of the mean are shown but are 
not visible outside symbol. The standard curve reports the concentration of cysteine in 
the cuvette. 
 
  Ferrozine  
Ferrozine reagent  
200 μL 37 mM ferrozine 
200 μL 1.14 M ascorbic acid  
1 mL 2 M ammonium acetate pH 9 
 
Ammonium iron (II) sulfate stock (30mM) 
11.8 mg ammonium iron (II) sulfate 
1 mL water 
 
This was prepared fresh every time, as iron (II) is readily oxidised to become iron (III) 
in the environment.  
 
Chelex resin preparation  
A 50 mL falcon tube was filled to the 25 mL mark with resin. This was then topped up 
to 50 mL with 100 mM Tris-HCl pH 8 and the tube was shaken vigorously by hand many 
times. This was then spun at 3220 g for 5 min at room temperature, separating the beads 
and buffer. The buffer was poured off and the process was repeated twice. Once washed 
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three times, the beads were topped up to 50 mL with fresh 100 mM Tris-HCl pH 8 and 
stored up to 30 days at 4°C.  
 
The ferrozine reagent measures the presence of Fe2+ by binding and forming a coloured 
complex (Figure 2.4). It forms a stable, soluble complex with ferrous iron that absorbs 
strongly at 562 nm without a large influence from other divalent cations (Stookey, 1970). 
In this assay, a standard curve is employed to determine an unknown iron concentration 
at a given absorbance (Figure 2.5). For the preparation of samples, 5 μL of protein, 5 μL 
TRIS buffer (100 mM, pH 8) and 5 μL of concentrated sulphuric acid were combined. 
Samples were incubated at 97°C for 30 minutes, after which the samples were centrifuged 
at 4°C, 13000 g for 1 minute. After centrifugation, 140 μL of ferrozine reagent was added, 
samples were vortexed and centrifuged again. In a 96 well plate, 120 μL of each sample 
was added to each well and the results were read at 562 and 750 nm. Data was analysed 
using Microscoft Excel, and GraphPad Prism (version 7). This method follows that used 
previously in the Wilbanks Laboratory (Tchesnokov et al., 2012).  
 
  
Figure 2.4. Ferrozine compound. Nitrogen that chelate the ferrous iron are shown in 
red. Iron has four binding sites, so two of these molecules come together to co-ordinate 
the metal ion.  
 
Purified protein samples that required iron loading, had a stoichiometric amount of stock 
30 mM ammonium iron (II) sulfate added. This was added to the protein and was left to 
incubate on ice for 10 min. Samples were applied to chelex resin to remove all unbound 
iron. Within 0.2 μM spin filters pin filters, 1 mL of resin mix (1:1 resin to buffer) was 
spun until dry. The incubated sample was then added to the resin (usually no more than 





min at 4°C. Once the sample are loaded with iron, a ferrozine assay was performed to 
analyse the occupancy.  
 
 
Figure 2.5. Ferrozine standard curve. Line slope 0.00030 ± 0.000002. Graphed are two 
technical replicates, error bars representing standard error of the mean are shown. 
Standard curve does not account for dilution factor. 
 
  Limited proteolysis 
This was conducted to determine if there were poorly folded domains of PCO1 (Fontana 
et al., 2004). To begin, 60 μL of 200 μM PCO1 was aliquoted into 5 microcentrifuge 
tubes. Four microlitres of 1 mg/mL proteinase K was added to four tubes (one tube 
without proteinase K was included as a control), which were then mixed by inversion. 
Each sample was left to incubate for either 5, 20, 60 or 120 min.  
 
At the end of each incubation time, the reaction was quenched with 100 μL of TCA and 
was left at -20°C for greater than 20 min. Samples were centrifuged at 12500 g for 10 
min at 4°C. The supernatant was discarded and the pellet was resuspended in 100 μL of 
100% ethanol. Centrifugation was repeated at the same specifications and again the 
supernatant was discarded. The pellet was left to dry at 65°C for 5 min with the 
microcentrifuge lid open for evaporation. After drying, the pellet was resuspended in 20 
μL of 5× SDS sample buffer and 0.450 μL of 1 M sodium hydroxide to adjust the pH. 




2.7  Nuclear Magnetic Resonance (NMR) 
Spectroscopy  
  1H NMR spectroscopy  
A 10 mM L-cysteine and 15 μM plant CDO sample was prepared by incubation for 2 h 
at room temperature. Standard samples of L-cysteine, cystine, Tris and CSA at 10 mM 
were also prepared. All samples were in 100 mM sodium phosphate at pH 7.2, with H2O 
as the solvent. Once the samples were loaded, 1H NMR was conducted using a 500 MHz 
magnet. Trimethylsilylpropanoic acid (TSP) was used as the reference and solvent 
suppression was conducted using pre-saturation.  
 
2.8 Computational work 
 Bioinformatics  
To formulate multiple amino acid sequence alignments Clustal Omega 
(www.ebi.ac.uk/Tools/msa/clustalo) was used, employing the function clustal w/ 
numbers (Sievers et al., 2014). The protein basic local alignment search tool (blastp) 
(blast.ncbi.nlm.nih.gov/Blast.cgi) was used to find similar amino acid sequences from an 
extensive database (Altschul et al., 1990). FASTA format was used to input sequences 
for both sites (Lipman and Pearson, 1985). The uniprot sever (www.uniprot.org) was 
used to search for protein sequences using only the gene or protein name (Consortium, 
2017).   
 
 Modelling  
Both swiss-model (swissmodel.expasy.org) (Arnold et al., 2006) and iterative threading 
assembly refinement (I-TASSER) (zhanglab.ccmb.med.umich.edu/I-TASSER) (Zhang, 
2008) were used to create homology models. Both sites are fully automated, and use 
similar protein sequences and structures as a model. No templates were specified and 
FASTA format was used to input sequences for both sites.  
 
UCSF-chimera software was used for the visualisation and analysis of homology models 
(Pettersen et al., 2004). Ribbon diagrams were mainly produced, with some surface 
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topology analysis. Commands were also used to permit the mapping of surface charge 
residues, and the mapping of surface hydrophobicity. 
 
 Protein sequence-based prediction 
To predict general characteristics based solely on amino acid sequence Expasy 
ProtParam (web.expasy.org/protparam) (Gasteiger et al., 2005) was used. This tool 
computes a pI, molecular weight and other physical and chemical parameters. Predictor 
of Natural Disordered Regions (PONDR) (www.pondr.com) VLXT function (Obradovic 
et al., no date) was used to determine the likelihood and protein instability and disorder. 
This was based on known disordered proteins and their sequences.  Secondary structure 
was predicted using PSIPRED v3.3 (bioinf.cs.ucl.ac.uk/psipred) (Buchan et al., 2013) 
with raw amino acid sequence as the input. This software uses known protein sequences 
and structures to determine the likelihood of secondary structure elements within the 
given protein sequence. Scanning the amino acid sequence for predicted motifs (based 
off known sequence motifs) was conducted using  Expasy ScanProsite 
(prosite.expasy.org) (Sigrist et al., 2012). Motifs with a high probability of being present 
were excluded.  
 
  Plasmid sequencing  
Plasmids that were sequenced (sequencing done by GAS at The University of Otago), 
were examined using 4Peaks software. Sequence quality was visually assessed and the 
nucleotide  sequence was copied into the Expasy translate tool 
(web.expasy.org/translate). This tool converts nucleotide sequences to amino acid 
sequences. The amino acid sequence could then be compared to the proposed sequence 
using either a pBLAST search (2.8.1) or a direct comparison using clustal omega (2.8.1). 
If the reverse primer sequence was being analysed, the raw nucledotide sequence was 
converted to the reverse complement (www.bioinformatics.org/sms/rev_comp) 
(Stothard, 2000) before being translated from a nucleotide to amino acid sequence.  
 
  Other 




2.9 Mass spectrometry (MS) 
All equipment and chemicals listed below are not found in the materials section as they 
were provided by the centre for protein research (CPR) at The University of Otago. All 
work was conducted by the CPR unless stated otherwise.  
 
 Identification of proteins 
To identify bands from SDS-PAGE, trypsin and/or chymotrypsin digestions were 
performed using automated liquid handling. Liquid chromatography mass spectrometry 
(LC-MS) was used as it allows for physical separation based on size (LC), followed by 
determination of fragment size using a mass spectrometer. This protein profiling at the 
CPR uses an UltiMate™ 3000 RSLCnano ultra-high performance liquid chromatography 
(uHPLC) system inline coupled to nanospray LTQ-Orbitrap XL™ mass spectrometry. 
Once fragments were identified, protein identification was done using sequence data-
base dependent search engines, including MASCOT and SEQUEST.  
 
To determine N-terminal truncation sites of the full length maize construct, N-termini 
were tagged in gel using sodium cyanoborohydride to dimethylate N-termini (lysines will 
also be dimethylated). After in gel N-terminal labelling of peptides, tryptic digestion was 
used to produce peptide fragments. Once fragmented, peptides were identified using 
liquid chromatography-tandem mass spectrometry (LC-MS/MS). MS/MS first separates 
ionised fragments using a mass to charge ratio, followed by collision-induced 
dissociation and which causes ion separation that is detected by a second mass 
spectrometer. This allows for increased sensitivity. Peptides with an N-terminal label 
were then identified, permitting determination of where the N-terminal region is being 
cleaved. 
 
  Identification of disulfide bonds 
To identify disulfide bonds within proteins, differential labelling followed by MS was 
used. The first label forms bonds only with reduced cysteines as they have a free thiol 
group. The label is not able to interact with cysteines that have formed a disulfide bond 
as it is protected. A reducing agent is added to break these disulfide bonds, and a second 
heavy label is added which can now interact with these free thiol groups. Once both labels 
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have been added, the peptide mass is determined. One can then tell the difference 
between the light and heavy labelling, and distinguish which state each cysteine was in.  
 
After labelling occurred, samples were digested using chymotrypsin and trypsin in 
parallel. Initial samples were labelled first with light iodoacetamide (IAM). Excess light 
IAM was removed using a spin filter and washed three times with buffer. Once washed, 
the sample was reduced using tris(2-carboxyethyl)phosphine (TCEP) and alkylated with 
heavy iodoacetic acid (IAA). Samples were subjected to tandem mass spectrometry 
(MS/MS).  
 
  Intact mass MS  
Intact mass determination was used to decipher which metal ion plant CDO binds. As 
different metal ions have different weights, the mass difference between protein with no 
ion bound and protein with an ion bound should indicate which metal is present. For the 
experiment, PCO1 and Arabidopsis ΔN protein were diluted to a final concentration of 
5-10 pM/μL. This was then buffer exchanged from post-dialysis Tris and sodium chloride 
concentrations, into 5 mM ammonium bicarbonate with trace amounts of sodium 
chloride. The intact mass was then determined using matrix assisted laser 
desorption/ionisation-time of flight (MALDI-TOF) mass spectrometry and compared to 
a calculated mass. MALDI-TOF uses a laser energy absorbing matrix to form ions from 
intact molecules present, which shift from a liquid to a gas phase. Ions fly toward the 
detector and their time of flight is indicative of the fragment mass (charges must be taken 
into account).  
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Chapter Three   
Arabidopsis thaliana CDO expression 
and purification  
To characterise plant CDO, it first must be expressed and purified. As cellular levels of 
plant CDO are usually low, recombinant over-expression was employed. As plant CDO 
does not appear to require any post-translation modifications, an E. coli prokaryotic cell 
line was used. This allows for speed, ease and low cost of production (Baneyx, 1999). 
After a period of over-expression in E. coli, cells were lysed, releasing plant CDO as it 
is an intracellular protein. Plant CDO was expressed fused with a Strep-tag® made of 
amino acids to permit affinity chromatography based purification. This tag selectively 
bound to Strep-tactin® resin, separating it from other cellular proteins. Once the resin 
was washed, plant CDO was eluted and used for further experiments. 
 
A. thaliana is a well-studied plant that is recognised as a model organism (Meinke et al., 
1998). It is commonly used in plant biology as it is small, easy to grow and phenotypic 
changes are easily identified (Somerville and Koornneef, 2002). Two isoforms of CDO 
(PCO1 and PCO2) from A. thaliana were the first constructs to be expressed and purified. 
A. thaliana CDO was chosen as Weits et al. (2014) worked on both of these isoforms and 
was able to detect expression in vivo and purify these proteins to show catalytic activity 
in vitro. It also appeared to represent CDO from other plant origins well as seen in 













Apple            ------------------------------------------------------------ 0 
Liverwort        GTILLVGNSVVLRY--VLMAESSVVSVTCENDAERSVAMAGYWALGACDSGTPAVLLLLA 298 
Tomato           ---MNIG---KILLSKRSVSGHNSSNISKKRKKK-KKKMELE------KR---------- 37 
Arabidopsis      GFEMKPEKEVLELISSKNQCKSNPNSVKKKNKNK-NKKMMMTWRRKKIDS---------- 50 
Rice             ---MRVEAGGLPELGSG---ARDPAGARRQRRRRQQRRPAM--PSAGAAA---------- 42 
Maize            ---MRVESSGGLPLPEL---ERQQAGAKRRRRRA---RAAA--AAAAPRT---------- 39 
 
 
Apple            ---------------MDCIILEKSKIQMLYKACNVVFSDL----------KALPTFRQIQ 35 
Liverwort        GNFCHQKTTCGNSDQHYSLKQPSLLLQNFFSAATWIRTSQPLDAYVCILSVVLPDH---- 354 
Tomato           ------------------KSSREDMVQKLYDTCKQIFAND--------S----------- 60 
Arabidopsis      ------------------PADGITAVRRLFNTCKEVFSNG--------GPGVIPSEDKIQ 84 
Rice             ------------------QPAPSPAVQGLFEACREVF-GA--------SAGAVPSPAGVE 75 
Maize            ------------------MAAPATAVQRLFEACREVFTGA--------GPGAVPPPAGVE 73 
                                       :: ::.:.  :  . 
 
Apple            WLKNLLGTFEAIDFGIDEFGSGRSPSSSP-------RSGQGLVSGQGISQITYIHVHECD 88 
Liverwort        ------DSIQASDVGLDEVDAMSQERGFGFFGTNGRRGRHTPMVARWAPPISYLHLYECE 408 
Tomato           --------LEPKDFKFTA--------PSLEF------SS-TNPGTVEAPLVTYIKIHECN 97 
Arabidopsis      QLREILDDMKPEDVGLTP--------TMPYF------RPNSGVEARSSPPITYLHLHQCD 130 
Rice             RIKSVLDSISAADVSLTR--------NMSYF------RR---VNSNGIPKITYLHLYECE 118 
Maize            RIKSVLDSITAADVRLTS--------SMPYF------RR---VDPYGTPKITYLHLYKCE 116 
                         :   *. :                                  ::*:::::*: 
 
Apple            HFSIGVFCFPAGATLPLHDHPGMTVFTKLLYGSVYFKSYDWIKVETSSSF---------- 138 
Liverwort        DFSMGIFCLPTSAQIPLHNHPGMTVLSKLLYGSMHVKAYDWVNPCDEKLNSDPSVRGVTS 468 
Tomato           KFSIGIFCLPPSGVIPLHNHPGMTVFCKLLAGTMHTTSYDWVQNHNHQANHDR------- 150 
Arabidopsis      QFSIGIFCLPPSGVIPLHNHPGMTVFSKLLFGTMHIKSYDWVVDAPM------------- 177 
Rice             AFSIGIFCLPPRGVIPLHNHPNMTVFSKLLFGELRVKSYDWADASQDST---D------- 168 
Maize            AFSIGIFCLPSRGVIPLHNHPGMTVFSKLLFGAMHIKSYDWAASQQDTP---D------- 166 
                  **:*:**:*  . :***:**.***: *** * :  .:*** 
 
Apple            -----RTFGLAGKVFDGVISSPCETRVLFPRSGGNIHSFTAVTPCAILDVLTPPYSDDHG 193 
Liverwort        SRALSCAARSAKLVVNRVLTAPCETATLHPTSGGNIHAFTAVTPCAVLDVLAPPYSAVTG 528 
Tomato           -GQHESRMRLAKVHVDDDFSAPCKSSVLFPESGGNMHCFKAITPCILLDVLGPPYSEAEG 209 
Arabidopsis      ---RDSKTRLAKLKVDSTFTAPCNASILYPEDGGNMHRFTAITACAVLDVLGPPYCNPEG 234 
Rice             -AQLQ-GARLAKVKVDGTLNAPCATSVLYPEDGGNLHCFTAHTACAVLDVLGPPYDDGSG 226 
Maize            -VQLQAGPRLAKVKVDGILTAPHETAVLYPEDGGNMHCFTAQNACAVLDVLGPPYDDGSG 225 
                           *   .:  :.:*  :  *.* .***:* *.* . * :**** ***    * 
 
Apple            RPSTYFFDFPIPSL--------------PAGYAVLEER--DMPEDLFVAGAPYLGPPIQA 237 
Liverwort        RHCTYYREAHSVGSNPGGIIANGEHREESQVETMLEEY--LPPDDFVVQRGEYRGPRVGP 586 
Tomato           RHCTYYQHYSYDHISLSDVNKEMK-EDEERSYAWLEERKD---EQFVVLGGTYDGPTIKL 265 
Arabidopsis      RHCTYFLEFPLDKLSSEDDDVLSS-EEEKEGYAWLQERDDNPEDHTNVVGALYRGPKVED 293 
Rice             RHCQHYNVSSSA-PSAGDSKP----LPGDDGYAWLEEC--EPPDNFHLVGSTYMGPRIVD 279 
Maize            RHCQYYNVRSSA-ISVAGSTI----LPGGDRYEWLEES--EPSRDFYLVGSTYMGPKILD 278 
                 * . ::                            *:*       .  :  . * ** : 
 
Apple            CDDRC 242 
Liverwort        ----- 586 
Tomato           ----- 265 
Arabidopsis      ----- 293 
Rice             N---- 280 
Maize            H---- 279 
 








Figure 3.1. Multiple sequence alignment of PCO1 and PCO2 from various plant 
origins. BLAST was used to source predicted PCO1 and PCO2 sequences from various 
plants. Clustal Omega produced the alignment and numbers correspond to last amino 
acid on the line. A star represents the same amino acid, whilst two dots represents very 
similar amino acids and one dot represents similar amino acids. The first 240 residues 
of Liverwort CDO are not included. Yellow shows conserved cysteines, green predicted 
catalytic tyrosine residue and blue shows predicted iron co-ordinating histidine 
residues. Accession numbers are as follows- Apple: XP_008341544, Liverwort: 
OAE21248, Tomato: XP_004232237 Arabidopsis: Q9LXG9, Rice: XP_015642636 
Maize: XP_008673605.  
 
3.1 PCO1 and PCO2 
First, both constructs were designed using the genes described by Weits et al. (2014) and 
ordered from GenScript. Plasmids containing either the PCO1 or PCO2 gene were 
transformed into BL21(DE3) E. coli cells, which resulted in several colonies. This was 
used to prepare an overnight culture and a subsequent trial expression was conducted at 
3 different temperatures, with samples taken at 3 different time points. The time points 
and temperatures with the most promising expression levels were subjected to solubility 
testing. Varying temperatures were tested as this often results in varying levels of protein 




 PCO1 and PCO2 expression  
 
Figure 3.2. SDS-PAGE of PCO1 and PCO2 expression at 18°C. Equal number of cells 
as judged by optical density at 600 nm (OD600), were loaded into each lane. The negative 
sign indicates sample before induction and the numbers following this represents number 
of hours after induction. Predicted mobility of PCO1 and PCO2 are indicated with black 
arrows. The lane labelled M contains molecular weight marker. Marker masses are 
indicated at left in kDa and each band contains 500 ng of protein.  
 
Overall, PCO1 (predicted mass of 34 kDa) expression was greater than of PCO2 
(predicted mass of 32 kDa) expression at 18°C (Figure 3.2). Based on the intensity of 
the bands, optimal levels of PCO1 expression are 6 h or 20 h post-induction. As 6 h of 
induction is less time intensive yet the same level of expression is achieved, this condition 
was chosen for solubility testing. PCO2 expression levels appeared low and did not 






Figure 3.3. PCO1 and PCO2 expression at 28°C. Equal number of cells as judged by 
OD600, were loaded into each lane. The negative sign indicates sample before induction 
and the numbers following this represents number of hours after induction. Predicted 
mobility of PCO1 and PCO2 are indicated with black arrows. The lane labelled M 
contains molecular weight marker. Marker as in Figure 3.2.  
 
PCO1 expression at 28°C was greater than that of PCO2 (Figure 3.3). Band density of 
PCO1 after 6 hours induction indicated that this induction time produced the greatest 
amount of protein, even with a greater number of cells loaded. Twenty hours of induction 
also produced a significant amount of PCO1. As 6 h and 20 h both produced reasonable 
amounts of protein, these samples were subjected to solubility testing. PCO2 expression 
did not seem to change dramatically based on the amount of time after induction. It 
appears as though 3 h produced the most protein, but this lane seems to have a greater 








Figure 3.4. PCO1 solubility. Amount loaded was constant to allow comparison. H 
indicates homogenate, S represents supernatant and P indicates pellet. Predicted mobility 
of PCO1 is indicated with a black arrow. The lane labelled M contains molecular weight 
marker. Marker as in Figure 3.2. Bacterial cells lysed using sonication.  
 
The homogenate analysed in Figure 3.2 and Figure 3.3 is a sample of the cell lysate, so 
indicates total protein content irrespective of solubility. After cell lysis, insoluble protein 
is spun down with cellular debris and is thus found in the pellet. Protein found in the 
supernatant is in solution after centrifugation, and therefore it is soluble. There was little 
protein in the pellet after expression at 18°C for 6 h (Figure 3.4). Both time points at 
28°C contained an insoluble fraction of PCO1 as bands appeared in the pellet lanes. The 
6 h time sample contained much more insoluble PCO1 as the band is much darker 
compared to the 20 h sample. This band may contain substantial unlysed cells due to poor 
sonication, as well as insoluble protein. The 20 h sample still contained a relatively large 






Figure 3.5. PCO2 solubility. Amount loaded was constant to allow comparison. H 
indicates homogenate, S represents supernatant and P indicates pellet. Predicted mobility 
of PCO2 is indicated with a black arrow. The lane labelled M contains molecular weight 
marker. Marker as in Figure 3.2.  
 
Both 28°C samples resulted in darker bands at the mass of PCO2 in the soluble fraction 
compared to the insoluble fraction (Figure 3.5). This means that expression under this 
temperature produces protein that is mostly soluble. The 20 h sample appears to have a 
slightly greater proportion of protein that is soluble. Expression at 37°C for 6 h resulted 
in a large band of PCO2 in the pellet lane, indicating that it is mostly insoluble protein 
under these conditions.  
 
Based on the solubility and expression gels, PCO1 was expressed at 18°C for 6 h. PCO2 
was expressed at 28°C for 20 h. The increase in solubility at lower temperatures in not at 
all surprising as the temperature growth range of A. thaliana is 16-25°C (Arabidopsis 
Biological Resource Centre, 2018). This suggests that most proteins within A. thaliana 
work optimally within this temperature range. Previous studies have also shown that 
expression of recombinant proteins at lower temperatures improves protein solubility 
(Schein and Noteborn, 1988). However, lowering the temperature comes at a cost as it 
slows growth and reduces yield. It may be of interest in the future to test the solubility of 
PCO2 at 18°C to see if solubility is improved compared to expression at 28°C. The 18°C 
samples were not tested in these experiments due to the lower expression at 18°C 
compared to 28°C. However, if the solubility of PCO2 increases substantially at the lower 




 PCO1 purification  
Once ideal expression conditions were determined, both proteins were subjected to trial 
purification using Strep-tag® affinity purification. Bacterial pellet was lysed using 
sonication, and the supernatant after centrifugation was purified using Strep-tag® resin 
or was loaded onto a Strep-tag® HP column on an FPLC. 
 
 
Figure 3.6. PCO1 bench-top syringe purification. Predicted mobility of PCO1 is 
indicated with a black arrow. The lane labelled H contains homogenate, S contains 
supernatant, F contains column flow-through, P contains purified protein and M contains 
molecular weight marker. Marker as in Figure 3.2.   
 
For the bench-top purification of PCO1, the dark band at ~34 kDa shows that a large 
amount of PCO1 was present in the homogenate (Figure 3.6). A band of a similar 
intensity was found at ~34 kDa in the supernatant, which means that PCO1 was soluble 
under these conditions. The dense band of PCO1 in the flow-through shows that not all 
of the protein bound to the resin. This is likely due to too much PCO1 being present for 
the resin to bind. Alternatively, this could be due to proteolysis removing the tag required 
for purification or misfolding resulting in tag inaccessibility.  
 
The protein lane (P) contains a large band suggesting protein that is reasonably pure. 
However, several contaminant bands can be seen at ~60 and 70 kDa, as well as a number 
of bands below the PCO1. The bottom bands may contain PCO1 that has been partially 
degraded by proteases at the N-terminal end. As the tag is found on the C-terminal end, 




chromatography. The top two bands were predicted to contain molecular chaperones that 
have bound the protein and were pulled out during purification. These bands were excised 
and sent for identification by MS.  
 
The results showed the top band to be 69kDa E. coli DnaK with 78% coverage 
(Appendix 2) and the lower band to be 57kDa E. coli groEL with 94% coverage 
(Appendix 3). Both of these proteins are chaperones, which are some of the most 
abundant proteins within E. coli cells. Under normal conditions DnaK makes up 1.4% of 
total protein within E. coli (Herendeen et al., 1979). These proteins bind other proteins 
that are misfolded to prevent intracellular aggregation and encourage proper folding 
(reviewed by Gasser et al. 2008 and Gottesman and Hendrickson 2000). The binding of 
chaperones to PCO1 was indicative of poorly folded subdomains or unfolded termini 
(Hellebust et al., 1990). As these proteins prevented the purified protein from being 
homogenous, this posed a potential problem for crystallography. Attempts were made to 
remove these chaperones from PCO1 (3.2.1). 
 
 
Figure 3.7. PCO1 Strep-tag® FPLC purification. The blue line represents absorbance 
at 280 nm in mAU (left axis) and the red line represents conductivity in mS/cm (right 
axis). Sample application was followed by a wash with running buffer until 65 mL elution 
volume, elution buffer was added until 105 mL elution volume, followed by a water wash 
until 120 mL, then a sodium hydroxide wash from 120-150 mL elution. The last step 
consisted of a wash with water.  
 
The chromatogram in Figure 3.7 had an initial flow-through peak (4-20 mL) in the 
absorbance up to 3250 mAu. This peak likely comprised cellular proteins that do not 
interact with the resin. The absorbance then decreased as the column was washed. The 
second peak at about 70 mL elution volume contained PCO1 as determined by SDS-
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PAGE (not shown). PCO1 was eluted in a relatively sharp peak. Changes to conductivity 
were due to changes in buffer conditions.  
 
PCO1 has been purified previously by Weits et al. and White et al. 2014.  Weits used a 
pDEST17 vector and PCO1 was N-terminally tagged with a cleavable hexahistidine 
tag. Expression was in Rosetta E. coli cells at an unspecified temperature for 18 h. 
Lysis buffer consisted of 50 mM HEPES-Na pH 7.5, 300 mM NaCl and 5 mM MgCl2. 
The protein was purified using a nickel affinity chromatography column. The elution 
buffer was similar to the lysis buffer but contained 150 mM imidazole and was pH 7. 
No SDS-PAGE gels were reported, and there was no mention of protein purity. The 
protein was frozen in 50% glycerol, suggesting some difficulty with protein solubility. 
 
White et al. used the same expression plasmid, but expressed PCO1 in BL21(DE3) 
cells and specified that expression was at 18 °C. Expression time was the same as 
Weits et al. Cells were lysed by sonication and the protein was purified using the same 
nickel affinity chromatography. There was no mention of the purification buffers, but 
it was declared that the protein was buffer exchanged into 250 mM NaCl and 50 mM 
Tris (pH 7.5) post-purification. An SDS-PAGE gel of purified protein showed pure 
(>90%) PCO1 with a very thin band of protein at ~70 kDa. This band could be DnaK, 
but it was not described. A few bands were present below the full length protein. This 
suggests these authors also had difficulty with truncations during purification as these 
bands may be comprised of cleaved full length protein.  
 
Overall the published protocols were similar to that reported here. The expression 
vector (pDEST17) differed slightly from the one used is these experiments (pET21+). 
Both vectors contained a T7 promoter which is induced with IPTG, carried amp 
resistance and permitted the ability to tag the protein of interest either at the N- or C- 
terminus. The main difference is that the PCO1 used in these experiments had a C-
terminal Strep-Tag® as opposed to an N-terminal His-tag. The buffers used also 
differed, the pH changed by 0.5 pH units, the NaCl concentration was higher and 
HEPES was used as opposed to Tris (for Weits et al.) As the type of tag and what 
termini the tag is fused to influences protein solubility the method used above to those 
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published may aid in producing a more stable protein. Changing buffer conditions can 
also influence this. 
 
 PCO2 purification  
 
Figure 3.8. PCO2 Strep-tag® FPLC purification. The blue line represents absorbance 
at 280 nm in mAU (left axis) and the red line represents conductivity in mS/cm (right 
axis). Fractions numbers relate to the gel in Figure 3.9. Sample application was followed 
by a wash with running buffer until 55 mL elution volume, elution buffer was added until 
90 mL elution volume, followed by a water wash until 115 mL, then a sodium hydroxide 
wash from 115-140 mL elution. The last step consisted of a wash with water.  
 
The initial peak in the absorbance (4-18 mL) in Figure 3.8 was the flow-through, and 
likely comprised cellular proteins that did not interact with the resin. The absorbance then 
decreased as the column was washed. The second peak at about 60 mL elution volume 
contained PCO2, which was eluted in a relatively sharp peak with a tail. The tail implies 
that there may be protein in a different state compared to that which eluted quickly. 






Figure 3.9. PCO2 Strep-tag® FPLC purification gel. Predicted mobility of PCO2 is 
indicated with a black arrow. The lane labelled H contains homogenate, SN contains 
supernatant and M contains molecular weight marker. Lanes labelled with a letter and a 
number are fraction numbers. Marker as in Figure 3.2. Chromatograph that relates to this 
gel is seen in Figure 3.8.  
 
There was no dense band of PCO2 present in the homogenate, implying that expression 
levels were not high (Figure 3.9). There is also no clear band of PCO2 in the supernatant. 
This may be because this purification used less pellet than the purification seen in Figure 
3.7, and PCO2 expression has been shown to be less than that of PCO1 in the past. 
Fraction A6 contained the most PCO2. This is not surprising run as this is where there is 
a peak in the absorbance in the chromatogram (Figure 3.8). Fraction A6 contains protein 
that is relatively pure, yet again contaminant bands are present. Four bands are seen at 
~60, 70, 45 and 36 kDa. The upper two bands could be the same contaminants found 
during PCO1 purification.  
 
3.2 Purified PCO1 assessment  
 PCO1 chaperone removal  
As there is a significant size difference between PCO1 and both chaperones, size 
exclusion chromatography could be used to separate the proteins. However, as the 
proteins co-purified during affinity purification the proteins may be interacting. This 
interaction must first be disrupted before separation by size exclusion chromatography 
as these bands may comprise cleaved full length protein. Two different methods were 




method was removal of all nucleotide by dialysis in the presence of EDTA and activated 
charcoal. 
 
The addition of ATP for the removal of DnaK has been used before (Hellebust et al., 
1990; Rial and Ceccarelli, 2002). The substrate binding and release cycle of DnaK is 
regulated by ATP binding. When DnaK has ATP bound it releases the bound substrate, 
and prepares to bind a new substrate. ATP hydrolysis occurs when the new substrate is 
bound, and DnaK continues to interact with the bound protein until the new ADP is 
replaced with an ATP (McCarty et al., 1995). A heat shock protein, GrpE, induces the 
removal of the ADP from DnaK allowing recycling of DnaK (Packschies et al., 1997). 
Unfortunately, in the case of GroEL the addition of nucleotide will induce substrate 
binding (Ishida et al., 2018). Nonetheless, removal of one chaperone is preferable to 
having both bound.  
 
 
Figure 3.10. PCO1 post-ATP incubation size exclusion. Sample was separated by a 
Superdex 75 column. The blue line represents absorbance at 280 nm in mAU (left axis) 
and the red line represents conductivity in mS/cm (right axis). Standard proteins elution 
position as shown at top: Thyroglobulin (660 kDa), Bovine Serum Albumin (67 kDa), 
Ovalbumin (43 kDa), Myoglobin (17 kDa) and Vitamin B12 (2 kDa). Standard values 
from (Moir, 2014) were aligned to these data using void volume. Fractions numbers 
relate to Figure 3.11.  
 
Separation over a Superdex 75 column resulted in two main peaks (Figure 3.10). The 
first peak at 45 mL elution volume contains protein that elutes quickly, and therefore is 
made of larger proteins, oligomers or large aggregates. This peak was expected to contain 
↓ 
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the aggregate plant CDO, or plant CDO bound to chaperones. The two shoulders implied 
there were a range of species, perhaps different ratios of DnaK to PCO1 molecules. The 
second peak that begins at 100 mL elution volume elutes later, and thus comprises 
smaller molecules. This peak likely comprised excess ATP. Gels were run to determine 
composition of major peaks (Figure 3.11). 
 
 
Figure 3.11. PCO1 post-ATP incubation size exclusion peak one. Predicted mobility 
of PCO1 is indicated with a black arrow. Lanes labelled with a letter and a number are 
fraction numbers. Lane labelled M contains molecular weight marker. Marker masses as 
in Figure 3.2. The chromatogram that relates to this gel is seen in Figure 3.10. 
 
SDS-PAGE suggested that fraction A4 contained PCO1 bound to groEL (59 kDa) and 
DnaK (69 kDa) (Figure 3.11). Fraction A5 contained PCO1 bound to DnaK (69 kDa) 
and a second unknown protein.  Fractions A6 and B1 appeared to contain PCO1 with 
little chaperones bound. These later fractions have much less contamination as the ratio 
of PCO1:chaperones has improved. This method is able to separate chaperone bound 
PCO1 and monomeric PCO1 but yield is low as much remains bound. Reproducing the 
experiment with a longer incubation with ATP may improve yield. 
 
Fractions from the second peak were also run on an SDS-PAGE gel. There was no protein 
detected in any of the fractions from C2 – D1 as no bands were present on the gel. It is 
likely that this peak was excess ATP eluting. As this molecule is so small, late elution is 
to be expected. The maximum absorbance of ATP is at 260 nm. However, it does have 





One of the groups who has used this method in the past followed ATP addition with a 
second incubation with denatured E. coli proteins (Rial and Ceccarelli, 2002). This would 
encourage DnaK that bound the protein of interest to bind other proteins. This approach 
could have improved the proportion of PCO1 released by DnaK. However, this would 
make the purified PCO1 preparation contaminated by many other proteins, and would 
require a further affinity purification step. 
 
Past students in the Wilbanks laboratory have also experienced issues with chaperones 
co-purifying with their protein of interest. To disrupt the interaction, dialysis with EDTA 
and activated charcoal was used. DnaK requires magnesium for high affinity binding of 
the nucleotide to the active site (Neuhofen et al., 1996). As EDTA is metal ion chelator, 
EDTA dialysis strips DnaK of Mg2+ and therefore lowers affinity of the protein for bound 
nucleotide. The activated charcoal absorbs free nucleotide so that it cannot bind to DnaK 
again (Roy, 1995). The release of the nucleotide appears to also induce release of the 
substrate. GroEL also binds Mg2+, which is required for catalysis. The removal of Mg2+ 
is predicted to decrease the stability of the quaternary structure, which would cause 







Figure 3.12. PCO1 post-EDTA dialysis size exclusion. Sample was separated by a 
Superdex 75 column. The blue line represents absorbance at 280 nm in mAU (left axis) 
and the red line represents conductivity in mS/cm (right axis). Standard proteins as in 
Figure 3.10. Fractions numbers relate to Figure 3.13. 
 
PCO1 was dialysed in the presence of EDTA and activated charcoal overnight, then was 
applied to a size exclusion column. After sample application, there is an initial peak in 
absorbance from 40 mL elution volume (Figure 3.12). This peak eluted quickly after 
sample addition, suggesting this peak comprises large molecules. A second double peak 
is then eluted at 90-100 mL elution volume. This double peak suggested that two slightly 
different molecules or the same molecule in varying states was present. As this is the 
second peak of the run, the molecule/s that comprise this peak are smaller than that of 
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Figure 3.13. PCO1 post-EDTA dialysis size exclusion peak one. Predicted mobility of 
PCO1 is indicated with a black arrow. Lanes labelled with a letter and a number are 
fraction numbers. Lane labelled M contains molecular weight marker. Marker as in 
Figure 3.2. The chromatogram that relates to this gel is seen in Figure 3.12. 
 
SDS-PAGE showed that fraction A10 contained considerable PCO1 and GroEL (Figure 
3.13). This fraction appears to contain proportionally less DnaK than the sample before 
separation by size exclusion. Based on the chromatogram peak, and resulting fractions 
on either side of A11, it is unlikely this fraction truly contains no protein. The lack of 
protein in fraction A11 may be due to under-loading, or issues with sample preparation. 
Fractions B1-3 contained an unknown protein with a very small amount of PCO1. 
Fractions C2-C4 contained only DnaK, suggesting that the attempt to separate PCO1 and 
DnaK was partially successful.  Fractions from the second peak were also run on SDS-
PAGE but no bands resulted. It is likely the second peak comprised ATP that was not 
removed by the activated charcoal.  
 
Neither of the methods described above were completely successful in separating a large 
portion of PCO1 from the chaperones without loss of PCO1. Given this, no extra steps 
were added into the purification protocol for PCO1. Instead, the focus was shifted on 
understanding why the chaperones were bound, and designing constructs that would 






 PCO1 instability  
The presence of chaperones during purification of PCO1 was the first suggestion that the 
protein was not fully folded. PCO1 also tended to precipitate within a few days at 4°C. 
Although this is not unusual, it does suggest the preparation could have been improved. 
To begin investigating this, PONDR® software was used to predict disordered regions 
of the protein in silico.  
 
 
Figure 3.14. PCO1 disorder prediction using PONDR® VLXT. A PONDR score of 
1 indicates an ideal prediction of disorder, and 0 indicates an ideal prediction of order. 
The threshold for assigning disorder is ≥ 0.5.  
 
The N-terminal region from the first residue to position 120 was predicted to be mostly 
disordered (Figure 3.14). The central region of the protein was predicted to be ordered, 
which is unsurprising as this is the proposed catalytic region of the protein. The C-
terminal end from ~250 – 300 was also predicted to be disordered. This supports the 
sequence alignment in Figure 1.9 where A. thaliana CDO has ~45 N-terminal and ~30 
C-terminal residues that extended beyond other CDO sequences. Results for the 
prediction of each individual residue can be found in Appendix 4. 
 
PONDR® and previous sequence alignments suggested that the N- and C- termini were 
disordered. To experimentally determine if the termini of the recombinant protein were 
disordered, a limited proteolysis was conducted. This method uses partial proteolytic 
digestion to determine whether or not an element is folded, unfolded or disordered based 
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on backbone accessibility to the protease (reviewed by Fontana et al. 1997). Regions of 
the protein that are folded into secondary structure elements are more slowly cleaved as 
the backbone lacks flexibility and displays steric hindrance to protease binding. Regions 
that are unfolded are readily cleaved as a flexible peptide bond acts as a better substrate 
for the protease (Fontana et al., 1986, 2004).  
 
Figure 3.15. PCO1 limited proteolysis. Enzyme used was a relatively non-specific 
serine protease, proteinase K. PCO1 digestion products are indicated with a right brace.  
Lanes differ by incubation time as indicated by numbers in minutes. Lane labelled M 
contains molecular weight marker. Marker as in Figure 3.2.  
 
Before the incubation was conducted, there was already some degradation of PCO1 as 
seen in the 0 min control sample (Figure 3.15). After 5 min of incubation, four bands 
were produced at ~36, 34, 32 and 30 kDa. A change of ~2 kDa is the weight of around 
18 amino acids based on the average weight being 110 Da. The same four bands are seen 
after 20 min of incubation. A fifth band may be present in the 5 and 20 min samples, but 
cannot be seen due to how the gel ran. Bands formed after 20 min of incubation were 
sent for peptide identification using MS in an attempt to determine where the termini 
cleavage sites were. Contamination of full length protein in each of the samples resulted 
in an unsuccessful experiment. Contamination is due to the smear characteristic seen on 
the gel, as the bands are not cleanly separated. Given this poor result, future N-terminal 
identification experiments were conducted using an N-terminal labelling technique prior 




Banding patterns on the gel after only 5 min suggested that there are some unfolded or 
disordered regions of the protein. It is likely that the disordered regions are the termini 
as a poorly folded catalytic domain would result in bands smaller than those observed. 
The computational and experimental results all imply that it is the disordered termini that 
are causing chaperone binding and general instability. These results were used to design 
truncations that removed any disordered regions of PCO1 (section 3.3). Removal of 
disordered regions was predicted to improve protein stability, and disrupt chaperone 
binding.  
 
3.3 PCO1 truncations  
Due to issues with the stability and purity of PCO1 and PCO2, truncated versions were 
designed. Both constructs were designed from PCO1 as PCO2 expression was not as 
plentiful and there were initial problems with purifying PCO2. As experiments and 
PONDR® analysis showed that it was the N and C terminal ends of PCO1 that appeared 
unstable and disordered, these regions were removed. One construct had residues 2-53 
of the N-terminal removed, and was thus termed ΔN. The second construct had the same 
N-terminal residues removed, as well as residues 248-293 of the C-terminal. This 
construct was termed ΔNΔC. Plasmids with genes for both constructs were supplied by 
GenScript and transformed into BL21(DE3) cells. Expression and solubility was tested 







 Expression and solubility of PCO1 truncations  
 
Figure 3.16. ΔN expression. Equal number of cells as judged by OD600, were loaded 
into each lane. The negative sign indicates sample before induction and the numbers 
following this represent number of hours after induction. Band identified as ΔN by MS 
is indicated with a black arrow. The lane labelled M contains molecular weight marker. 
Marker as in Figure 3.2. Note ΔN runs higher than expected on SDS-PAGE gels. 
 
At 18°C there appears to be little expression of ΔN (predicted mass of 28 kDa) until 20 
h post induction (Figure 3.16). The same is to be said of 28°C, although a small band 
can be seen after 6 h of induction. There is little to no expression of ΔN at 37°C as no 
bands of ΔN are visible. As expression after 6 h and 20 h in all temperatures looked 
resulted in reasonable expression levels, all of these samples were subjected to solubility 
testing.  
 
Figure 3.17. ΔNΔC expression. Equal number of cells as judged by OD600, were loaded 
into each lane. The negative sign indicates sample before induction and the numbers 
following this represents number of hours after induction. Predicted mass of ΔNΔC is 
indicated with a black arrow. The lane labelled M contains molecular weight marker. 






For ΔNΔC (predicted mass of 23 kDa) all temperatures tested resulted in reasonable 
expression. (Figure 3.17). At 18°C expression increases with time post induction, with 
the most being expressed after 20 h. A different pattern is seen at 28°C as little is 
expressed until 20 h post induction. Expression at 37°C appears similar to that of 18°C, 
with increasing expression with increasing induction time. All 6 and 20 h samples were 




Figure 3.18. ΔN solubility. Amount loaded was constant to allow comparison. H 
indicates homogenate, S represents supernatant and P indicates pellet. Band identified as 
ΔN by MS is indicated with a black arrow. The lane labelled M contains molecular 
weight marker. Marker as in Figure 3.2. 
 
Samples after 6 h of induction did not produce as much soluble protein as the 20 h 
induction samples (Figure 3.18). However, both 6 h samples resulted in a higher 
proportion of soluble ΔN than insoluble ΔN. It also appears that the 6 h samples contain 
a high proportion of ΔN as opposed to other cellular proteins. Of the 6 h samples, 28°C 
produced the most protein thus 28°C for 6 h was chosen as the optimal conditions for 
expression of ΔN. The solubility of ΔN at 37°C was analysed with no promising results 






Figure 3.19. ΔNΔC solubility. Loading was kept constant to allow for comparison. H 
indicates homogenate, S represents supernatant and P indicates pellet. ΔNΔC is indicated 
with a black arrow. The lane labelled M contains molecular weight marker. Marker as in 
Figure 3.2.   
 
ΔNΔC is soluble under most conditions (Figure 3.19). It appears to be almost completely 
soluble at 18°C after expression for 6 h, and 20 h. There is a small amount of insoluble 
protein in the 20 h sample yet as the 20 h sample loading is darker. When considering 
the samples at 28°C, the same trend is seen as in the 18°C samples. It is almost completely 
soluble after 6 h induction, and appears to be less soluble after 20 h induction. This could 
again only be due to greater loading. Expression at 18°C for 6 h appeared to produce the 
greatest proportion of soluble protein, thus these conditions were chosen for future 
expression. The solubility of ΔNΔC at 37°C was analysed but was not found useful, and 
thus is included in the appendix (Appendix 5).  
 
 Purification of ΔN and ΔNΔC truncations of PCO1 
Once expression conditions were selected, trial purification of both proteins was 
conducted using Strep-tag® affinity purification. Bacterial pellet was produced using the 
conditions specified in 3.1.3. The bacteria were lysed using sonication, and the 
supernatant after centrifugation was loaded onto a Strep-tag® HP column on an FPLC. 






Figure 3.20. ΔN Strep-tag® FPLC purification. The blue line represents absorbance at 
280 nm in mAU (left axis) and the red line represents conductivity in mS/cm (right axis). 
This chromatogram is representative of the chromatogram that produced Figure 3.21 and 
Figure 3.22. Sample application was followed by a wash with running buffer until 70 
mL elution volume, elution buffer was added until 115 mL elution volume, followed by 
a water wash until 130 mL, then a sodium hydroxide wash from 130-155 mL elution. 
The last step consisted of a wash with water. 
 
The initial peak in the absorbance (2-25 mL) likely comprises cellular proteins that do 
not interact with the resin (Figure 3.20). The second peak at about 70 mL elution volume 
contained ΔN as shown by SDS-PAGE. Two insignificant peaks were seen during the 
regeneration steps of the protocol. These peaks are likely ΔN that bound tightly to the 
resin, therefore the interaction was not disrupted by the elution buffer. These interactions 
were instead disrupted by washing the column with water and sodium hydroxide 















Figure 3.21. ΔN Strep-tag® FPLC purification peak one. Lanes labelled with a letter 
and a number are fraction numbers. Lane labelled M contains molecular weight marker. 
Marker as in Figure 3.2. Fraction E11 eluted at 70 mL elution volume. 
 
Fractions A7 and B12 appears to have no dense bands around where ΔN would be found 
on a gel (Figure 3.21). This implies that all the protein was binding to the column. 
Fraction E11 corresponds to the shoulder of the flow-through peak. This protein runs 
approximately where ΔN would be, suggesting the shoulder may be ΔN that had failed 
to bind to the column. This failure to bind may have been due to protein folding in a way 
that prevents the tag from interacting with the resin.  
 
 
Figure 3.22. ΔN Strep-tag® FPLC purification peak two. Lanes labelled with a letter 
and a number are fraction numbers. The lane labelled M contains molecular weight 
marker. Marker masses as indicated in kDa and contain an unknown amount of protein.  
 
ΔN eluted over several fractions as many dense bands can be seen on the gel (Figure 
3.22) Band density shows that a large amount of the protein was able to be purified. The 
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resulting protein was pure and no contaminants were seen. The lack of chaperones or 
other contaminants implied that the protein was likely to be folded correctly. Together, 
the observation suggests that the N-terminal truncation has removed the disordered 
region but has not compromised the ability of the protein to fold correctly.  
 
 
Figure 3.23. ΔNΔC Strep-tag® FPLC purification. The blue line represents absorbance 
at 280 nm in mAU (left axis) and the red line represents conductivity in mS/cm (right 
axis). This chromatogram is similar to the chromatogram that produced samples used in 
Figure 3.24. Sample application was followed by a wash with running buffer until 50 
mL elution volume, elution buffer was added until 100 mL elution volume, followed by 
a water wash until 115 mL, then a sodium hydroxide wash from 115-130 mL elution. 
The last step consisted of a wash with water. 
 
The initial peak in the absorbance comprised cellular proteins that do not interact with 
the resin (Figure 3.23). The second peak at about 60 mL elution volume contained 
ΔNΔC, which was eluted in a peak with a tail. This tail implies that a fraction of the 
protein was able to bind with the resin with a slightly stronger affinity. This could mean 
that this protein is in a different state to the protein that eluted immediately. Two other 
small peaks can be seen during the regeneration steps of the protocol. These peaks are 
likely ΔNΔC that bound tightly to the resin, therefore the interaction was not disrupted 
by the elution buffer. These interactions were instead disrupted by washing the column 





Figure 3.24. ΔNΔC Strep-tag® FPLC purification gel. Lanes labelled with a letter and 
a number are fraction numbers. M indicates molecular weight marker. Marker as in 
Figure 3.2. Where ΔNΔC is predicted to run is indicated with a black arrow. Fraction 
A6 eluted at 55 mL elution volume.  
 
The homogenate and supernatant lane of Figure 3.24 shows that ΔNΔC was present and 
soluble before the purification was carried out. Fractions A6-B8 all contained ΔNΔC, yet 
many contaminants were present. The same chaperones that were seen with PCO1 and 
PCO2 appear to be present, indicating issues with protein folding. Two other main 
contaminants were present at ~43 and 36 kDa. These proteins could also be chaperones, 
but this was not assessed. One of these contaminant proteins present could be DnaJ, a 
40 kDa heat shock protein that interacts with DnaK (Liberek et al., 1991). Mass 
spectrometry would aid in determining if this is the case.   
 
When looking at the resulting purified protein for both truncations, it is clear that removal 
of the N-terminal improved protein folding and thus solubility. Removal of both termini 
had a negative impact on the protein, as there could be several chaperones bound. This 









3.4 PCO1 nucleic acid binding  
After the first purification of PCO1, the concentration of purified protein was attempted 
to be measured using the absorbance at 280 nm. A spectrum was taken from 220 to 
360 nm to assess absorbance. Almost all proteins have a maximum absorbance at 280 nm 
due to the presence of aromatic amino acids (tyrosine, phenylalanine and tryptophan in 
particular) (Layne, 1957). However, PCO1 had a maximum absorbance at 260 nm.  
 
A lack of absorbance at 280 nm has in past been the result of specific interaction of buried 
aromatic amino acids (Lakowicz, 1999). This was tested by taking native PCO1 spectra 
and comparing it to spectra of PCO1 that was denatured using urea. There was no change 
in the spectrum (not shown). It was also considered that there was a lack of aromatics or 
a higher ratio of phenylalanine to the other aromatics. This is not the case as PCO1 has 8 
tyrosine, 12 phenylalanine and 4 tryptophan residues. The shift in absorbance could also 
have been due to the presence of chaperones, as DnaK contains only 1 tryptophan and 
groEL contains none (sequences from Uniprot database analysed on Expsay). This would 
heavily influence the spectral properties as tryptophan contributes the most absorbance 
to the 280 nm reading (Held, 2003).   
 
The alternative explanation is the presence of nucleic acid. The presence of the 
heterocyclic rings which make up the bases causes nucleic acids to have a maximum 
absorbance at 260 nm (Layne, 1957). Nucleic acids are negatively charged molecules so 
will readily interact with positive charges. In the first 47 residues of the N-terminal region 
of PCO1 there are 13 lysine and 2 arginine residues. As the pKa of the side chains of 
these amino acids are 10.5 and 12.5 respectively, these residues are positively charged at 
the pH the protein was purified in (pH 8) (Grimsley et al., 2009). These positively 
charged residues would readily interact electrostatically with the negative nucleic acid 
molecules. To determine if PCO1 bound DNA, purified protein was run on an agarose 
gel and stained with ethidium bromide. ΔN was included to assess if the N-terminal 





Figure 3.25. Agarose gel of PCO1 and ΔN. The first two lanes contain PCO1, and the 
end two lanes contain ΔN. The protein lanes labelled with “b” indicate that the protein 
sample had been boiled before being loaded onto the gel. Lane labelled M contains DNA 
ladder. The size of each marker is indicated to the left in bp. The smearing effect is due 
to how the protein runs through the agarose.  
 
The first lane containing PCO1 shows a large amount of nucleic acid which appears to 
be a range of lengths (Figure 3.25). There are two distinct bands at ~2000 and 150 bp. 
The top distinct band is likely DNA bound to protein and the bottom band is free DNA. 
When PCO1 was boiled, only one distinct band was present at just less than 100 bp. This 
suggests all DNA is now free as heat has disrupted the interaction. ΔN had distinct bands 
at approximately the same lengths as PCO1. Unlike PCO1 samples, boiling had no effect 
on these DNA bands. Thus suggests DNA present may not be bound to ΔN. Alternatively, 
ΔN could be very heat stable and thus heat does not interrupt the interaction between the 
protein and DNA. To test this definitively, one could perform heat denaturation of ΔN 
and assess this with circular dichroism.  
 
As distinct bands were observed, this implied that the interaction between PCO1 and 
DNA may be physiological and not an artefact. If binding was unspecific one would see 
DNA of a range of sizes as opposed to distinct bands. The removal of the N-terminal 
resulted in substantially less or no nucleic acid binding even though ΔN was more 
concentrated than PCO1. Thus, it was clear that the removal of the N-terminal decreased 
the amount of nucleic acid that PCO1 bound. This supports the theory that DNA binding 
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may be mediated by charged residues of the N-terminal. Experiments that followed 
focused on determining with what type of nucleic acid PCO1 was interacting.  
 
 
Figure 3.26. Agarose gel of PCO1 with nucleases. Gel contains PCO1 incubated with 
DNase I or RNase A.  
 
When comparing the samples digested with DNase and RNase to the control lane, both 
bands had a reduction in intensity (Figure 3.26). As DNase cleaves DNA molecules, the 
loss in intensity suggests that DNA is present. RNase digests RNA, indicating that RNA 
was also present. There was a complete digestion of sample in the DNase lane, whilst 
only a portion of the RNase lane was digested. This implies that there was a greater 
proportion of DNA to RNA. The DNase used was ostensibly RNase free so the result 
observed was as a result of DNase activity. The RNase stock did contain some DNase as 
it was grade II, thus reduction of DNA intensity in the RNase lane could be due to DNase 
activity.  
 
Overall, nucleic acid digestion suggested that PCO1 binds DNA. Further experiments 
should be conducted with more specific nucleases to determine which type of DNA 
PCO1 interacts with. DNase I is able to cleave both double stranded (dsDNA) and single 
stranded DNA (ssDNA), but has a strong preference for dsDNA (Suck, 1994). Whereas 
Mung Bean nuclease is highly specific for single stranded nucleic acids (Johnson & 
Laskowski, 1968). Thus digestion with these nucleases, should help determine if the 
DNA is single stranded or double stranded. If PCO1 binds dsDNA, it is likely that the 
interaction is physiologically relevant. As PCO1 acts on transcription factors that are 
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found in the nucleus (close to the double stranded genomic DNA), PCO1 binding dsDNA 
would localise the protein to its target. PCO1 being in close proximity to its targets will 
enable catalysis to happen quicker, permitting a faster response to oxygen deprivation.  
 
3.5 Summary 
All A. thaliana constructs that were designed were able to expressed and purified. All 
purified proteins were subjected to mass spectrometry for identification. This was to 
ensure that the correct protein was purified, and that no mutations were present in the 
protein. All proteins purified were identified with high confidence. See Appendix 6 
(PCO1), Appendix 7 (PCO2), Appendix 8 (ΔN) and Appendix 9 (ΔNΔC).  
 
Figure 3.27. Summary of all CDOs purified from A. thaliana. The lanes labelled M 
contains molecular weight marker. Marker masses are indicated in kDa and each band 
contains ~500 ng of protein. Construct name is above each gel lane.  
 
With the exception of ΔN, all of the proteins co-purified with chaperones (Figure 3.27). 
PCO1 co-purifies with two chaperones which were identified as DnaK and groEL. ΔNΔC 
and PCO2 also co-purify with these chaperones, and two other main contaminant 
proteins; one of which could be DnaJ. Attempts were made to remove these chaperones 
from PCO1 using ATP incubation or EDTA dialysis followed by gel filtration, with 






Both PCO1 and PCO2 have truncated protein as seen in the bands below the full length 
protein band (Figure 3.27). Limited proteolysis, sequence alignments and in silico work 
suggests that these truncations are likely N- and C-terminal. Removal of the N-terminal 
end resulted in a protein that had no chaperones bound, indicating that solubility and 
stability had greatly improved. Removing both the N- and C-terminal ends resulted in a 
protein which co-purified with chaperones and two other contaminants. This suggests 
that removing the C-terminal end decreases protein stability and thus solubility. An 
ethidium bromide stained agarose gel showed that PCO1 binds DNA, potentially electro-
statically via its N-termini.  Although this may be physiologically relevant, DNA binding 
increases protein heterogeneity and thus decreases protein quality for crystallography. 








Zea mays and Orzya sativa CDO 
expression and purification 
As PCO1 and PCO2 both co-purify with chaperones, this compromises crystallography 
due to the lack of homogeneity (McPherson, 1999). Two shortened constructs of PCO1 
were produced, one which resulted in pure protein without obvious contaminants, and a 
second protein that was predicted to bind even more chaperones than PCO1 and PCO2. 
To extend attempts to crystallise plant CDO, the closest PCO1 homologue from two 
additional species (termed PCO2 in both cases) was expressed in E. coli and purified 
using Strep-tag® affinity chromatography. These constructs were designed based on 
experimental results with constructs from A. thaliana.  
 
4.1 Zea mays constructs  
Zea mays, or maize, is cultivated worldwide to produce cereal grain. It is a vital source 
of food globally, and it also used as a fuel source (Ranum et al., 2014). One billion tonnes 
were produced in 2016, 100 million tonnes greater than that of wheat and rice 
(FAOSTAT, 2017). The increasing production and improvement in maize yield is of 
exceptional importance with increasing population size (Godfray et al., 2010). 
Manipulation of cellular proteins that influence crop survival could enhance yield, 
providing more food. Two versions of maize CDO were expressed and purified, and 
designated “Maize A” and “Maize B”.   
 
 Maize A construct 
Maize A is the full length predicted PCO2 isoform. The plasmid was obtained from 
GenScript and was overexpressed in BL21(DE3) E. coli cells. Three expression 
temperatures were tested for 3 different lengths of time. The solubility of the protein at 
these different time points was tested, and pellet which was produced from the most 




Figure 4.1. Maize A expression. Equal number of cells as judged by OD600, were loaded 
into each lane. The negative sign indicates sample before induction and the numbers 
following this represent hours after induction. Band identified as Maize A by MS is 
indicated with a black arrow. The lane labelled M contains the molecular weight marker. 
Marker masses are indicated in kDa and each band contains 500 ng of protein.  
 
There does not appear to be any expression of maize A (predicted mass of 31 kDa) until 
20 h after induction at 18°C (Figure 4.1). At 28°C, there was noticeable expression after 
only 3 h. The level of expression did not seem to increase dramatically after 6 or 20 h of 
induction. Induction at 37°C appeared to express the most protein as these bands are the 
darkest. Strangely, 3 and 20 h seemed to produce the greatest amount of protein. All 6 
and 20 h samples were subjected to solubility testing. After purification and mass 
spectrometry-based identification it was concluded that Maize A runs higher on an SDS-







Figure 4.2. Maize A solubility at 18°C. Loading was kept constant to allow comparison. 
H indicates homogenate, S represents supernatant and P indicates pellet. Band identified 
as Maize A by MS is indicated with a black arrow. The lane labelled M contains 
molecular weight marker. Marker as in Figure 4.1.  
 
At 18°C a minimal amount of maize A was expressed, however all that was expressed 
appears to be soluble (Figure 4.2). A band can be seen in the homogenate at where maize 
A runs for both 18°C samples. A band of the same intensity in the same position can be 




Figure 4.3. Maize A solubility at 28 and 37°C. Loading was kept constant to allow 
comparison H indicates homogenate, S represents supernatant and P indicates pellet. 
Where maize A is expected to run is indicated with a black arrow. The lane labelled M 







Induction at 28°C led to almost completely soluble protein, regardless of induction time 
(Figure 4.3). This was determined as bands of maize A in the homogenate are mirrored 
by bands of similar intensities in the supernatant. Only light bands of maize A bands were 
seen in the pellet fraction for these samples. In the 37°C samples, almost all maize A 
protein found in the homogenate was in the pellet fraction after centrifugation. Although 
there appeared to be a greater amount of protein expressed at 37°C, this protein was not 
suitable for purification as it was not soluble. Given the results for the expression trial, it 
was decided that maize A would be expressed at 28°C for 20 h.  
 
 
Figure 4.4. Maize A Strep-tag® FPLC purification. The blue line represents 
absorbance at 280 nm in mAU (left axis) and the red line represents conductivity in 
mS/cm (right axis). Fractions in this chromatogram relate to Figure 4.5. After sample 
application, the column was washed with running buffer from 10- 50 mL. Elution buffer 
ran through the column from 50-90 mL until a water wash from 90-110 mL. This was 
followed by a sodium hydroxide wash from 110-135, and finished with a water wash.  
 
The initial peak in the absorbance was the flow-through whichcomprised cellular proteins 
that did not interact with the resin (Figure 4.4). The second peak at about 55 mL elution 
volume contained maize A, which was eluted in a peak with a front shoulder. This 
shoulder couldcomprise maize A that was in a different state, as it interacted with the 





Figure 4.5. Maize A Strep-tag® FPLC purification gel. The lane labelled M contains 
molecular weight marker and lanes labelled with a letter and a number are fraction 
numbers. Fractions present are from one FPLC run. Where maize A is expected to run is 
indicated with a black arrow. Marker as in Figure 4.1. Gel corresponds to chromatogram 
in Figure 4.4. 
 
Fractions A2-A5 from the purification contained flow-through which comprised cellular 
proteins (Figure 4.5). As no distinct bands of maize A were in these lanes, it appears all 
protein present was able to bind to the resin. Fraction C6 contained a very small amount 
of protein whilst fraction C7 contained most of the eluted maize A. A range of fractions 
around the elution peak were run as the peak contained a front shoulder, however no 
dense bands resulted. 
 
The protein eluted was relatively pure, with a few contaminants present. A light band can 
be seen at 22 kDa, and a number of other light bands can be seen directly below maize 
A. Proteins under the dense maize A band may be truncated versions of the full-length 
protein. Like PCO1, sequence analysis shows that maize A appears to have disordered 
N- and C-terminal ends. Truncations must be at the N-terminus as C-terminal truncations 
would remove the Strep-tag® and prevent maize A from interacting with the resin. As 
distinct bands were formed, it is probable that proteases were cleaving the N-terminal at 
sites of enhanced sensitivity to proteases such as disordered loop regions. The cells used 
to express this protein were deficient in two of the main E. coli proteases (Lon and OmpT) 
which prevented excessive proteolysis during expression (New England Biolabs, 2018). 






Bands below the protein were analysed by MS coupled with an N-terminal labelling 
technique to determine where the protein was being cleaved. Bands from the gel in 
Figure 4.27 were excised for this experiment, including the band of full length at 31 kDa, 
and the predicted truncations at ~29, 27 and 21 kDa. The results showed that the full 
length protein had been purified, and that the N-terminal methionine remained intact. The 
29 kDa band was truncated at residue 30-33, and the 27 kDa band was truncated at residue 
77-80. The last band at 21 kDa led to an inconclusive result, as peptides did not appear 
to match those of maize A. This suggests that it may be a contaminant. The results show 
that the N-terminal is susceptible to truncation, and demonstrates that previous construct 
designs are plausible as cleavage at residue 30-33 corresponds closely with position 51 
of A. thaliana PCO1. Data for this experiment can be found in Appendix 10.  
 
Improving purified Maize A homogeneity 
The observation of distinct bands below maize A on an SDS-PAGE gel was amplified 
by sample concentration (see 4.3). An attempt was made to separate these bands from 
the full length maize A protein. As the N-terminal of the protein contains a large number 
of positively charged amino acids (9 of the first 30 residues), removal of regions of the 
N-terminal should influence the pI of the protein dramatically. A sample of concentrated 
protein was applied to a cation exchange resin, SP HP (a negatively charged resin that 
binds positively charged molecules). The predicted pI of maize A is 8.5 (as determined 
by Expasy). When the pH is less than the pI the molecule is positively charged, so the 
cation exchange was conducted at pH 7. The predicted pI of maize A when the N-terminal 
is truncated decreases. Thus, the truncated versions of the protein should be negatively 








Figure 4.6. Cation exchange chromatography of maize A. The blue line represents 
absorbance at 280 nm in mAU (left axis) and the red line represents conductivity in 
mS/cm (right axis)/ Fractions produced the samples used for Figure 4.7. The column was 
run using a pH 7 HEPES buffer.  
 
A large peak in initial absorbance suggests that truncated maize A did not interact with 
the cation exchange resin as predicted (Figure 4.6). However, the full length construct 
also did not interact with the resin as no other peaks are seen in the chromatogram. This 
could be due to the theoretical pI of the protein being wrong, or local charge 
concentration. If DNA was bound to maize A, such as with PCO1, this would also 
influence pI. There could have also been an issue with the resin, as the column used was 
several years old. Fractions from the cation exchange chromatography were analysed on 
an SDS-PAGE gel. 
 
 
Figure 4.7. Maize A cation exchange chromatography gel. The lane labelled M 
contains molecular weight marker and lanes labelled with a letter and a number are 




Protein eluted from the column was contained within fraction F2 (Figure 4.7). The dense 
band in this fraction ran at ~ 64 kDa. This is not the size of maize A, but is very close to 
the size of maize A if it had dimerised. Dimerisation could also explain why maize A did 
not interact with the cation exchange resin as expected. The change in buffer conditions 
could have encouraged dimerisation of the protein, as all other work with plant CDO had 
been conducted in tris at pH 8. Some larger products are also present as seen by the smear 
at the top of the lane. These could have been aggregates of maize A or related to the 
contaminants that were present after purification. Although the dense band was not 
confirmed as maize A, it is unlikely to be another protein as the sample that was loaded 
onto the column was relatively pure maize A. This could be confirmed using MS in the 
future. 
 
As this is a reducing gel, it is interesting that the protein remains dimerised. Before 
samples are loaded they are mixed with a range of denaturing compounds and boiled. If 
the protein remains a dimer after this process then it is likely a covalent interaction 
between the two monomers. PCO1 has also been shown to form higher order structures 
in certain conditions. This is explored in Chapter 5. This interaction could be an artefact 
of in vitro purification, but could also be physiologically relevant as dimerisation of 
proteins is a common mechanism used to control protein activity.   
 
 Maize B construct  
As maize A was prone to truncation which prevented a homogenous sample from being 
produced, a truncated version was synthesised. This construct, termed maize B, had 
residues 1-39 removed based on results from PCO1 truncations. A plasmid was 
purchased from GenScript, and was transformed into BL21(DE3) E. coli cells. 
Expression trials were conducted at a range of temperatures and time points, followed by 





Figure 4.8. Maize B expression. Equal number of cells as judged by OD600, were loaded 
into each lane. The negative sign indicates sample before induction and the numbers 
following this represents number of hours after induction. Where maize B is expected to 
run is indicated with a black arrow. The lane labelled M contains molecular weight 
marker. Marker as in Figure 4.1.  
 
Expression levels of maize B (predicted mass of 27 kDa) under all conditions were 
promising (Figure 4.8). When inducing the protein at 18°C, a band was present after 3 h 
which becomes denser as the induction time increases. This is also true of 28°C and 37°C. 
All 6 and 20 h samples were subjected so solubility testing.  
 
 
Figure 4.9. Maize B solubility at 18°C and 28°C. Loading was kept constant to allow 
for comparison. H indicates homogenate, S represents supernatant and P indicates pellet. 
Where maize B is expected to run is indicated with a black arrow. The lane labelled M 







The general trend for solubility was that most of maize B was insoluble (Figure 4.9). 
Both 18°C time samples contained almost all of maize B in the pellet fraction. There was 
a small amount that was soluble, as a modest band of maize B could be seen in the 
supernatant for both time points. The same is true of the 28°C time points. It appeared as 
though maize B was also generally insoluble after expression at 37°C (Figure 4.10). 
There was only a small amount of protein in the soluble fraction after 6 h of induction at 
37°C. A 20 h induction time at 37°C did not improve solubility.  
 
 
Figure 4.10. Maize B solubility at 37°C. Loading was kept constant to allow 
comparison. H indicates homogenate, S represents supernatant and P indicates pellet. 
Where maize B is expected to run is indicated with a black arrow. The lane labelled M 
contains molecular weight marker. Marker as in Figure 4.1. 
 
After analysis of the expression trial results, it was determined that under these lysis 
conditions the greatest proportion of soluble protein was produced with induction at 18°C 
for 6 h. Protein produced under these conditions was purified to determine whether or 







Figure 4.11. Maize B Strep-tag® FPLC purification. The blue line represents 
absorbance at 280 nm in mAU (left axis) and the red line represents conductivity in 
mS/cm (right axis). This chromatogram is representative of the chromatogram that 
produced the samples used in Figure 4.12. After sample application, the column was 
washed with running buffer from 20- 65 mL. Elution buffer ran through the column from 
65-100 mL until a water wash from 100-115 mL. This was followed by a sodium 
hydroxide wash from 115-145, and finished with a water wash.  
 
The initial peak in the absorbance comprised cellular proteins that did not interact with 
the resin (Figure 4.11). The second peak at about 70 mL elution volume contained maize 
B, which was eluted in a peak with a slight front shoulder. Maize B that eluted in this 
shoulder was likely in a different state as it interacted with the resin with slightly less 
affinity than maize B that eluted in the main peak.  
 
 
Figure 4.12. Maize B Strep-tag® FPLC purification gel. Lanes labelled with a letter 
and a number are fraction numbers.. Where maize B is expected to run is indicated with 






The first 3 fractions contain many cellular proteins, confirming that the initial absorbance 
was flow-through (Figure 4.12). It appears as though no or little maize B was in these 
fractions. Thus, all maize B that was loaded onto the column was able to interact with 
the resin, and that the column was not overloaded. Most of maize B eluted in the fraction 
B12. There are many contaminants present in this sample, with 5 main contaminant 
bands. As the column was washed thoroughly before elution, it is likely many of these 
contaminants interact with maize B or have some affinity for the resin. Three of the bands 
were predicted to be chaperones including DnaK (69 kDa), groEL (60 kDa), and DnaJ 
(40 kDa).  
 
The gel in section 4.3 had all five bands (including the band predicted to contain maize 
B) sent for MS to be identified. The results showed that maize B had been purified, with 
70% sequence coverage. The top two bands were comprised of DnaK (27% coverage) 
and groEL (53% coverage) as expected. The bottom two bands contained ribosomal 
protein S1 (47 kDa, 30% coverage) and elongation factor thermo-unstable (EF-Tu) (43 
kDa, 67% coverage) (Appendix 11).  
 
The presence of chaperones implies the protein was not folding correctly. Chaperone 
binding is also seen with other plant CDOs including PCO1 and PCO2 (See Chapter 3). 
The ribosomal protein S1 is an acidic, RNA binding protein that is part of the 30S 
ribosomal subunit (Draper and Hippel, 1978). It unwinds mRNA structures before entry 
into the ribosome, so is an important protein for translation (Subramanian, 1983). The 
reason for the interaction between maize A and the ribosomal protein S1 is not clear. EF-
Tu is a GTP requiring enzyme that promotes binding of aminoacyl-tRNA to the A-site 
of the ribosome, aiding in translation. EF-Tu is the most abundant protein in E. coli 
(Weijland et al., 1992), which may explain its presence in the purified protein solution.  
 
Improving Maize B solubility  
Not only did the protein appear to bind chaperones, but it appeared cloudy after elution. 
It was concluded that maize B had solubility issues, therefore, attempts were made to 
improve the solubility. A range of different lysis conditions were trialled. The theoretical 
pI was computationally calculated, and this was used to decipher what conditions to use. 
As the pI was predicted to be 6.1, buffers were produced to cover two pH units either 
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side of this value. Sodium citrate pH 4 and 5, and Tris pH 7.1 and 8 were employed. 
Excess salt, L-arginine and TWEEN®20 have in the past improved the solubility of other 
proteins so these solutions were also included in certain samples (Leibly et al., 2012; 
Lebendiker and Danieli, 2014). Further details of this experiment can be found in 2.4.10. 
 
Although a range of conditions were trialled in order to improve protein solubility, it is 
difficult to say whether or not any were successful. No clear bands of maize B can be 
seen in either of the gels (Appendix 12) except for the pellet fraction of lysis condition 
3. There is no obvious reason for the lack of protein in any of the samples. When the 
samples were centrifuged before being loaded on the gel, it is possible aggregate maize 
B was spun down to the bottom of the tube and not loaded. To prevent this in the future, 
the samples could be boiled for longer. 
 
A further expression trial of maize B was also conducted. This time, a different E. coli 
cell was used. Origami® cells are generally used for proteins that have difficulty folding 
as they contain disulfide bonds. Little maize B appeared to be expressed in this cell line 
so solubility testing or a trial purification was not conducted. The expression gel can be 
found in Appendix 13. Overall, expressing maize B in BL21(DE3) cells at 18°C for 6 h 
produced enough soluble protein for further experiments. In the future, it may be of 
interest to try expressing in another prokaryotic cell line. Eukaryotic cells lines could also 
be evaluated. 
 
4.2 Orzya sativa construct  
Orzya sativa or more commonly, rice, is a staple food source for over 3.5 billion people 
worldwide, and is of particular importance to those living in developing parts of Asia and 
sub-Saharan Africa. It plays a vital role in food security and the economy, providing over 
200 million jobs (Muthayya et al., 2014). Furthermore, it is fast becoming a model 
organism like Arabidopsis (Rensink and Buell, 2004). During cultivation, rice is often 
subjected to flooding conditions, therefore plant CDO may be very important for plant 




A plasmid containing the PCO2 isoform from rice was purchased. The construct was 
designed with residues 1-34 removed in an effort to improve protein stability, as this was 
proven to be the case with A. thaliana CDO (see Chapter 3). This construct was 
transformed into BL21(DE3) E. coli cells and was subsequently used to perform 
expression trials. Three temperatures were tested for 3 different lengths of time. The 
protein was termed ΔNR (N-terminal removed rice construct). For these expression trials, 
a clearly induced Coomassie stained band was analysed however the identity was never 
confirmed by MS.  
 
 
Figure 4.13. ΔNR expression in BL21(DE3). Equal number of cells as judged by OD600, 
were loaded into each lane. The negative sign indicates sample before induction and the 
numbers following this represents number of hours after induction. Where ΔNR is 
expected to run is indicated with a black arrow. The lane labelled M contains molecular 
weight marker. Marker as in Figure 4.1. 
 
 At 18°C there appeared to be little expression of ΔNR (predicted mass of 27 kDa) until 
6 h, and the most expression was after 20 h (Figure 4.13). When expressing at 28°C there 
was similar expression after 3 and 6 h, with the most ΔNR expressed after 20 h. 
Expression seemed to increase with induction time in the 37°C samples as the bands got 






Figure 4.14. ΔNR expressed in BL21(DE3) solubility at 28°C and 37°C. Loading was 
constant to allow for comparison. H indicates homogenate, S represents supernatant and 
P indicates pellet. Where ΔNR is expected to run is indicated with a black arrow. The 
lane labelled M contains molecular weight marker. Marker as in Figure 4.1. 
 
It appeared as though ΔNR was almost completely soluble under all conditions (Figure 
4.14). At 28°C the ΔNR band in the homogenate was the same intensity as the band found 
in the supernatant under this condition. This was also true of the 28°C 20 h sample, 
although the bands were more prominent suggesting more protein is present. The samples 
at 37°C showed the same trend.   
 
 
Figure 4.15. ΔNR expressed in BL21(DE3) solubility at 18°C. Loading was constant 
to allow for comparison. H indicates homogenate, S represents supernatant and P 
indicates pellet. Where ΔNR is expected to run is indicated with a black arrow. The lane 






There appeared to be somewhat more insoluble ΔNR at 18°C compared to 28 and 37°C 
(Figure 4.15).  After 6 h of induction, the band in the homogenate at ~27 kDa was found 
to be of similar intensity in the supernatant. A small band of this protein was found in the 
pellet under this condition. At 20 h, there appears to be slightly more protein present in 
the pellet. This implies that a greater portion of the protein was insoluble.  
 
Given the expression and solubility testing results, it was decided that expression would 
be conducted at 28°C for 20 h. Although there was comparable expression and solubility 
of ΔNR at 37°C for 20 h, 28°C had worked well in the past for other similar constructs. 




Figure 4.16. ΔNR expressed in BL21(DE3) Strep-Tag® FPLC purification. The blue 
line represents absorbance at 280 nm in mAU (left axis) and the red line represents 
conductivity in mS/cm and the X-axis shows elution volume in mL. Fractions numbers 
are included as this is the chromatogram that produced the samples analysed in Figure 
4.17. After sample application, the column was washing with running buffer until 60 mL, 
and this was followed by elution buffer from 60- 90 mL. A water wash occurred from 
90-110 mL followed by sodium hydroxide from 110-140 mL. The last wash was with 
water.  
 
The initial peak in the absorbance was comprised of cellular proteins that do not interact 
with the resin (Figure 4.16). This peak had a long tail, suggesting there is a protein/s 
present that is interacting weakly with the resin. During elution there was no peak in 
absorbance, suggesting that no ΔNR had bound the column. A second possibility is that 
the interaction between the protein and the resin was not being disrupted by the elution 
buffer. This would be surprising as the elution buffer from the same batch was used 
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successfully with other constructs. If this was the case, there would also be a large elution 
peak during column regeneration. It was thought that the protein weakly interacting with 
the column during the flow-through tail was ΔNR. This was tested by running these 




Figure 4.17. ΔNR expressed in BL21(DE3) Strep-Tag® FPLC purification gel. Lanes 
labelled with a letter and a number are fraction numbers. Where ΔNR is expected to run 
is indicated with a black arrow. The lane labelled M contains molecular weight marker. 
Marker as in Figure 4.1. Chromatogram that produced these fractions is found in Figure 
4.16.  
 
There is a prominent band where ΔNR is predicted to run in the flow-through (Figure 
4.17). This suggests that the protein may not have interacted with the resin. There was 
no other protein found in the remainder of the peak. The tail of the flow-through appears 
to comprise a non-protein molecule with an absorbance at 280 nm.  
 
As no protein was purified, it was thought that no protein had been expressed. The bands 
interpreted as ΔNR could have been another cellular protein. In an effort to produce ΔNR, 
it was expressed in two other cell lines. Samples of the expression trials were taken at 
various time points, and various temperatures were tested. All samples with acceptable 










Expression of ΔNR in BL21(DE3) pLysS cells 
BL21(DE3) pLysS cells are canonically used for producing proteins that are toxic to 
bacterial cells. These cells contain the pLyS plasmid which prevents any uninduced 
expression by inhibiting basal levels of the T7 RNA polymerase (Invitrogen, 2018). 
Although toxicity is not predicted to be an issue ΔNR, changing cell lines can change the 
experimental outcome.  
 
 
Figure 4.18. ΔNR expression in BL21(DE3) pLysS. Equal number of cells as judged 
by OD600, were loaded into each lane. The negative sign indicates sample before 
induction and the numbers following this represent hours after induction. Where ΔNR is 
expected to run is indicated with a black arrow. The lane labelled M contains molecular 
weight marker. Marker as in Figure 4.1.  
 
Induction at 18°C showed a prominent band after 3 h, with expression increasing slightly 
after 6 and 20 h (Figure 4.18). At 28°C the same trend is seen. Expression at 37°C 
showed bands after 3 and 6 h induction, but no protein after 20 h. The absence of a band 
in this lane is likely due to under-loading as no other cellular proteins are visible in this 
lane.  All pre-induction samples have no protein expressed, but this may be because many 
of the pre-induction lanes appear under-loaded. All 6 and 20 h samples were subjected 
to solubility testing (Appendix 14 and Appendix 15). Given the results from the 
expression and solubility testing, pellet produced at 28°C for 6 h was used for a trial 







Expression of ΔNR in Origami™ (DE3) cells 
These cells are designed to aid proteins that have difficulty folding in E. coli cells as they 
contain disulfide bonds. Origami™ contains mutations in the two genes, thioredoxin 
reductase and glutathione reductase. These mutant proteins aid in the formation of 
disulfide bonds in the cystoplasm, which is highly reducing under usual conditions. As 
with the other cell lines used, they are inducible with IPTG and compatible with plasmid 
containing amp resistance (Bessette et al., 1999). An attempt was made to express ΔNR 
in Origami™ cells as both computational and experimental evidence suggested that plant 
CDO may contain disulfide bonds (Chapter 5).  
 
 
Figure 4.19. ΔNR expression in Origami™ (DE3). Equal number of cells as judged by 
OD600, were loaded into each lane. The negative sign indicates sample before induction 
and the numbers following this represent hours after induction. Where ΔNR is expected 
to run is indicated with a black arrow. The lane labelled M contains molecular weight 
marker. Marker as in Figure 4.1.  
 
The bands present where ΔNR would run become increasingly dense over the induction 
period (Figure 4.19). At 18°C there was limited expression until 20 h, which contained 
the most protein. However this lane does appear to be over-loaded as other cellular 
proteins were also denser. Induction at 28°C was more successful than that of 18°C. 
There was expression after 3 h of induction, but the amount of protein produced did not 
seem to increase substantially for the next two time points. The sample at 37°C lacked 
any expression. All 6 and 20 h samples were subjected to solubility testing (Appendix 
18 and Appendix 19). Given these results, pellet produced from induction at 28°C for 6 





After attempts were made to express ΔNR in three different cells lines were unsuccessful, 
it was thought that the protein was not expressing at all. To determine if the bands 
analysed were ΔNR, the band at ~27 kDa from the 28°C 6 h supernatant lane of 
Appendix 14 was sent for identification using MS. The results showed that the protein 
was a 26 kDa E. coli chloramphenicol acetyltransferase with 35% identity (Appendix 
22). As there were no peptides of ΔNR present, it was confirmed that the protein was not 
expressing in BL21(DE3) pLysS, and potentially the other cell lines tested. 
 
The lack of protein expression could be due to a range of factors. It was considered that 
the plasmid may have an early stop codon or the wrong inducer was being used for the 
plasmid. The plasmid was sequenced by GAS and the results showed that both the insert 
and the plasmid were correct (Appendix 23). Other factors considered were protein 
toxicity, ribosomal stalling and poor folding (Rosano and Ceccarelli, 2014). Protein 
toxicity was ruled out as the protein was able to be efficiently transformed into 
BL21(DE3) cells which do not prevent uninduced expression. 
 
Ribosomal stalling was considered as this prevents the protein from being translated, and 
can lead to degradation of the mRNA (Sunohara et al., 2004). Stalling is often due to the 
presence of a string of rare codons or a specific sequence that the ribosome recognises 
(Krasheninnikov et al., 1991; Peil et al., 2013). As it is widely known that E. coli has 
different codon bias to eukaryotic cells (Buchan and Stansfield, 2005), maize B was 
codon optimised for E. coli in the synthetic gene used. Given this, maize B does not 
appear to contain any likely ribosomal stalling sites.  
 
The most likely reason is poor protein folding. If a protein is folded incorrectly, it can be 
tagged for degradation in the cell by chaperones (Gething and Sambrook, 1992). If this 
was the case, it would mean that the protein is expressing as is expected, but the translated 
product is being degraded quickly after. As it appears that expression levels were low in 
Origami™ cells, it is likely that the failure to fold correctly is not disulfide bond related. 
For future experiments, it is suggested that the C-terminal Strep-tag® is removed and 
replaced with a hexahistidine tag. As this is already built into the construct, simple 




4.3 Summary  
All Zea mays constructs were able to expressed and purified. All purified proteins were 
subjected to mass spectrometry for identification. This was to ensure that the correct 
protein was purified, and that no mutations were present in the protein. All proteins 
purified were identified with high confidence. See Appendix 10 (Maize A) and 
Appendix 11 (Maize B).  
 
Figure 4.20. Summary of all purified Maize CDO constructs. The lane labelled M 
contains molecular weight marker. Marker as in Figure 4.1. Ma indicates maize A, and 
Mb indicates maize B.  
 
Both constructs purified from maize did not produce chaperone free protein (Figure 
4.20). Maize A binds what appears to be DnaK, and has a range of degradation products 
that arise post-purification. These truncated products could not be removed using cation 
exchange chromatography. Maize B interacts with 5 contaminant proteins, two of which 
have been confirmed to be chaperones. This implies there are folding issues with the 
construct. Unlike maize A, maize B does not lead to the production of many truncated 
versions of the protein post-purification. This implies that the truncation has prevented 
proteolysis of maize B’s termini.  
 
The construct of Oryza sativa origin, ΔNR, was not able to be expressed and therefore 
was not able to be purified. Future experiments should focus on trying to remedy this. As 




Chapter Five  
Structural modelling and analysis  
One of the most informative elements of protein characterisation is determining the 
structure. Gaining structural insights not only makes physical properties clear, but it also 
provides an idea of protein function and dynamics. Atomic resolution models can be 
experimentally determined using several methods including NMR spectroscopy, X-ray 
crystallography and electron microscopy. The most common method is X-ray 
crystallography (Smyth and Martin, 2000), with 86% of all structures in the protein data 
bank (PDB) determined by this method in 2011 (Dessau and Modis, 2011).  
 
Protein crystals are formed by supersaturating purified protein, which slowly precipitates 
to form an ordered crystalline structure under certain conditions. When an X-ray beam 
hits the protein crystal, it diffracts to form a characteristic pattern of spots termed a 
diffraction pattern. If a clear diffraction pattern is produced, it can be analysed to produce 
an electron density map. This map is then used to fit the amino acid sequence using the 
preferred geometry of each amino acid, and knowledge of the chemical nature of the 
polypeptide. Once the sequence is fitted to the map and the structure is deemed 
energetically favourable, the atomic model is produced (Nurachman, 2004; Drenth and 
Mesters, 2007).  
 
Unfortunately, it can be difficult to crystallise certain proteins for reasons such as 
flexibility and heterogeneity. Instead, a computational method termed homology 
modelling can be employed to predict the structure. This method uses the assumption 
that similar amino acid sequences will have a similar structure. This is often correct as 
sequences evolve quickly, whilst the structure retains the same general topology as 







This technique uses the amino acid sequence of the protein of interest and a known 
homologous protein structure to produce a 3-D model of the protein of interest.  In silico 
structural predictions are not as precise and reliable as experimentally determined 
structures, but they provide rapid results that are inexpensive. The process begins with 
recognising a template by aligning the two sequences. A backbone is generated using the 
template co-ordinates, and loops are modelled in the gaps. Side chains are then orientated 
and the model is optimised to ensure energetic favourability. See review by (Dorn et al., 
2014) for more information on approaches to modelling.  
 
5.1  Homology models 
Models of PCO1 were produced using two servers, SWISS-MODEL and I-TASSER. 
SWISS-MODEL used bacterial CDO (3USS) as the template to which the server found 
16% sequence similarity to PCO1. I-TASSER utilised mammalian CDO (2B2H) as the 
template, which shares 24% sequence identity with PCO1 (calculated using BLAST). A 
protein with greater than 80 amino acids requires a template with greater than 25% 
homology for confidence in the resulting model (Sander and Schneider, 1991). Both 
values are outside the suggested minimum sequence identity, but nevertheless only a few 
homologues are available with a solved structure. The automated function was used for 
the SWISS-MODEL tool, see (Swiss Institute of Bioinformatics, 2018) for details on 
modelling framework. The automated function of I-TASSER was also employed with no 






Figure 5.1. Comparison of homology models. The side chains of histidine residues that 
co-ordinate the iron (orange sphere in the left model) are shown as sticks. For the SWISS- 
MODEL (left), core structure was modelled. PDB accession number 3USS was used as 
the template and Gobal Model Quality Estimation (GMQE)= 0.33 and QMEAN= -4.47. 
The I-TASSER model (right) showed the full structure, and the template used was PDB 
accession number 2B2H. Estimated TM-score =0.37±0.13 and C-score=-3.04. Chimera 
was used to produce these images. 
 
Both models produced contained the same overall architecture (Figure 5.1). The central 
component of the structures comprise  a β-barrel with iron co-ordinating histidine 
residues. The SWISS-MODEL was able to orientate the histidines with iron present in 
the model, whereas the I-TASSER model does not have the histidines in the correct 
orientation for this to occur. The histidines however, are in close enough proximity to 
interact if side chains are reoriented. Two α-helices in the central structure are also 
present on both models. Two further α-helices are present on the C-terminal end of the 
I-TASSER model as it modelled the ends. The I-TASSER model does appear to contain 
more loop regions than the SWISS-MODEL. Quality assessment of each model is 








 SWISS-MODEL homology model  
 
 
Figure 5.2. SWISS-MODEL homology model of PCO1. The left depicts a homology 
model of PCO1 (tan). The side chains of histidine residues that co-ordinate the iron 
(orange sphere) are shown as sticks. The right shows PCO1 (blue) superimposed on 
mammalian CDO (tan, PDB accession number 2B5H). N- and C-terminal residues of 
PCO1 are not modelled. PDB accession number 3USS was used as the template for the 
PCO1 model and Chimera was used to produce these images. Quality measures as in 
Figure 5.1.  
 
In regards to overall structure, PCO1 is comprised of a β-barrel with two prominent α-
helices (Figure 5.2, left). As seen in mammalian CDO, there is a predicted cupin-like 
motif also present in PCO1. The only elements of the structure that differ are within 
loops. Slight changes in loop sizes may be as a result of the need to accommodate 
different substrates. The 3-His triad which co-ordinates the central iron overlays well, 
with slight differences in one of the histidines (Figure 5.2, right). The His-triad 
conservation in PCO1 predicts that PCO1 binds iron the same way, suggesting that iron 
is important for the catalytic mechanism. The secondary structure of the PCO1 model is 
plausible as it contains predicted cupin motifs and β-sheets. The lack of modelling for 




When considering model quality, two main parameters are assessed in SWISS-MODEL, 
GMQE and QMEAN. GMQE is a measure that considers alignment of the target and 
template, as well as the template search method. This value is between 0 and 1, where a 
higher value indicates a better quality model. The GMQE value for this model was 
reported as 0.33 therefore suggesting the model is not of high quality. This is because the 
target does not fit the template, which is unsurprising with only 16% sequence similarity. 
A QMEAN value is an estimate formed by combining a range of geometric properties 
that assess both local and global folding quality. It compares features of the model to 
features seen in other structures to determine how likely they are. A QMEAN value of 0 
indicates good agreement between the model and other reported structures. When the 
score drops below -4.0, the model is designated as low quality. This model had a score 
of -4.47, placing it in the low quality category. Given this, the structure should be 




Figure 5.3. SWISS-MODEL homology model of PCO1 surface topology. Blue 
shading refers to the nitrogen atoms of the iron co-ordinating histidine residues. Model 
is the same as in Figure 5.2. 
 
The theoretical substrate entry site is large and lines up well with the His-triad and iron 
(Figure 5.3). The substrate entry site is large compared to that of mammalian CDO (not 
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pictured). This is likely due to the need for PCO1 to accommodate a much larger 
substrate, as it is a polypeptide. Interestingly, the active site is open on both sides of the 
structure. One possible reason for entry on both sides of the structure is that it permits 
entry of the co-substrate, molecular oxygen, after the target peptide has entered the active 
site. If there were only one entry site, and the peptide entered first this could block 
molecular entry, and thus prevent catalysis. This active site model allows a random rather 
than sequential order of substrate binding. 
 
 
Figure 5.4. SWISS-MODEL homology model of PCO1 with catalytic residues. 
Tyrosine 229 is shown with a red side chain (OH group) and phenylalanine 213 is also 
shown. Model is the same as in Figure 5.2. 
 
In mammalian CDO, a tyrosine residue within the active site is proposed to play an 
important role in catalysis (See 1.5.1). This tyrosine is completely conserved among 
CDO from other origins (Figure 1.9). PCO1 does not have a tyrosine residue in this 
position, instead it is replaced by phenylalanine. As the His-triad is conserved, it is 
proposed that the iron catalytic mechanism is also conserved. This would mean that a 
hydroxyl group in close proximity to the active site would also be required in PCO1. It 
is proposed that a tyrosine 229 could act as the catalytic tyrosine (Figure 5.4). No other 
hydroxyl groups are predicted to be in close proximity to the active site. A tyrosine in 
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this position is completely conserved in plant CDO from all species in the sequence 
alignment in Figure 3.1.  
 
 In this model the distance between the phenylalanine and central metal ion was 
determined to be 6.6 Å (Figure 5.4).  The tyrosine present in the model was shown to be 
4.2 Å from the central metal ion. Although this does not assess whether or not the 
molecule is in the correct orientation, it appears that the tyrosine is close enough spatially 
to aid in catalysis. To determine if this theory is correct, a Y228F mutant could be 
produced. Phenylalanine would occupy the space in the same manner, but the proposed 
catalytic hydroxyl group would not be present.  
 
 I-TASSER homology model  
 
 
Figure 5.5. I-TASSER homology model of PCO1. The side chains of histidine residues 
that co-ordinate the iron are shown as sticks. Tyrosine 229 is also shown with a red side 
chain (OH group). PDB accession number 2B5H was used as a reference and Chimera 
was used to produce the image. Quality assessment as in Figure 5.1.   
 
This model predicts a structure comprising mostly β-strands (Figure 5.5). There are two 
α-helices close to the core β-barrel, and two further α-helices are suggested at the C-
terminal end. The N-terminal end appears to be an irregular loop, aligning with previous 
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experimental data suggesting it is disordered. The histidines of the iron co-ordination 
sphere are present in close proximity as expected. However, the side chains would require 
re-orientation to co-ordinate a metal ion. This is unsurprising as the model was energy 
minimised without iron present. Tyrosine 229 in this model is close to the active site 
showing that a role in catalysis is spatially plausible. 
 
A C-score is a value to describe the confidence in the quality of the model. The number 
range is from -5 to 2, where the larger the number the better the quality. This model has 
a C-score of -3.04, which implies little confidence in the model quality. This is likely due 
to the lack of sequence similarity between plant and mammalian CDO. The TM-score is 
a measure of how closely related the model structure and the query structure are post-
modelling. This is used as it is not as sensitive to local error as the estimated root-mean-
square deviation of atomic positions (RMSD). A TM-score of 0.37±0.13 shows that the 
models show relatively similar geometry. Overall, the model assessment parameters 
suggest the model is of average quality, and should be analysed with caution.  
 
 
Figure 5.6. I-TASSER homology model of PCO1 superimposed on mammalian 
CDO. PCO1 (blue) is superimposed on mammalian CDO (tan). The side chains of 
histidine residues that co-ordinate the iron (orange sphere) are shown as sticks. PDB 
accession number 2B5H was used as a reference and Chimera was used to produce the 




The core structure of the I-TASSER model and the mammalian CDO structure share 
many similarities (Figure 5.6). They both contain a series of β-strands and the cupin 
motif that forms the characteristic β-barrel fold. Only two α-helices are present in the 
central structure for both mammalian and PCO1. The only element that differs between 
the two core structures is the loop formations. This is unsurprising as the sequences are 
not similar, and the substrate size differs extensively. The N- and C-terminal regions of 
the two proteins are very different. PCO1 has extended ends that are not present on 
mammalian CDO. The N- terminal appears to be a disordered loop, whilst the C-terminus 
appears to contain two α-helices as well as irregular regions. This aligns with previous 
experiments that suggested these regions were disordered (Chapter 3). The C-terminus 
is more ordered than that of the N-terminal, which is perhaps why C-terminal removal 
resulted in several co-purifying contaminants, including at least two chaperones. 
 
 
Figure 5.7. I-TASSER homology model of PCO1 surface topology. Iron co-ordinating 
histidine residues are shown as sticks. Model as in Figure 5.5. Quality assessment as in 
Figure 5.1. 
 
The iron co-ordinating residues align well with the proposed substrate entry site (Figure 
5.7). This substrate entry site does not penetrate to the other side of the protein as with 
the SWISS-MODEL homology model. The I-TASSER model seems to predict sequential 
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binding. It has been shown experimentally that the O2 molecule must enter the active site 
first in mammalian CDO for catalysis to occur. This sequential binding, with O2 first, is 
consistent with the arrangement of this active site. The exterior of the protein may aid in 
recognising the substrate, as the peptide would extend out of the protein and interact with 













Figure 5.8. PCO1 and RAP2.12 surface topology with charge distribution. RAP2.12 
(left), PCO1 (right). Blue represents a positive charge, and red represents a negative 
charge. I-TASSER was used to produce both models. PDB accession number 2B5H was 
used as a reference for PCO1 and Chimera was used to produce the image. Quality 
assessment for PCO1 as in Figure 5.1. Active site of PCO1 is facing forward.  
 
The positively charged region at the bottom of the RAP2.12 structure is the DNA binding 
domain (Figure 5.8, left). This allows electrostatic interactions with the negatively 
charged DNA. This is important for the role of RAP2.12 as it is a transcription factor, 
and must interact with the DNA to perform its function. RAP2.12 also has a negatively 
charged region at the top of the structure. There are no known functions for this 
negatively charged region, although it is a feature of many transcription factors. This may 
be present to balance the pI of the protein, or it could be present to permit an interaction 
with PCO1. The model of RAP2.12 mostly comprises loops, and no similar transcription 
factor structures have been solved. This resulted in a structure with low confidence, and 
thus suggests the model should be analysed with caution.  
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When the charges are mapped on the exterior of PCO1, it is clear that there are two 
distinct regions (Figure 5.8, right). The left side (as shown) is positively charged which 
would be permit both a mutually exclusive electrostatic interaction with DNA or with 
RAP2.12. The negatively charged region on the right may be present to balance the pI of 
the protein, or to allow another unknown interaction. Charges were also mapped on 
mammalian CDO to determine if this was characteristic of all CDOs. The charge 
distribution was even on mammalian CDO (Appendix 24), therefore the charge 
distribution of PCO1 is specific and likely reflects its function. Production of a docking 
scheme using molecular dynamic tools could aid in assessing this relationship further.   
 
 
Figure 5.9. I-TASSER homology model of ΔN surface topology. Red shading refers 
to the histidines of the iron co-ordinating histidine residues. PDB accession number 
2B5H was used as a reference and Chimera was used to produce the image. Image was 
produced by removing the first 40 residues of the model in Figure 5.1. Quality 
assessment as in Figure 5.1. 
 
When the model of PCO1 was produced in Figure 5.7, the substrate entry site appeared 
to be smaller than expected. Although a single amino acid could easily fit in this space, 
a peptide is much larger. The N-terminus sits close to the substrate entry site, and so it 
was thought that it may move for substrate binding. The lack of regular structure in this 
element also suggested that movement is possible. This is directly supported by limited 
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proteolysis conducted in Figure 3.15. Given this theory, a ΔN model was produced to 
see if this would change the size of the active site.  
 
The active site in Figure 5.9 is indeed much larger than the active site of the full length 
model. The histidine residues are still aligned well within the active site, as expected. 
Below the active site, there is a concave element to the structure. This could act as a cleft 
for binding of the amino acids of peptide targets that protrude outside the active site, 
aiding in substrate recognition. This cleft could be responsible for recognising the end of 
the ~10 amino acid N-terminal recognition sequence of all PCO1 targets. 
 
5.2 Disulfide bonding   
When analysing the sequence alignment of plant CDOs from various plant origins, it was 
observed that there were an array of conserved cysteines (yellow in Figure 3.1). PCO1 
cysteine residues 129, 138 and 218 were completely conserved between the species 
analysed. Cysteine residues 21 and 230 were not at all conserved and residues 65, 197, 
and 235 were mostly conserved. The presence of highly conserved cysteines can 
highlight important structural or catalytic roles. As cysteine residues can participate in 
covalent disulfide bonding, they contribute to structural rigidity (Fass, 2012). Given this, 






Figure 5.10. SWISS-MODEL homology model of PCO1 with cysteine residues 
mapped. The side chains of histidine residues that co-ordinate the iron (orange sphere) 
are shown as sticks. Cysteine side chain residues are shown as red sticks, and residue 
position is labelled. N- and C-terminal residues are not modelled. PDB accession number 
3USS was used as a reference and Chimera was used to produce these images. 
 
Mapping of PCO1 cysteine residues (N-terminal C21 was not included) on a homology 
model suggested a number of pairs in close enough proximity to interact (Figure 5.10). 
In particular, C65 and C129 (left) were predicted to interact, along with C138 and C218 
(top right). Although the side chains appeared to lack the correct orientation to mediate 
an interaction, the orientation is based solely on a model and therefore may not be correct. 
If there are disulfide bonds present in PCO1 as suggested, then it is possible that the 
presence of chaperones during purification may be due to misfolding as a result of 
incorrect disulfide bonding.  
 
This result aligns well with the sequence comparison data, as it also suggests C65, 129, 
138 and 218 are important structurally. Both the conservation of these residues and 
placement on the structure suggest a role in disulfide bonding. The presence of disulfide 
bonds was tested experimentally by running an SDS-PAGE gel of PCO1 in the presence 












Figure 5.11. PCO1 ± BME. Where PCO1 is expected to run is indicated with a black 
arrow. The lane labelled M of the left SDS-PAGE gel contains molecular weight marker. 
Marker masses are indicated in kDa and each band contains 500 ng of protein.  
 
BME is present in SDS-PAGE loading dye to reduce cysteine residues and promote 
protein denaturation. This ensures that protein runs as a clean band, and it migrates as 
expected on an SDS-PAGE gel. PCO1 ran as expected when denatured by BME as a 
clean band at 36 kDa (Figure 5.11). When no BME was present, the band of PCO1 was 
smeared and protein ran both higher and lower than expected. A band is also found at the 
top of the gel, suggesting potential higher order structures with intermolecular disulfide 
bonds are present. DnaK and groEL contaminants run as discrete bands independently of 
reductant. Both are deficient in cysteine, groEL completely so. As changes were observed 
in the band of PCO1 in the absence of BME, this suggests that there are intramolecular 
and/or intermolecular disulfide bonds present in the purified, recombinant protein.  
 
To determine which residues are forming disulfide bonds, reduction and alkylation 
experiments were conducted followed by MS. Iodoacetamide (IAM) and iodoacetic acid 
(IAA) are chemicals that are able to attack free thiol groups, and thus can be used to tag 
reduced cysteine residues. Light and heavy versions of these chemicals were used to 
enable differentiation based on molecular weight. For the experiment, PCO1 was 
exposed to light IAM, then reduced and exposed to heavy IAA. This means that any 
residues with light IAM were not protected and were unlikely to be participating in 
disulfide bonding. Residues with heavy IAA were protected from IAM until reduced, and 






Figure 5.12. Alternative labelling of PCO1 cysteines followed by MS. Grey arrows 
indicate cysteine residues covered in peptides not detected, green- light IAM, red- IAA 
and purple both labels. Analysis done by Torsten Kloeffman of the CPR. Residue 
numbers are to the labelled to the left.  
 
Cysteine residues 21, 138 and 218 were not detected (Figure 5.12). This may due to the 
formation of large fragments post-digestion that are not able to be detected by the mass 
spectrometer. Cysteine 65 showed both labels, which suggests that it could be 
participating in disulfide bonding such as predicted. Cysteine 129, 197 and 236 were not 
protected, and therefore do not appear to be participate in disulfide bonding. Only one 
cysteine residue, C230 was confirmed to form a disulfide bond. This residue was not 
predicted to form a disulfide bond, thus this was an unexpected result. 
 
As there were only two residues that appeared to form disulfide bonds, C230 and C65, 
these residues were assessed spatially in the structure in Figure 5.10 to determine if they 
could interact. Cysteine 65 is constrained by an α-helix, whilst C230 is part of a long 
loop region. The flexible loop region of C230 could permit the movement required to 
allow these residues to come into close proximity.  
 
Unfortunately, two residues of interest (C218 and C138) were not able to be detected. 
Cysteine C65 also give rise to an ambiguous result. It would be preferable to repeat this 
experiment to ensure the reliability of these results, and to resolve the uncertainty of 
specific residues. Using chemical labels that have a greater mass difference such as 
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proprietary isotope coded affinity tag reagents would aid in improved data as it is easier 
to distinguish between the two labels. Digestion with a different enzyme could also 
improve the result, as different peptides would result. A further experiment that could be 
conducted is mutating each of the cysteine residues and assessing protein folding. 
Removal of cysteines participating in disulfide bonds should decrease protein stability, 
and prevent proper folding.  
 
Intriguingly, the presence of disulfide bond may permit a conformational change in 
relation to redox state. The role of cysteine residues as redox sensitive switches has been 
seen with other proteins (Barford, 2004). As plant CDO acts as an oxygen sensing 
protein, this cysteine mediated conformational change may switch the protein from an 
‘off” to an ‘on’ state or vice versa. For example, if normoxia oxidised the cysteine 
residues, this would encourage disulfide bonds and lead to plant CDO being switched 
‘on’. The ‘on’ state would then allow the protein to act on targets, as they are not required 
in normoxia. Conversely, when oxygen levels are low the cysteine residues would be 
reduced and not able to form disulfide bonds. This would switch the protein ‘off’ by 
encouraging a conformational state that prevents or decreases substrate binding. There is 
also a possibility that oxidation reduces plant CDO activity, and reduction increases it. 
This relationship could be explored further using reactive oxygen species and reductants 
in vitro.  
 
As MS experiments showed that PCO1 may contain disulfide bonds, a refolding 
experiment was conducted to determine if this could improve protein stability. Refolding 
was induced by incubating PCO1 overnight with varying ratios of reduced (GSH) and 
oxidised (GSSG) glutathione. GSH encourages the reduction of disulfide bonds, whilst 
GSSG aids in the formation of disulfide bonds. Presence of a mixture of GSH and GSSG 
allows for the re-organisation of disulfide bonds, to ensure the correct bonds are formed 
(Gilbert, 1990). The correct disulfide bond formations permit the protein to fold properly, 






Figure 5.13. PCO1 refolding samples ± BME. Lane labelled C contains control, 1, 5 
mM GSH, 0.5 mM GSSG, 2, 5 mM GSSG, 0.5 mM GSH and 3, 2 mM of each. Where 
PCO1 is expected to run is indicated with a black arrow. The grey arrow indicates the 
band that had relative motility calculated.  The lane labelled M contains molecular weight 
marker. Marker as in 5.11.  
 
The results could not be assessed under the conditions of BME as this reduces any newly 
formed disulfide bonds. A reducing SDS-PAGE gel was run for comparison, and to 
assess protein concentration (Figure 5.13, left). The control sample, as well as sample 3 
(5 mM GSSG, 0.5 mM GSH) appeared to have less protein loaded, even though all 
samples were prepared from the same stock (Figure 5.13, right). All samples in the 
presence of glutathione appear to have formed higher order structures.  
 
The higher order structures may comprise PCO1, or PCO1 and multiple DnaK 
monomers. To determine this, the bands at ~68, 140 and 180 kDa were excised and 
subjected to identification using MS. The results showed that the ~68 kDa band 
comprised DnaK, and the other two bands were higher order structures of PCO1 as only 
background levels of DnaK was found (Appendix 25). The size of the ~140 kDa 
molecule was determined using Rf (Appendix 26) to estimate how many PCO1 
monomers were present. The results indicated that this band was a tetramer (138 kDa, 
allows for four 34 kDa PCO1 monomers), and it is likely that the above bands are simply 






The formation of higher order structures of PCO1 in a non-reducing gel suggest that 
intermolecular disulfide bonds may be present. Strangely, no dimer or trimers were 
observed. This means that several CDO molecules are required to form stable higher 
order structures. Interestingly, intracellular proteins usually lack disulfide bonds as the 
cytosol is a reducing environment. However, these experiments suggest there are 
intermolecular disulfide bonds, and thus when difficulty with solubility and expression 
arose with some constructs Origami™ cells were used (Chapter 4). The samples from 
this experiment were further analysed by testing iron binding efficiency and performing 
kinetic assays; these results are found in Chapter 6.  
 
5.3  Domain analysis  
PCO1 was submitted to a range of online servers to decipher if the protein contained any 
motifs. ScanProsite showed several potential glycosylation and myristylation sites as 
well as a multitude of potential phosphorylation sites (Appendix 27).  However, all of 
these potential post-translational modifications are often found with high frequency, and 
therefore significance is difficult to assess lacking biological information. The final motif 
hit suggested an N-terminal nuclear localisation signal (NLS).  
 
NLS tags allow entry of the protein into the nucleus of the cell. Two classic types of NLS 
exist, monopartite and bipartite. Monopartite consists of either a series of basic amino 
acids (>4) (Kalderon et al., 1984) or the consensus sequence K(K/R)X(K/R) (Dang and 
Lee, 1988). Bipartite is a series of basic amino acids followed by a 10-12 amino acid 
linker, followed by a second string of basic amino acids (K/R)(K/R)X10–12(K/R)3/5. The 
size of linker sequence is optimal for the binding groove of importin, the nuclear 
localisation mediating protein (Kosugi et al., 2009).  
 
The predicted NLS of PCO1 was scored with low confidence, suggesting that this should 
be assessed with caution. This proposed NLS is within the N-terminal domain of the 
protein, which is thought to be disordered. The sequence was reported to be bipartite, 
conforming to the proposed consensus sequence (K/R)(K/R)X10–12(K/R)3/5. Of the 
nuclear proteins, 56% contain a NLS whilst only 4% of cytoplasmic proteins contain this 
motif. This means that almost all proteins with  this motif are transported into the nucleus 
131 
 
(Lacasse and Lefebvre, 1995). This result is consistent with protein size, as only proteins 
smaller than 40 kDa are able to be transported though the nuclear pores (Lange et al., 
2006). This would also explain why the N-terminus lacks structure as it needs to be 
exposed for protein-protein interactions that allow for nuclear import. This is consistent 
with data by Weits et al. which used fluorescent labelling to show that PCO1 is a nuclear 
protein (Weits et al., 2014).  
 
For 90% of the proteins with a known NLS and DNA binding domain, these regions 
overlapped in the protein sequence (Cokol et al., 2000). This suggests a dual purpose for 
the sequence, and reflects that NLS are comprised of many positively charged basic 
residues. These regions allow for an electrostatic interaction with the negative charged 
DNA, as well as regulation by nuclear transport mediating proteins. The linker region of 
bipartite NLS has also been shown to interact with DNA, mediating DNA binding (Choo 
and Klug, 1993). This result further suggests that DNA binding by PCO1 is not an 
artefact of purification, and that it may be important for protein activity in vivo (Chapter 
3).  
 
To experimentally determine if PCO1 does contain an N-terminal NLS, fusion to a green 
fluorescent protein (GFP) could be used.  If PCO1 and ΔN were both tagged with GFP, 
one could assess protein localisation within the cell. If the N-terminal domain does 




After producing computational homology models, crystallography was attempted to 
produce an experimental model. Although homology models provide a detailed view of 
predicted protein structure, generating an experimental model is much more reliable. 
Forming an experimental model would also allow the presence of disulfide bonds to be 
explored, as well as suggesting which residues are important for catalysis based on 




 Arabidopsis thaliana constructs  
Before crystallography was performed, purified A. thaliana protein samples were 
assessed. Ideally, protein samples are monodispersed, as this implies that the sample is 
homogenous. Homogenous protein samples are more likely to form crystals as each of 
the protein units are identical, allowing for optimal crystal packing. The technique used 
was dynamic light scattering (DLS) to determine the size and distribution of particles in 
solution. Several parameters were assessed. 
 
Table 5.1. DLS of A. thaliana PCO1 derivatives.   
Construct R (nm)1 
Polydispersity 
(%)2 
MW (kDa) Mass (%)3 Counts4 
PCO1 9.9 36.1 721 96.6 27 
ΔN 2.6 12.7 33 95 27 
ΔNΔC 7.3 23 351 77 29 
1R refers the hydrodynamic radius, and is a further measure of molecule size. 
2Polydispersity <20% is indicative of monodispersity. 
3Mass shows what percentage of the total solution is comprised of the stated molecular 
weight. 
4Counts indicates the number of readings taken to obtain the values listed.  
 
DLS suggested that the purified PCO1 assessed was not a homogenous sample as 
polydispersity is 36% (Table 5.1). The molecular weight of PCO1 was predicted to be 
~34 kDa, therefore a molecular weight of 721 kDa implies that large aggregates were 
present in solution, which may have been comprised of PCO1 alone or PCO1 in complex 
with chaperones. DNA bound to PCO1 may have also influenced the results. ΔN had low 
polydispersity, and the molecular weight was close to the predicted molecular weight of 
ΔN of 28 kDa. This shows that the purified ΔN assessed was homogenous. ΔNΔC had 
23% polydispersity, which is above the recommended value for homogenous protein 
samples. The molecular weight reported, 351 kDa, was much higher than the predicted 
molecular weight of ΔNΔC of 23 kDa. This suggested that large aggregates of ΔNΔC or 




DLS results for PCO1 suggested very large aggregates were present in solution. DLS can 
at times be problematic, giving false readings due to dust present in the samples or 
cuvette. Given this, a further experiment was conducted to ensure the reliability of the 
DLS data for PCO1. Gel filtration was used as it enables one to determine the size of 
proteins components within solution. If large aggregates are present, then a peak will be 
present early in the chromatogram.  
 
 
Figure 5.14. PCO1 Superdex 200 gel filtration. The blue line represents absorbance at 
280 nm in mAU (left axis) and the red line represents conductivity in mS/cm (right axis). 
Standard elution volumes indicated by a black arrow, with molecular weight indicated in 
kDa. Standard proteins: Thyroglobulin (660 kDa), Ovalbumin (43 kDa), Myoglobin (17 
kDa) and Vitamin B12 (2 kDa). Standard values from (Hsu, 2009). Fractions relate to the 
samples used for Figure 5.15. Resin was sephadex.  
 
Gel filtration resulted in three clear peaks (Figure 5.14). The first peak at 120 mL eluted 
quickly, and therefore was made of larger protein/s. The standard indicates this peak was 
comprised of proteins slightly larger than 670 kDa. This is likely to be the large 
aggregates of PCO1 detected by DLS. There are two very small peaks, one at 185 and 
one at 220 mL elution volume. The sizes of molecules eluting in this peak were ~65 kDa 
and ~35 kDa, which is consistent with DnaK and PCO1 respectively. The second main 
peak that begins at 270 mL, overlapped with a peak at 300 mL elution volume. As these 
peaks eluted later, they comprised smaller molecules (around 2 kDa). Gels were run to 
determine what the peaks comprised. 
 
↓ ↓ ↓ ↓ 




Figure 5.15. PCO1 Superdex 200 gel filtration SDS-PAGE gel. A letter followed by 
a number indicates a fraction, and numbers above indicates the first number of the 
fraction e.g. 1.C.2. The lane labelled M contains molecular weight marker. Where PCO1 
is expected to run is indicated with a black arrow.  Marker as in Figure 5.10. 
Chromatogram that relates found in Figure 5.14. Ten microlitres of each fraction was 
loaded.  
 
The first peak from the chromatogram in Figure 5.14 produced a band on an SDS-PAGE 
gel at ~36 kDa (Figure 5.15). This suggests that the peak comprised PCO1 aggregates 
or higher order structures. As this peak eluted early and comprised PCO1 this suggested 
the DLS was correct. The first of the insignificant peaks resulted in a thin band at ~ 69 
kDa, suggesting that the peak comprised DnaK.  The second insignificant peak, as well 
as the two peaks at the end of the run showed no bands on a gel. This implies that a non-
protein molecule with an absorbance at 280 nm is eluting, or that the concentration is 
below that which can detected by SDS-PAGE.   
 
Overall, it appears that co-purification with chaperones, DNA binding and higher order 
structures have affected the homogeneity of the PCO1. Co-purification with chaperones 
also has influenced homogeneity of ΔNΔC. This suggests that both PCO1 and ΔNΔC are 
not optimal for protein crystallography. Unfortunately, no means were produced to 
remove the chaperones and improve protein homogeneity (3.2.1). Therefore, these 
proteins were used for crystallography experiments regardless. In the past, protein 
crystals have been formed from impure samples, with some protein purification methods 
even employing crystallography to separate the protein of interest from other cellular 




This is due to the fact ΔN is monodisperse, and monomeric. Given this, crystallographic 
efforts focused primarily on ΔN. All protein samples were incubated with Fe2+ before 
plating unless stated otherwise. 
 
Pre-crystallisation screen 
All initial protein samples were subjected to a pre-crystallisation screen. This gives one 
an idea of what protein concentration to use for crystal screens. To do this, protein 
samples were mixed with reagents and precipitation type was observed. Heavy 
precipitate suggested lowering protein concentration, whilst clear drops suggested 
increasing protein concentration. The ideal concentration for all constructs was below 8 
mg/mL, as higher concentrations resulted in heavy, amorphous precipitation.  
 
High throughput screening 
Crystal Screen HT was the first high-throughput screen used, and consisted of drops with 
400 nL of 5 mg/mL protein and 550 nL of well solution. Almost all resulting drops had 
some form of precipitation but no crystals were formed and no interesting conditions 
were determined from this plate. This experiment was followed up by a second trial using 
the same screen with fresher protein and 3 different protein concentrations (2, 3.5 and 5 
mg/mL). The method was also changed, as sitting drops were used. Again, nearly all 
drops resulted in some form of precipitation (not pictured). However, with a protein 
concentration of 2 mg/mL, a potential crystal was obtained after 4 days (Figure 5.16, 
left). The proposed crystal has a symmetrical edge and optical activity in cross polarised 














Figure 5.16. Putative PCO1 crystal from the second Crystal Screen HT attempt. 
Left is an image taken under visible light, right is an image taken under cross polarised 
light. Conditions include 0.5 M ammonium sulfate, 30% v/v 2-methyl-2,4-pentanediol 
(MPD) and 0.1 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, pH 7.5). 
Protein concentration was 2 mg/mL.  
 
Although a potential crystal was obtained during high throughput screening (Figure 
5.16), it was not large enough to use for X-ray diffraction. Therefore, the conditions in 
which the proposed crystal were obtained were optimised to see if a larger crystal could 
be produced. Although a range of drops formed precipitate, no crystals were produced.  
 
The next attempts focused on ΔN and ΔNΔC, and changing the metal ions used. Other 
metal ions were added as mammalian CDO was first crystallised with Ni2+ bound, and at 
the time no experimental evidence existed to prove that plant CDO’s preferred metal ion 
is iron. PCO1 was incubated with either Ni2+, Co2+ or Fe2+ and used with crystal screen 
HT. The shortened constructs were used with crystal screen HT after incubation with 
only Fe2+ as the addition of the other metal ions caused immediate precipitation. The final 
protein concentration for all constructs were 8, 6 and 2 mg/mL. Promising results were 
found in several drops of the PCO1 plates, as well as a drop prepared using ΔN. No 





Figure 5.17. Putative PCO1 crystals after incubation with various metal ions. Left, 
crystals imaged under visible light formed under condition 0.2 M Magnesium chloride, 
0.2 M HEPES sodium pH 7.5 and 30% v/v 2-propanol with 2 mg/mL of PCO1 incubated 
with cobalt. This is representative of other crystals formed in these conditions. Right, 
diffraction pattern of a frozen crystal taken from drop to the left.  
 
Condition A12 (0.2 M Magnesium chloride, 0.2 M HEPES sodium pH 7.5 and 30% v/v 
2-propanol) from the Crystal Screen HT resulted in the formation of crystals for the 8, 6 
and 2 mg/mL samples of PCO1 with Fe2+ and Co2+ (Figure 5.17, left). Crystals only 
formed in the 2 mg/mL sample of PCO1 with Ni2+. Crystals from the 2 mg/mL PCO1 
with Co2+ drop were mounted at both room temperature and frozen in liquid nitrogen. For 
the frozen crystal, glycerol was added as a cryoprotectant. A diffraction pattern was then 
collected for both crystals mounted. The diffraction pattern for both indicated that all 





Figure 5.18. Drops containing sea urchin crystals. Both drops are under the conditions: 
0.2 M ammonium sulfate, 0.1 M sodium cacodylate trihydrate pH 6.5 and 30% w/v 
polyethylene glycol (PEG) 8,000. Left contains 6 mg/mL of PCO1 incubated with Fe2+, 
whereas right contains 2 mg/mL of ΔN also incubated with Fe2+. Images taken under 
visible light.  
 
Two drops under the conditions of 0.2 M ammonium sulfate, 0.1 M sodium cacodylate 
trihydrate pH 6.5 and 30% w/v PEG 8,000 also lead to the formation of crystals (Figure 
5.18). These crystals differ to those in Figure 5.17 in their morphology. As these 
conditions differ greatly compared to those that formed salt crystals, and as the 
morphology also differs, it may have indicated that these crystals were made of protein. 
“Sea urchin” crystals such as those seen in Figure 5.18 are difficult to use for diffraction 
as they generally result in single crystals that are too small. However, the results from 
these conditions gave rise to the opportunity to optimise the conditions to produce larger, 
single crystals that may be suitable for diffraction.  
 
To optimise these conditions, a range of PEG 8,000 and PEG MME 5,000 concentrations 
were used from 24 – 34%, with other solutes kept constant. Final protein concentrations 
of PCO1 ranged from 2- 8 mg/mL and ΔN ranged from 0.5- 4 mg/mL. An additive screen 
was also used with conditions of Figure 5.18 for optimisation. This was a Morpheus 
additive screen at 10% v/v which was added to the well solution.  A further plate was 
prepared that varied all solutes. Ammonium sulfate was used at 0.1- 0.4 M whilst sodium 
cacodylate was used at 0.1 M with pH ranging from 5 to 7.4  Drops prepared were both 
sitting and hanging, and ranged from 0.3- 2 μL in size. Unfortunately, all variation 
screens produced were unsuccessful, and the initial experiment could not be reproduced. 
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As varying the conditions from Figure 5.18 did not result in any crystals, a range of other 
screens were employed. Three plates were prepared using the following screens: JCSG, 
PACT and INDEX. PCO1 and ΔN concentrations used were 6, 4 and 2 mg/mL, and drops 
prepared were 0.5 μL sitting drops. As the addition of substrate to enzymes has aided 
with crystallisation in the past (Hassell et al., 2007), these screens were produced both 
with and without the addition of a penta-peptide substrate. The peptide sequence 
(CGGAI) was derived from the N-terminal motif of PCO1 targets. The peptide was added 
after incubation with iron, with a 2 fold more peptide than protein. These twelve plates 
did not produce any promising results, nor suggest conditions that could be optimised to 
produce crystals.   
 
As no improved crystals were produced in the JCSG, PACT and INDEX screens, the sea 
urchin crystals in Figure 5.18 were broken into single crystals and mounted. These 
crystals were small in size (< 50 μM) so were shot using the MX2 beam line at the 
Australian Synchrotron. These crystals did not diffract, but showed no evidence of being 
a salt crystal. Thus it was predicted that these crystals were formed of poorly ordered 
protein. As the sea urchins could not be reproduced, and the crystals that were formed 
did not diffract, further crystallography screens were trialled.  
 
As PEG showed some success in the past, 96-well PEGRx HT and PEG ion HT screens 
were purchased. These screens were prepared with both PCO1 and ΔN at 6, 4 and 2 
mg/mL. Drops prepared were sitting, and 0.3- 0.6 μL in size. A further PEG screen 
(MD1-14 clear strategy screen 1) was also trialled in a 24-well format with 10, 8, 6 and 
4 mg/mL of both PCO1 and ΔN. Drops were sitting, and were 2 μL in size. None of the 
above PEG screens were successful in producing promising conditions or crystals.  
 
Attempts were also made to crystallise PCO2. Three screens were employed for a wide 
range of coverage. These screens were Crystal Screen HT, PEG ion HT and PEG Rx HT. 
The protein was used at 6, 4 and 2 mg/mL concentrations in sitting drops that were 0.3- 
0.6 μL in size. No crystals resulted and the screens gave little insight into optimisation to 




 Zea mays constructs  
After the lack of success with all A. thaliana constructs, plant CDO from maize was 
employed. Both a full length maize (maize A) and N-terminally truncated version of 
maize (maize B) were able to be expressed and purified. Maize A and maize B were used 
with 2 screens: Crystal Screen HT and PEG Rx HT. Drops were sitting and volumes 
ranged from 300 – 400 nL. Protein concentrations for both maize constructs were 6, 4 
and 2 mg/mL. No crystals or drops of interest were formed from maize A, but maize B 
resulted in two drops of interest.  
 
 
Figure 5.19. Maize B spherulites from Crystal Screen HT. Both images taken under 
visible light. Left are spherulites formed in 0.2 M calcium chloride, 0.1 M HEPES pH 
7.5 and 28% v/v PEG 400. Right are spherulites formed in 0.2 M calcium acetate, 0.1 M 
sodium cacodylate and 18% w/v PEG 8000. Spherulites were formed in these conditions 
under all maize B concentrations tested.  
 
Maize B produced small spherulites in two different conditions (Figure 5.19). The 
spherulites clustered around areas of dense protein precipitation. Spherulites from the 
right drop did not have any absorbance at 280 nm (Appendix 28). This does not give an 
indication that the spherulites were made of protein, but does not rule it out. Spherulites 
from the right drop showed absorbance at 280 nm and had activity in cross polarised light 
(Appendix 29). This features suggest that the spherulites comprised protein. As the only 
similarity between the two drop solutions was the presence of calcium and PEG, it was 
predicted that calcium was inducing the production of the spherulites. Given this, a screen 
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was set up with a range of PEG and buffer conditions (Rows A-D of the PEGRx HT 
screen) with 0.05, 0.1 and 0.2 M calcium chloride or calcium acetate. The maize B 
concentration used was 3 mg/mL. 
 
 
Figure 5.20. Optimised Maize B spherulites from PEGRx HT with calcium. Left 
image was taken under cross polarised light, whilst right image was taken under visible 
light. Spherulites formed in 0.1 M calcium chloride, 0.1 M Tris pH 8 and 30% v/v PEG 
400. Maize B concentration was 3 mg/mL.  
 
Larger spherulites were formed in many of the drops on the PEGRx HT with calcium 
plate such as those in Figure 5.20. The spherulites pictured absorbed at 280 nm and had 
activity in cross polarised light suggesting that they may comprise protein (Appendix 
30). Drops that contained calcium chloride were more likely to form larger spherulites, 
therefore calcium chloride was used in future experiments. Although this is an 
improvement on the small spherulites observed in the past, no crystals were produced. It 
was proposed that making larger crystal drops may slow nucleation and enhance the 
likelihood of crystal formation, thus this was performed. The larger drops were 2.4 μL in 



















Figure 5.21. Large drop Maize B spherulites from PEGRx HT with calcium. Both 
images were taken under visible light. Left, sea urchins formed in 0.1 M calcium chloride, 
0.1 M citric acid pH 3.5 and 34% v/v PEG 200. Right, spherulites formed in 0.1 M 
calcium chloride, 0.1 M BIS-TRIS propane and 30% w/v PEG 6000. For both drops, the 
maize B concentration was 3 mg/mL.  
 
Two drops of interest were produced. One drop had sea urchin crystals under visible light 
(Figure 5.21, left), but lacked any cross polarised activity and had no absorbance at 280 
nm elements. The lack of these features suggests that the sea urchin crystals may not be 
comprised of protein. The other drop contained crystalline looking features (Figure 5.21, 
right). These putative crystals not only had activity under cross polarised light but also 
had absorbance at 280 nm (Appendix 31), this suggest that they comprisedprotein. Given 
the results for this, a further optimisation plate was produced.  
 
For the variation screen buffer pH, PEG concentration and protein concentration were 
varied. Citric acid was used at 0.1 M pH 3, 3.5, 4 and 4.5, and PEG 200 was varied from 
40-20 % in 4% increments. BIS-TRIS propane was used at 0.1 M, pH 8, 8.5, 9 and 9.5, 
whilst PEG 6000 was varied from 34-14% in 4% increments. The maize B concentrations 
used were 4, 3 and 2 mg/mL and drops sizes were 300-400 nL. Calcium chloride was 
added to the protein stock for a final concentration of 0.1 M. Unfortunately, no crystals 
were produced, and the original results were not able to be replicated. Seeding could be 




Homology models of plant CDO were produced from two different servers. Both models 
gave varying ideas on protein structure and substrate entry. The histidine triad was 
present in a similar orientation to mammalian CDO in both models. Both models 
suggested that the N- and C-termini lack order, supporting results of previous 
experiments. Modelling also suggested that PCO1 may bind its target using ionic 
interactions. After all cysteine residues were mapped onto one of the models, it was 
predicted that plant CDO contained disulfide bonds.  A range of experiments were then 
conducted which were able to support the presence of disulfide bonds in recombinant 
CDO. Although it is not known if the bonds are inter- or intra-protein, future experiments 
to determine this were outlined.  
 
Crystallography began with assessing PCO1 and both A. thaliana shortened constructs. 
DLS suggested that ΔN was homogenous and monodisperse, whilst ΔNΔC and PCO1 
were not. This was predicted to be due to the presence of chaperones and/or DNA binding 
in the case of PCO1. DLS suggested that PCO1 was forming large aggregates, so this 
was further tested and confirmed by the use of size exclusion chromatography. All A. 
thaliana constructs were used in an attempt to produce crystals. ΔN produced sea urchins, 
however they did not diffract. No other A. thaliana constructs formed diffracting crystals, 
thus constructs from maize were employed. Maize B produced promising results but no 




Chapter Six   
Functional characterisation:              
Iron binding and kinetics 
6.1 Iron binding  
It is predicted that approximately 40% of all proteins bind metal ions, and are termed 
metalloproteins (Thomson and Gray, 1998). Around 25-35% of these proteins require a 
metal ion for catalysis, whilst almost all require metal ions for protein folding and 
stability (Waldron and Robinson, 2009). These ions are usually co-ordinated by oxygen, 
sulfur or nitrogen groups of amino acid side chains (Yamashita et al., 1990). Most often, 
transition metals (e.g Mn2+, Fe2+/3+, Co2+, Ni2+, Cu2+ and Zn2+) are bound as they have 
preferable physiochemical properties such as a small atomic radius and low density. 
These metals also allow for strong electromagnetic and electrostatic interactions, and are 
readily bioavailable (Williams, 1997).  
 
Previous experiments with CDO from other origins showed CDO is an iron-binding 
protein and that iron is required for catalysis (Tchesnokov et al., 2012). Plant CDO also 
contains the same 3-His iron binding co-ordinate sites found in other CDO proteins. The 
binding stoichiometry of mammalian CDO was shown to be 1:1 experimentally by the 
ferrozine assay (Tchesnokov et al., 2012). The same experiment was attempted with 
PCO1 but the results were inconclusive. It was originally thought that this may be an 
interaction between the negatively charged DNA bound to the N-terminal, and the 
positively charged iron. The C-terminus also has a number of negative charges that could 
interact with the iron electrostatically. However, binding stoichiometry was also 
inconclusive with ΔN and ΔNΔC. Given this, it was predicted that plant CDO may not 





Figure 6.1. Intact mass spectrometry data for ΔN. M refers to molecular weight (in 
Da) determined for each of the prominent peaks (left) and ΔM indicates the difference in 
molecular weight (in Da) between the two prominent peaks (right). The charge for both 
of these figures is +20. 
 
The intact mass experiment for both PCO1 and ΔNΔC did not result in interpretable data. 
Therefore, only data produced by the ΔN was analysed. The results showed two 
prominent peaks; one peak with a mass of 27972 Da and a second peak with a mass of 
28036 Da (Figure 6.1, left). The predicted average mass of the ΔN without the N-
terminal methionine is 27974.28 Da, which corresponds well with the first large peak. 
The second large peak is believed to be ΔN with a metal ion bound, which has been 
sequestered from within E. coli during expression. The two insignificant peaks between 
the larger peaks are likely the protein co-ordinated with 2 and 3 water molecules 
respectively. The difference between the two large peaks is 63.63 Da (Figure 6.1, right) 
which matches the addition of zinc (65.38 u ± 0.002 u) minus two protons (to give no net 
change in charge). The weight of iron is 55.845 ± 0.002, which is substantially different 
than the change in mass observed.  
 
This result is unexpected as other CDOs co-ordinate iron. Previous experiments with 
mammalian CDO show that it is able to bind zinc, but the resulting protein lacks catalytic 
activity (Chad R Simmons et al., 2006). If plant CDO does bind zinc, this would not 
allow the redox chemistry to permit dioxidation of targets. This suggests that this may be 






iron should be conducted to corroborate this result. Trace analysis could also be 
performed by the Centre for Trace Element Analysis within the Otago University 
Department of Chemistry.  
 
This result is partially inconsistent with particle-induced X-ray emission with a micro-
focussed beam experiments conducted by White et al. Both PCO1 and PCO4 were 
analysed, and results showed there were 0.3 ± 0.12 iron atoms per molecule for PCO1 
and 0.31± 0.015 iron atoms per molecule for PCO4 after purification from E. coli. Both 
PCO1 and PCO4 also showed high levels of nickel binding (greater than that of iron), 
but this was predicted to be an artefact of His-tag affinity purification (White et al., 2017). 
Although the paper suggests that iron is the main metal ion co-ordinated, PCO4 did show 
trace amounts of zinc (0.13 ± 0.02 atoms per molecule).   
 
As White et al. also showed some zinc binding, the result from Figure 6.1 was somewhat 
validated. However, this does not explain why iron was not shown to be bound. The result 
may be due to a change in intracellular metal concentrations between bacterial and plant 
species. Free or loosely bound metal ion levels must be kept low due to cytotoxicity, but 
the pool must be large enough to accommodate newly formed proteins and other cellular 
processes. In an E. coli the most common metal ion present is iron, however only 1% of 
total iron concentration comprised free iron (~10 μM) (Keyer and Imlay, 1996; Semsey 
et al., 2006). Zinc is the second most common metal ion in E. coli (Porcheron et al., 
2013), but again free zinc is not readily available as it is in femtomolar concentrations 
(Outten and O’Halloran, 2001). As it is proposed that more iron is present in a typical 
E. coli cell compared to zinc, this does not explain these results. Another proposed theory 
was that the amount of metal ions found in media was likely to influence what is bound 
to the protein. As peptone is derived from an animal source the amount of metal ions 
vary with each batch. In LB, iron is often the most common metal present, followed 
closely by zinc (Outten and O’Halloran, 2001). This variability could explain differences 
in results here as compared to White et al.  
 
 As Figure 6.1 shows the intact mass of ΔN, this could explain the change in metal 
binding. PCO1 and ΔN could have different metal affinities, although this is unlikely as 
the active site is within the domain shared by both constructs. Zinc is not able to support 
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the redox chemistry required to perform the proposed catalytic reaction. This again 
suggested that zinc is either an artefact of expression in E. coli or as a non-native 
construct was analysed (Porcheron et al., 2013). Given this, and that literature suggests 
that iron is the preferred central metal ion in other CDOs, the 3-His triad is present, and 
White et al. showed that plant CDO does bind iron, attempts were made to improve iron 
binding.  
 
After the purification of plant CDO, iron occupancy was tested using a colorimetric 
ferrozine-based assay (Tchesnokov et al., 2012). Without loading the sample with iron, 
occupancy usually remained below the accuracy of the assay post-purification. As metal 
ion binding usually enhances the stability of ion binding proteins, an experiment was 
performed to increase iron occupancy. This experiment consisted of expressing the 
protein with iron (III) in the media. This was used as opposed to Fe2+ as bacterial iron 
transporters prefer the Fe3+ oxidation state under aerobic conditions (Braun, 2003). A 
reduction in IPTG concentration was also tested as this could improve iron occupancy. 
As one would expect less protein to be expressed, there would then be a larger ratio of 
iron to protein in the media.   
 
 
Figure 6.2. PCO1 expression with iron and reduction of IPTG. Loading was 
normalised. Amount of IPTG used to express indicated at the top in μM, and the flask 
where iron was added is indicated by the addition of +Fe3+. The negative symbol shows 
expression before IPTG addition and the + symbol shows expression 6 h post-IPTG 
addition. Where PCO1 is expected to run is indicated with a black arrow. The lane 
labelled M of the SDS-PAGE gel contains molecular weight marker. Marker masses are 





Expression of PCO1 using 100 μM of IPTG resulted in a clear band of protein (Figure 
6.2). Using only 1 and 0.1 μM did not lead to prominent levels of expression, as a dense 
band of protein is not found on the gel where PCO1 would be expected to run. There is 
a slight band for both IPTG concentrations but it is insignificant compared to the 100 μM 
samples. The flask that contained iron resulted in a dense band, suggesting that PCO1 
was over-expressed in this sample. As it appeared that all samples expressed produced at 
least a small amount of PCO1, all cultures were spun into a pellet and PCO1 was 
attempted to be purified.  
 
 
Figure 6.3. Bench-top purification of PCO1 with varying IPTG induction 
concentrations. Amount of IPTG used to express indicated at the top in μM. H shows 
homogenate, S- supernatant, F- flow-through and P- purified protein. Where PCO1 is 
expected to run is indicated with a black arrow. The lane labelled M of the SDS-PAGE 
gel contains molecular weight marker. Marker as in Figure 6.2.  
 
There is a large band of PCO1 in the homogenate lane of the 100 μM sample in Figure 
6.3. A band is also seen in the supernatant, suggesting the protein was mostly soluble. A 
band in the protein lane shows that PCO1 was able to be purified, but a band still seen in 
the flow-through suggests that a second purification could have yielded more protein. 
Purification of the 1 μM sample shows minimal PCO1 in the homogenate, supernatant 
or flow-through. Given this, it is unsurprising that no PCO1 was present in the purified 







Figure 6.4. Bench-top purification of PCO1 with varying IPTG induction 
concentrations and iron addition. Amount of IPTG used to express indicated at the top 
in μM, and flask expressed with iron is indicated with Fe3+. H shows homogenate, S- 
supernatant, F- flow-through and P- purified protein. Where PCO1 is expected to run is 
indicated with a black arrow. The lane labelled M contains molecular weight marker. 
Marker as in Figure 6.2.  
 
The 0.1 μM IPTG sample (Figure 6.4) shows the same trend as the 1 μM sample from 
Figure 6.3. It appears there was no band of PCO1 in the homogenate, supernatant or 
flow-through lanes. Thus, the lack of purified protein is not surprising. This implies that 
little PCO1 was expressed, which concurs with the absence of a dense band in Figure 
6.2. The 100 μM sample expressed with iron in the media shows considerable bands in 
the homogenate and the supernatant. As these bands are the same density, this implies 
that all protein present was soluble. A clean band is seen in the protein lane showing that 
PCO1 was successfully purified. The presence of a band in the flow through shows that 
there was an excess of PCO1 for the amount of resin used, and that more protein could 
be purified with a further round of purification.  
 
Overall, a reduction in IPTG concentration lowered the levels of expression dramatically. 
This then prevented the purification of detectable protein levels from these samples. 
Protein was able to be purified from both samples that were induced with 100 μM of 
IPTG. The addition of iron to the media did not change the amount of protein that was 
expressed or purified. Both of the purified protein samples were tested to determine the 






Figure 6.5. Iron saturation levels of purified protein ± iron addition. The control 
sample was induced with 100 μM IPTG and did not have iron added to the media. The 
growth with iron sample (+Iron) contained 200 μM of Fe3+ within the media and was 
induced with 100 μM IPTG. Error bars shown with purified protein samples depict the 
assay detection limit whilst error bars shown with post-purification iron addition show 
standard error of the mean. 
 
Both purified protein samples had low levels of iron binding, below the assay detection 
limit (Figure 6.5). However, a large increase in iron saturation was able to be achieved 
when iron was added to purified protein for both samples. The control sample occupancy 
levels rose to around 60% and the +iron sample rose to around 70%. Although the mean 
implies that a higher level of saturation was achieved in the +iron sample, this is not 
statistically significant. In conclusion, adding iron to the medium during growth did not 
improve the initial iron saturation levels or iron uptake after purification. Thus, growth 
with iron was not a worthwhile addition to the expression protocol.  
 
As previous experiments with mammalian CDO showed that iron binding was essential 
for catalysis (Tchesnokov et al., 2012), it was postulated that this is also true of plant 
CDO. To determine if iron binding was essential for catalysis, the refolding experiment 
samples from 5.2 were used. These samples were predicted to form a range of folded 
states, therefore iron binding efficiency of each sample was predicted to be different. Iron 
occupancy of each sample was tested using the ferrozine assay. Each sample was then 
subjected to a kinetic assessment using Ellman’s assay. Iron occupancy and catalytic 





Figure 6.6 Iron bound to refolding experiment samples. Amount of iron bound is 
in μM and the concentration of PCO1 was 100 μM. GSH refers to reduced glutathione, 
whilst GSSG refers to oxidised glutathione. Data averages shown as mean ± standard 
error of the mean. One way ANOVA used for statistical significance, P-value of star 
shown is 0.0194.  
 
The control sample (i.e protein as purified) resulted in ~80 μM of iron bound, whilst the 
5 mM GSH/0.5 mM GSSG sample appeared to have more bound with ~90 μM of iron 
(Figure 6.6). However, the difference between the two is not statistically significant. The 
5 mM GSSG/0.5 mM GSH sample resulted in ~40 μM of iron bound, and 2 mM of each 
enzyme resulted in ~70 μM bound. Both of these samples bind significantly less iron 
than the control and 5 mM GSH/0.5 mM GSSG samples. Thus, the addition of >0.5 mM 
of GSSG resulted in reduced iron binding.  
 
As less iron binding was seen with the addition of 2 mM GSSG and the occupancy 
lowered further with 5 mM GSSG, there is an inverse relationship between GSSG 
addition and iron occupancy. Increased iron occupancy is thought to be a measure of 
native protein folding, thus these results suggested that the protein is better folded with 
GSH present. As GSH reduces the exposed cysteine residues in PCO1, this indicates that 
the protein is in a more stable conformation state with reduced cysteine residues. To 
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determine how conformational state and iron binding influenced catalytic efficiency, 
kinetic assays were conducted. 
 
Figure 6.7 Velocity of substrate depletion using refolding experiment samples. The 
concentration of PCO1 was 5 μM as determined by the ferrozine, thus all protein 
measured had iron bound. The substrate used was pentapeptide (sequence CGGAI) at 25 
mM to ensure saturation. GSH refers to reduced glutathione, whilst GSSG refers to 
oxidised glutathione. Raw data with error bars found in Appendix 32. Data averages 
shown as mean ± standard error of the mean. T-test showed a P-value of 0.0359 for 
samples with a star.  
 
With a PCO1 concentration of 5 μM, the control sample showed an observed velocity of 
0.3 mM/min, whilst the 5 mM GSH/0.5 mM GSSG sample showed upwards of 0.4 
mM/min (Figure 6.7). The sample with 5 mM GSSG/0.5 mM GSH showed little activity 
with only ~0.05 mM/min. The 2 mM of GSSG and GSH sample achieved an observed 
velocity of ~0.35mM/min- with slightly higher activity than that of the control sample. 
The 5 mM GSH/0.5 mM GSSG sample proceeded with the highest velocity, followed by 
the 2 mM each and control samples. The 5 mM GSSG/0.5 mM GSH sample was 
significantly slower than the other samples. Again, this data suggests that >0.5 mM 




A clear correlation is seen between iron occupancy and velocity of substrate depletion. 
The sample that contained the most iron proceeded the quickest. The next two samples 
had similar iron levels, and thus catalysis was at a similar rate. The sample with the lowest 
iron concentration resulted in the slowest substrate depletion, but at an even slower rate 
than one would predict. This implies a catalytic threshold for measured iron occupancy, 
where <50% occupancy results in a relatively inactive protein species. It is possible that 
in vivo iron occupancy differs to in vitro results. This may be because artefactual zinc 
may offer some competition for binding.  
 
The change in iron binding/activity can also be linked to the redox state of cysteine 
residues present within the protein. When increased amounts of reducing GSH is present, 
catalytic efficiency increases. As the amount of GSSG increases past 0.5 mM, substrate 
depletion slows. This implies that the protein is more active when cysteine residues are 
reduced, and less active when cysteine residues are oxidised. This may offer a mechanism 
for control of plant CDO as it is a redox protein. Reactive oxygen species could be tested 
to determine how they influence the catalytic activity of PCO1. The flooding response, 
like other stress responses, is mediated in part by reactive oxygen species (Fukao et al., 
2011). This is consistent with oxidising conditions turning CDO “off”.  
 
6.2 Kinetics  
Gaining an understanding of how enzymes operate is essential for enzyme 
characterisation. Kinetic characterisation of an enzyme results in a range of parameters 
which describe the enzyme’s speed (Vmax) or (kcat), and affinity for substrate (Km) 
(Michaelis and Menten, 1913). Characterisation can also be performed in the presence of 
inhibitors to determine their effects. Enzymes catalyse reactions by binding to substrate 
and lowering the activation energy of product formation. Most enzymes are optimised to 
bind one substrate in the correct orientation, while some can bind multiple substrates 
productively. Substrate or transition state analogues can also be employed to determine 
the catalytic mechanism, or active site features. 
 
The native substrates of plant CDO are group VII ethylene response factor proteins. 
These proteins contain an N-terminal motif for recognition, which begins with a cysteine 
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residue. Experiments using an oxygen electrode and high performance liquid 
chromatography (HPLC) by Weits et al. (2014) showed that PCO1 was able to dioxidise 
free cysteine as opposed to an N-terminal cysteine as part of a peptide. As this substrate 
is much different compared to that of the native plant CDO substrate, the reported result 
was unexpected. In order to assess whether plant CDO is indeed able to catalyse the 
formation of CSA from free cysteine, 1H NMR was conducted.  
 
 
Figure 6.8. 1H NMR spectra of standards and cysteine incubated with CDO. 
Manipulation of spectra was conducted using Mestrenova. Tris standard not included for 
simplicity. Resonances attributed to either α or β carbons and Tris are indicated on the 
uppermost trace in which each appears. Probe used was trisodium phosphate (TSP).  
 
Within the spectra of Figure 6.8, a significant number of peaks presented with scalar 
coupling causing further splitting. The CSA standard spectrum (green) consisted of two 
split doublets at 4.12 and 2.79 ppm, as well as a triplet with some splitting at 2.68 ppm.  
The cysteine standard (purple) produced a triplet at 3.94 ppm and a split quartet at 3.04 
ppm. The peaks produced by cystine (red) are less prominent, but are visible with a 
quartet 4.08 ppm, a split doublet at 3.37 ppm and a second quartet 3.18 ppm. Other peaks 














Within the cysteine incubated with CDO sample (blue), a quartet is seen at 4.08 ppm, 
followed by a triplet with some splitting at 3.94 ppm. A large singlet composed of Tris 
is visible at 3.70 ppm, alongside a split doublet at 3.37 ppm and a second quartet ~3.18 
ppm. A third quartet with splitting is present at 3.04 ppm. The peaks produced by the 
sample with CDO are slightly broader than the other samples due to the presence of 
paramagnetic iron.  
 
When comparing the NMR spectra of cysteine incubated with plant CDO to the standard 
spectra, it is clear that plant CDO did not produce CSA under these conditions (blue, 
Figure 6.8). A triplet at 3.94 ppm and a split quartet at 3.04 ppm indicates the presence 
of cysteine, representing unutilised substrate. A quartet at 4.08 ppm, a split doublet at 
3.37 ppm and a further quartet at 3.18 ppm is indicative of cystine. This implies that plant 
CDO forms cystine instead of CSA whilst utilising cysteine as substrate. As the cystine 
peaks produced in two hours with plant CDO are comparable in size to those produced 
overnight without enzyme (not shown), it is likely this reaction is enzyme catalysed. 
Mammalian CDO also shows this activity in some conditions. 
 
Overall, proton NMR data showed that PCO1 is not able to dioxidise free cysteine. This 
means that plant CDO is not a cysteine dioxygenase, but a cysteinyl dioxygenase. Given 
these results, a dipeptide substrate (cysteine followed by a glycine) was used to determine 
if the addition of a second amino acid would enable dioxidation to occur. A glycine was 
chosen as the second residue based on the N-terminal motif of proposed plant CDO 
targets. The activity of PCO1 with this substrate was then characterised using Ellman’s 
assay. 
 
In order for kinetic characterisation to begin, a titration was conducted to assess the 
relationship between enzyme concentration and substrate at a set concentration. If the 
graph is linear, it suggests that the reaction is limited only by the amount of enzyme 
present. A linear dependence also shows that there are no limiting factors to catalysis, 
such as product inhibition or lack of co-factors. Given this, the initial evaluation is crucial 







Figure 6.9. PCO1 titration with dipeptide substrate. Each data point was produced in 
duplicate using technical replicates and error bars represent standard error of the mean. 
Data produced using Ellman’s reagent in a 96-well plate format. Substrate concentration 
was set at 28 mM. Raw data can be found in Appendix 33.  
 
Substrate depletion occurs at a rate of 0.04 mM/min without any enzyme present, 
suggesting a basal rate of reaction (Figure 6.9). Product formation in this case is likely 
dipeptide forming intermolecular disulfide bonds. This prevents interacting thiol groups 
from being measured and thus depletes substrate levels just as does CSA formation. This 
may be due to the pH of the reaction, as an increasing pH encourages disulfide bond 
formation due to decreasing hydrogen ion availability. This is further highlighted by the 
pKa of the thiol group of cysteine being noticeably lower than the pH of the reaction 
(pKa of 5.14 as opposed to reaction pH of 7.5). When the pKa is lower than that of the 
pH, the thiol group will be deprotonated to form a sulfur anion, which is free to act as a 
nucleophile in disulfide bond formation. The addition of DTT or ascorbic acid was 
considered, however dismissed as this would interfere with the results by reacting with 
the Ellman’s reagent, obscuring signal from substrate cysteine.  
 
Velocity increases linearly from the basal rate based on increasing enzyme concentration 
until 10 μM of PCO1. Within this range, the reaction is not limited by product inhibition 
or by the lack of co-substrate, molecular oxygen. This data suggested that any of the 
enzyme concentrations tested above were suitable for Michaelis-Menten based analysis, 
and has identified a background level of cysteine formation. To ensure that the enzyme 
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concentration was easily measurable, and that it was well within the linear range, 6 μM 
of PCO1 was chosen for these experiments. 
 
 
Figure 6.10. Michaelis-Menten analysis of PCO1 with dipeptide substrate. Enzyme 
concentration was 6 μM and error bars represent standard error of the mean of technical 
triplicates. Data produced using Ellman’s reagent in a 96-well plate format. Raw data can 
be found in Appendix 34. Fit was done via GraphPad Prism Michaelis-Menten function. 
Data averages are shown as mean ± standard error of the mean. Curve represents a fit of 
Michaelis-Menten equation to data of 0-30 mM substrate. Fit has an R2 of 0.98 and 
absolute sum of squares 0.0014.  
 
The data were well fit by the Michaelis-Menten model as suggested by an R2 of 0.98 and 
an absolute sum of squares of 0.0014. Above a substrate concentration of 25 mM no 
further rate enhancement is observed (Figure 6.10). Vobs plateaus as more active sites 
become occupied due to approaching substrate saturation. A Vmax of 0.5 ± 0.1 mM/min 
was fit. Catalysis at 40 mM dipeptide concentration proceeds slower than one would 
expect. This may be because the reaction pH is heavily influenced by addition of a large 
volume of the stock peptide solution which has a pH of ~3. After the experiment, this 
was tested by the use of pH paper, which confirmed this theory. A resulting drop of pH 
could slow the enzyme, therefore this point was excluded from the fit. 
 
The fit yielded a Km of approximately 30 ± 10 mM. This Km is high, reflecting that the 
enzyme does not have a high affinity for this substrate. This is not surprising as the 
dipeptide used is not the native substrate of PCO1. To explore the relationship between 
Dipeptide Concentration (mM) 
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the enzyme and substrate further, a larger peptide was employed. This peptide was a 
tripeptide, consisting of the amino acids (in order) CGG. This is again derived from the 
N-terminal motif of native PCO1 targets.  
 
The same enzyme concentration was used so that the tripeptide data could be directly 
compared to the dipeptide data. Thus, experiments were conducted using a set PCO1 
concentration of 6 μM, and used a range of substrate concentrations. However, under 
these conditions the reaction appeared to proceed too quickly to be quantitated in the 
same way. Substrate was 50% depleted before collection of the first sample at 4 mins. 
Given this, an experiment was conducted to further characterise the slope of the line.  
 
 
Figure 6.11. Substrate depletion of tri-peptide by PCO1. The concentration of enzyme 
used was 6 μM and initial tripeptide concentration was 15 mM. This was conducted once. 
Data analysis was produced using a 96-well plate format using Ellman’s reagent. 
Samples were taken every 15 sec for 6 min.  
 
The trend seen in Figure 6.11 shows a steep drop followed by a plateau. This repeats 
data seen in previous experiments with the tripeptide. It appears as though the reaction 
proceeds quickly in the first 2 min of the reaction until 5 mM substrate is reached. This 
is consistent with the Km of the interaction between PCO1 and this substrate being greater 
than 5 mM. Given this, further studies using the tripeptide should be done using a lower 
enzyme concentration to slow the linear phase. This would enable one to better assess 
the efficiency of PCO1 with the tripeptide substrate. Conversely, one could keep the 
enzyme concentration at 6 μM and characterise all samples within the first 4 min of the 
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reaction, only using the initial linear phase to plot the slope and determine reaction 
velocity.  
 
This preliminary result suggests that PCO1 has a higher affinity for the tripeptide 
compared to CG as the predicted Km has decreased. As an apparent increase in substrate 
affinity with a peptide larger by only one amino acid has occurred, this may suggest that 
increasing peptide size may further increase substrate affinity. Given this relationship, 
one can hypothesise that substrate affinity would increase up until 10 amino acids where 
the N-terminal recognition motif of plant CDO targets end. A plateau would then likely 
occur, as amino acids outside this region are unlikely to interact directly with or near the 
active site of plant CDO. This interaction could be explored further using target N-
terminal peptides of varying length as substrate. Future kinetic experiments should use 
tools like NMR and MS to determine whether or not the correct product is being formed 
as Ellman’s based assays only assess substrate depletion.  
 
6.3 Summary 
Intact mass spectrometry data suggested that plant CDO may bind Zn2+ as opposed to 
iron as predicted. As this experiment was conducted with ΔN instead of full length PCO1, 
the change in metal affinity may be an artefact of truncation, or zinc binding could be an 
artefact of in vitro purification. Published data by White et al. suggested that PCO1 does 
in fact bind iron, thus experiments were conducted in an attempt to improve iron binding. 
Dropping the level of inducer reduced expression levels, and addition of iron to the media 
had no effect on purified protein iron occupancy. Instead, post-purification iron addition 
supported the greatest iron occupancy. Samples from the refolding experiment in 
Chapter 5 showed increased iron binding under mildly reducing conditions. This may 
imply improved protein folding in this state, and kinetic analysis suggests that the 
reduction and oxidation of disulfide bonds in PCO1 may control a redox switch 
manipulating catalytic activity.  
 
Proton NMR showed that PCO1 is not able to catalyse the formation of CSA from free 
cysteine as can mammalian CDO. These results disputed data published by Weits et al. 
Kinetic analysis of PCO1 with a dipeptide substrate gave a Vmax of 0.5 ± 0.1 mM/min 
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and a Km of 30 ± 10 mM. These values suggest PCO1 is capable of catalysing dipeptide 
substrate depletion, but shows that substrate affinity is low. Preliminary analysis of PCO1 
with tripeptide imply that catalysis is faster, and that the Km is lower – suggesting 
increased substrate affinity. This may mean that larger substrates, closer to those of plant 
CDO’s native substrate, permit better recognition, catalytic efficiency and substrate 






Conditions were established for expression and purification for plant CDO from a range 
of species. Expression trials of PCO1 and PCO2 from A. thaliana showed that optimal 
expression resulted from induction at 18°C for 6 h and 28°C for 20 h respectively. SDS-
PAGE showed that PCO1 co-purified with two main contaminants, identified by MS as 
chaperones, implying that expressed protein is not fully folded. PCO1 produced by White 
et al. appeared to contain little heterogeneity, perhaps as a result of using a His-tag instead 
of a Strep-tag® (White et al., 2017). PCO2 co-purified with 3 contaminants, two of which 
appeared to be the same contaminants found in purified PCO1. This suggested that PCO2 
also presents with protein folding issues. Incubation of PCO1 with ATP followed by size 
exclusion chromatography was used in an attempt to remove bound chaperones. This was 
able to separate plant CDO from DnaK but with low yield. A second method was then 
attempted; EDTA dialysis followed by size exclusion. This resulted in less DnaK binding 
but had no influence on binding by groEL, just as with the ATP incubation.  
 
As the chaperones could not be removed efficiently, two shortened variants of PCO1 
were designed. These designs were informed by in silico disorder predictions and 
experimental definition of domain boundaries by limited proteolysis. PONDR® 
predicted both the N- and C-termini are disordered. This aligns well with results of the 
limited proteolysis, which showed cleavage of termini. Expression trials for these 
constructs showed that optimal expression of ΔN and ΔNΔC resulted from induction at 
28°C for 6 h and 18°C for 6 h respectively. The ΔN variant resulted in protein with no 
contaminants bound, and thus was homogenous. Conversely, the ΔNΔC variant bound 
even more contaminants than PCO1. This suggests that removal of the N-terminals aids 
in stabilising the protein, or removes the binding site of the chaperones. Removal of the 
C-terminal destabilises the remaining catalytic domain.   
 
Throughout the purification of PCO1, it was noted that the maximum absorbance was at 
260 nm as opposed to 280 nm. This suggested that PCO1 was binding nucleic acid. An 
agarose gel was run and stained with ethidium bromide which confirmed the presence of 
nucleic acid. This novel finding was further explored by treatment with nucleases 
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suggesting that PCO1 was binding DNA. This binding could be physiologically relevant 
as the transcription factor targets of plant CDO also localise to DNA. Localisation would 
improve speed of substrate binding, which is important as environmental factors that 
cause anoxia, such as flooding, arise unpredictably. 
 
To extend attempts to crystallise plant CDO, PCO2 from two additional species were 
explored. These constructs were designed based on experimental results with constructs 
from A. thaliana and analysis of disorder and structural predictions. Expression trials 
suggested that for the Z. mays constructs maize A and maize B, optimal expression 
resulted from induction at 28°C for 20 h and 18°C for 6 h respectively. O. sativa 
expression and purification was not as straightforward. Expression trials were attempted 
in BL21(DE3), BL21(DE3) pLysS and Origami™ (DE3) cells. It appeared as though 
ΔNR expressed in all cell lines based on SDS-PAGE gels, but purification resulted in no 
protein produced. Thus it appeared that the protein does not accumulate, or it was not 
expressed. The plasmid was sequenced, showing that the correct plasmid and insert were 
used. Other possibilities were explored, with the most likely cause being poor folding 
which resulted in post-translational degradation. Expression of rice CDO in E. coli was 
not pursued further.  
 
Two different servers were used to produce models of PCO1, I-TASSER and SWISS-
MODEL. Both models were similar, suggesting that PCO1 contains a core β-barrel 
homologous to mammalian and bacterial CDO. I-TASSER modelled the ends of PCO1, 
proposing that the N-terminal was a completely disordered loop region whilst the C-
terminal had an α-helix alongside large loop regions. Terminal modelling was analysed 
with caution due to low confidence in the model termini due to lack of a template. 
SWISS-MODEL did not model the ends as the template mammalian CDO does not 
contain extended ends as in PCO1. Both models had the iron binding site at the same 
position as mammalian CDO as shown by superimposing the structures. This predicts 
that plant CDO is able to co-ordinate a metal ion.  
 
Surface representations of these models predicted different modes of substrate entry. The 
SWISS-MODEL had an active site that transverses the entire catalytic domain, implying 
that molecular oxygen could enter one side, whilst the peptide is already bound to the 
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other. This would prevent the peptide from blocking co-substrate entry.  The model 
produced by I-TASSER had a small entry site on only one side of the molecule. This 
opened up dramatically after removal of the N-terminal. This may mean that the N-
terminal must move before the substrate can enter the catalytic site. This would allow for 
modulation of activity. Surface charges were also mapped to PCO1, showing that charge 
distribution was uneven. This may permit interaction with DNA on the positively charged 
side and RAP2.12 on the negative side as this protein also contains uneven charge 
distribution.  
 
Other features of the models were explored such as cysteine arrangement and assessing 
potential catalytic residues. All cysteine residues present in the SWISS-MODEL were 
highlighted to evaluate whether or not disulfide bonding could be present. This was 
considered as there are a number of conserved cysteine residues in CDO across a range 
of plant species. It was also considered that a requirement for disulfide bonds may relate 
to why there are issues with protein folding in the full length constructs. Given where the 
residues were spatially, C65 and C129 were predicted to interact, along with C138 and 
C218. Furthermore, all of these residues are highly conserved across a range of plant 
species. 
 
To experimentally determine this, differential labelling followed by MS was used. These 
results showed that C230 and C65 may interact, although a number of peptide 
fingerprints were not found during data assessment. These data showed that disulfide 
bonds are likely present in the structure. This may present a means of modulating activity 
as plant CDO is a redox protein. The formation of disulfide bonds could be a reflection 
of oxidation state in the environment, and thus modulate structure and protein activity as 
a result.  
 
Further in silico experiments scanning motifs within PCO1 revealed that a NLS is 
present. This signal is found on the N-terminal of the protein and tags PCO1 for entry 
into the nucleus. This is an important feature of the protein, as transcription factor targets 
act within the nucleus and thus plant CDO may also be in the nucleus to dioxidise these 
targets when required. The NLS detected is a bipartite signal, which is characterised by 
the consensus sequence (K/R)(K/R)X10–12(K/R)3/5. It is found in PCO1 as: 
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KKNKNKNKKMMMTWRRK, with the spacer region being 12 amino acids. This aligns 
with localisation experiments conducted by Weits et al. who showed that PCO1 and 
PCO2 are nuclear proteins (Weits et al., 2014).  
 
To determine the quality of the models produced, attempts were made to crystallise plant 
CDO. Several high through-put screens were prepared with PCO1, PCO2, ΔN, ΔNΔC, 
maize A and maize B. A greater number of screens were prepared with ΔN as this protein 
was shown to be homogenous by DLS. Other constructs assessed by DLS were predicted 
to form aggregates, or contain contaminant proteins. PCO1 aggregation was confirmed 
by size exclusion chromatography. Peptide substrate, and differing metal ions were used 
as additives to assess different ways of stabilising structure and promoting crystal growth. 
Sea urchin crystals were produced under a condition of crystal screen HT, with PCO1 
and iron in the drop. Optimisation of these conditions was attempted but no further 
crystals were produced. The sea urchin crystals were mounted and assessed using a 
micro-focused beam at the Australian Synchrotron, but resulted in no diffraction pattern. 
Maize B also produced an interesting result from a condition of the crystal screen HT 
plate. A number of small spherulites formed after a few days. These conditions were 
extensively optimised, resulting in larger spherulites but no crystals were formed.  
 
A number of difficulties presented when attempting to determine iron binding 
stoichiometry of PCO1. This raised questions about metal ion binding, including whether 
or not PCO1 binds iron at all. This question was explored using intact MS. Surprisingly, 
the results suggested that ΔN was binding zinc. This may have been an artefact of in vitro 
purification, or removing the N-terminal could have resulted in a differing metal affinity 
to PCO1. Published data by White et al. showed that PCO1 binds predominantly iron. 
Given this, attempts were made to increase iron binding of PCO1. This was attempted by 
lowering the IPTG concentration used to induce to lessen production of PCO1 or adding 
iron to the media. Neither of these methods worked, and instead the optimal way of 
increasing iron occupancy was determined to be loading of iron post-purification.  
 
Kinetic studies were also performed. Previous studies by Weits et al. showed that PCO1 
was able to dioxidise free cysteine to form CSA (Weits et al., 2014). This was tested by 
NMR, which showed that PCO1 did not catalyse the formation of CSA, but instead 
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catalysed the formation of cysteine. Peptide substrates were also explored. A di-peptide 
substrate designed from the N-terminal consensus of target proteins produced an 
approximate Km of 30 ± 10 mM and an approximate Vmax of 0.5 ± 0.1 mM/min. When a 
tri-peptide was used, the reaction proceeded much faster and proposed a lower Km. This 
suggested that PCO1 has a higher affinity for longer substrates, which is unsurprising 
given the length of the natural peptide substrate. The refolding experiment also showed 
that PCO1 is able to dioxidise penta-peptide but parameters were not assessed.  White et 
al. conducted NMR experiments which also show that PCO1 is able to dioxidise the N-
terminal cysteine of peptides. These peptides were also modelled off target N-termini, 
and data produced proved that dioxidation was occurring (White et al., 2017). This aligns 
well with data presented in this thesis, which also suggests dioxidation is occurring on 
peptides modelled from the same N-terminal motif. 
 
Overall, CDO from two plant species were able to be expressed and purified. This 
included 3 full length constructs and 3 shortened variants. A rice shortened variant did 
not accumulate to a detectable level, or was not able to be expressed. Removal of the N-
terminal of A. thaliana PCO1 aided in protein homogeneity. This alongside sequence 
alignment, homology models and limited proteolysis suggested the N-terminal domain 
is disordered. This region also contains an NLS, and provides a charged region which 
contributes to DNA binding. These features may allow regulation of plant CDO. 
Furthermore, the disorder in this region may act as a regulatory switch as removal 
increased the size of the substrate entry site dramatically in a homology model. Removal 
of the C-terminal was detrimental suggesting it contributes to protein folding.  
 
Homology modelling and MS data suggested that PCO1 contains disulfide bonds. 
Disulfide bonds are an important feature of protein structure and absence of these bonds 
in vitro may explain difficulties with protein folding. These disulfide bonds may also 
play a role in regulation of activity as plant CDO is a redox protein. Thus, as oxidation 
state of the environment can influence disulfide bonding of the protein, this may allow a 
switch that can turn plant CDO from an “off” to an “on” state or vice versa. ΔN was 
shown to bind zinc in vitro but this was not demonstrated with a native construct. 
Following this, kinetic data was produced which suggest that PCO1 is faster with larger 
peptide substrates, which is unsurprising given the size of the native target peptide. 
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Kinetic data also showed that PCO1 was not able to dioxidise free cysteine residues. 
Characterisation of plant CDO has given rise to a range of potential features that can be 
further explored. Understanding these features may eventually lead to manipulation that 
can enhance crop yield.  
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Future directions  
This preliminary investigation established expression and purification conditions that 
open up a range of future directions for this study. A number of constructs were able to 
be purified, however almost all co-purified with chaperones. Further attempts to remove 
these chaperones may be beneficial to crystallographic and kinetic studies. One construct, 
ΔNR, was not able to be purified. It was determined that this may be due to the protein 
not expressing or accumulating as one would expect. This result could also be due to the 
truncation preventing proper protein folding. It would be of interest to explore this 
further: a first step would be attempting to purify the full length version of rice PCO2. 
This is of interest as it may aid in determining the structure of plant CDO using 
crystallography.  
 
Exploration into the role of the N-terminus of PCO1 is also of interest. To determine if 
DNA binding is specific, a pool of randomly cleaved genomic DNA from A. thaliana 
could be incubated with nuclease-treated, purified PCO1. After recovery of PCO1 by 
affinity chromatography, one could sequence all co-purifying DNA. If over represented 
sequences are found, then synthetic DNA could be used to establish a consensus binding 
sequence. A NLS is also predicted to be present on the N-terminus of PCO1. This element 
could be studied further by fusing a GFP with PCO1 or ΔN, and expressing in plant 
tissue. If the NLS is present in the first 52 amino acids, PCO1 will translocate into the 
nucleus, whereas ΔN will not. In a complementary experiment it can be determined 
whether the first 52 residues tagged with GFP would translocate into the nucleus in a 
plant cell.  
 
Future structural studies should be aimed to probe disulfide bonding, either inter- or intra-
molecular. These bonds may be important not only structurally, but could also permit a 
means of catalytic regulation. This could be explored by treating PCO1 with reactive 
oxygen species or reductants prior to conducting enzymatic assays. Crystallography may 
be best continued with the use of further constructs from different species, both full 
length and those analogous to ΔN. Crystallography could also be continued with those 
already purified yet with chaperones removed. These chaperones could be removed by 
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protein dialysis in the presence of EDTA followed by gel filtration, even though low 
yield results.  
 
Iron binding could be further explored by use of Mössbauer spectroscopy to explore 
oxidation state and binding orientation. The ferrozine assay could be used for 
determining stoichiometry of binding, yet needs to be further optimised. As DNA is 
negatively charged, nuclease treatment of PCO1 may remove potential unspecific iron 
binding and improve ferrozine data. This could also be achieved by exploring the iron 
binding stoichiometry of ΔN. 
 
Further kinetic studies could also be conducted. Extending analysis of the relationship 
between substrate peptide size and catalytic properties would be of interest. This could 
be achieved by further Ellman’s assays which chart Michaelis-Menten kinetics with a 
range of peptide substrates. Other techniques like NMR and MS could be used to 
characterise products. Understanding these factors could aid in determining how 
substrate recognition occurs. These various future approaches could permit an 
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Appendix 1. RAP2.2 sequence aligned to RAP2.12 using BLAST. Uniprot used to 
find sequences, RAP2.12 accession no. Q9SSA8 and RAP2.2 accession no. Q9LUM4. 
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Appendix 3. Mass spectrometry results for groEL. 
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1  MGFEMKPEKE VLELISSKNQ CKSNPNSVKK KNKNKNKKMM MTWRRKKIDS 
VLXT  DDDDDDDDDD D            DDDDDDDD DDDDDDDDDD DDDDDDDDDD 
 
51  PADGITAVRR LFNTCKEVFS NGGPGVIPSE DKIQQLREIL DDMKPEDVGL 
VLXT  DDDDDD                    DDDDDD DDDDDDDDDD DDDDDDDDDD 
 
101  TPTMPYFRPN SGVEARSSPP ITYLHLHQCD QFSIGIFCLP PSGVIPLHNH 
VLXT  DDDDDDDDDD DDDDDDDD 
 
151  PGMTVFSKLL FGTMHIKSYD WVVDAPMRDS KLAKLKVDST FTAPCNASIL 
VLXT                                                         
 
201  YPEDGGNMHR FTAITACAVL DVLGPPYCNP EGRHCTYFLE FPLDKLSSED 
VLXT                                                     DDD 
 
251  DDVLSSEEEK EGYAWLQERD DNPEDHTNVV GALYRGPKVE DSAWSHPQFE 
VLXT  DDDDDDDDDD DDDDDDDDD         DDD DD         DDDDDDDD D 
 
Appendix 4. PCO1 single residue disorder prediction using PONDR® VLXT. D 
indicates residues predicted to be disordered, the lack of a D indicates residues predicted 
to be ordered. Scores associated with these predictions can be found in Figure 3.X. 




Appendix 5. ΔNΔC and ΔN solubility at 37°C. Amount loaded was kept constant to 
allow comparison. H indicates homogenate, S represents supernatant and P indicates 
pellet. Where ΔNΔC and ΔN are expected to run is indicated with black arrows. The lane 
labelled M contains molecular weight marker. Marker masses are indicated in kDa and 








1 MGFEMKPEKE VLELISSKNQ CKSNPNSVKK KNKNKNKKMM MTWRRKKIDS 
51 PADGITAVRR LFNTCKEVFS NGGPGVIPSE DKIQQLREIL DDMKPEDVGL 
101 TPTMPYFRPN SGVEARSSPP ITYLHLHQCD QFSIGIFCLP PSGVIPLHNH 
151 PGMTVFSKLL FGTMHIKSYD WVVDAPMRDS KTRLAKLKVD STFTAPCNAS 
201 ILYPEDGGNM HRFTAITACA VLDVLGPPYC NPEGRHCTYF LEFPLDKLSS 
251 EDDDVLSSEE EKEGYAWLQE RDDNPEDHTN VVGALYRGPK VEDSAWSHPQ 
301 FEK     
Appendix 6. PCO1 sequence coverage from MS identification. Residues in bold were 
peptide matched. Sequence coverage is 71%, the enzyme used for digestion was trypsin.  
 
1 MGTDTVMSGR VRKDLSKTNP NGNIPENRSN SRKKIQRRSK KTLICPVQKL 
51 FDTCKKVFAD GKSGTVPSQE NIEMLRAVLD EIKPEDVGVN PKMSYFRSTV 
101 TGRSPLVTYL HIYACHRFSI CIFCLPPSGV IPLHNHPEMT VFSKLLFGTM 
151 HIKSYDWVPD SPQPSSDTRL AKVKVDSDFT APCDTSILYP ADGGNMHCFT 
201 AKTACAVLDV IGPPYSDPAG RHCTYYFDYP FSSFSVDGVV VAEEEKEGYA 
251 WLKEREEKPE DLTVTALMYS GPTIKESAWS HPQFEK  
Appendix 7. PCO2 sequence coverage from MS identification. Residues in bold were 
peptide matched. Sequence coverage is 41%, the enzyme used for digestion was 
chymotrypsin.  
 
1 MGITAVRRLF NTCKEVFSNG GPGVIPSEDK IQQLREILDD MKPEDVGLTP 
51 TMPYFRPNSG VEARSSPPIT YLHLHQCDQF SIGIFCLPPS GVIPLHNHPG 
101 MTVFSKLLFG TMHIKSYDWV VDAPMRDSKL AKLKVDSTFT APCNASILYP 
151 EDGGNMHRFT AITACAVLDV LGPPYCNPEG RHCTYFLEFP LDKLSSEDDD 
201 VLSSEEEKEG YAWLQERDDN PEDHTNVVGA LYRGPKVEDS AWSHPQFEK 
Appendix 8. ΔN sequence coverage from MS identification. Residues in bold were 





1 MGITAVRRLF NTCKEVFSNG GPGVIPSEDK IQQLREILDD MKPEDVGLTP 
51 TMPYFRPNSG VEARSSPPIT YLHLHQCDQF SIGIFCLPPS GVIPLHNHPG 
101 MTVFSKLLFG TMHIKSYDWV VDAPMRDSKL AKLKVDSTFT APCNASILYP 
151 EDGGNMHRFT AITACAVLDV LGPPYCNPEG RHCTYFLEFP LDKLSSAWSH 
201 PQFEK     
Appendix 9. ΔNΔC sequence coverage from MS identification. Residues in bold were 






Appendix 10. MS of N-terminal labelling of maize A. Band 1 is full length protein, band 2 runs at 29 kDa on a gel, band 3 at 27 kDa and band 
4 at 21 kDa. Digestion was with chymotrypsin. Gel the bands are excised from can be found in Figure 4.26, Ma.  
 No Enzyme   Abundances  
Annotated Sequence Modifications # PSMs 
Positions 
in Protein B1 B2 B3 B4 
[-].MRVESSGGLPLPELERQQAGAKR.[R] 
1×Dimethyl [K22]; 1×Dimethyl 
[N-Term] 6 [1-23] 4.57E+07      
[-].MRVESSGGLPLPELERQQAGAKR.[R] 
1×Deamidated [Q]; 1×Dimethyl 
[K22]; 1×Dimethyl [N-Term] 2 [1-23]     
[-].MRVESSGGLPLPELERQQAGAK.[R] 
1×Deamidated [Q]; 1×Dimethyl 
[K22] 4 [1-22] 1.53E+06      
[-].MRVESSGGLPLPELERQQAGAK.[R] 
1×Dimethyl [K22]; 1×Dimethyl 
[N-Term] 13 [1-22] 2.51E+08 1.65E+05    
[-].MRVESSGGLPLPELERQQAGAK.[R] 
1×Deamidated [Q]; 1×Dimethyl 
[K22]; 1×Dimethyl [N-Term] 6 [1-22] 3.55E+06      
[-].MRVESSGGLPLPELERQQAGAK.[R] 
1×Acetyl [N-Term]; 1×Dimethyl 
[K22] 2 [1-22] 2.70E+06      
[-].MRVESSGGLPLPELERQQAGA.[K] 1×Dimethyl [N-Term] 7 [1-21] 5.33E+07 2.62E+04 2.08E+04  
[-].MRVESSGGLPLPELERQQAG.[A] 1×Dimethyl [N-Term] 2 [1-20] 2.86E+06      
[-].MRVESSGGLPLPELERQQA.[G] 1×Dimethyl [N-Term] 3 [1-19] 8.91E+06      
[-].MRVESSGGLPLPELERQQ.[A] 1×Dimethyl [N-Term] 6 [1-18] 7.95E+06 2.24E+04   1.80E+04 
[-].MRVESSGGLPLPELERQ.[Q] 1×Dimethyl [N-Term] 6 [1-17] 1.72E+07 5.74E+03   2.94E+03 
[-].MRVESSGGLPLPELER.[Q] 1×Dimethyl [N-Term] 2 [1-16] 4.76E+06      
[-].MRVESSGGLPLPELE.[R] 1×Dimethyl [N-Term] 2 [1-15] 6.66E+05      
[M].RVESSGGLPLPELERQQAGAK.[R] 
1×Dimethyl [K21]; 1×Dimethyl 
[N-Term] 3 [2-22] 4.84E+06      
[R].VESSGGLPLPELERQQAGAK.[R] 
1×Dimethyl [K20]; 1×Dimethyl 
[N-Term] 2 [3-22] 4.88E+06      
[E].SSGGLPLPELERQQAGAK.[R] 
1×Dimethyl [K18]; 1×Dimethyl 
[N-Term] 2 [5-22] 1.44E+06      
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[S].SGGLPLPELERQQAGAK.[R] 1×Dimethyl [K17] 1 [6-22] 2.62E+05      
[L].PLPELERQQAGAK.[R] 1×Dimethyl [K13] 3 [10-22] 2.90E+06      
[L].PELERQQAGAK.[R] 1×Dimethyl [K11] 2 [12-22] 1.66E+06      
[R].AAAAAAAPRTM.[A] 
1×Oxidation [M11]; 1×Dimethyl 
[N-Term] 2 [30-40]  5.20E+04    
[A].AAAAAAPRTMAAPATAVQ.[R] 
1×Oxidation [M10]; 1×Dimethyl 
[N-Term] 2 [31-48]     
[A].AAAAAAPRTMA.[A] 
1×Oxidation [M10]; 1×Dimethyl 
[N-Term] 1 [31-41]     
[A].AAAAAAPRTM.[A] 
1×Oxidation [M10]; 1×Dimethyl 
[N-Term] 2 [31-40]  5.80E+04   1.74E+03 
[A].AAAAAPRTMAAPATAVQ.[R] 
1×Oxidation [M9]; 1×Dimethyl [N-
Term] 2 [32-48]  7.19E+05    
[A].AAAAAPRTMAAP.[A] 
1×Oxidation [M9]; 1×Dimethyl [N-
Term] 1 [32-43]     
[A].AAAAAPRTMA.[A] 
1×Oxidation [M9]; 1×Dimethyl [N-
Term] 1 [32-41]     
[A].AAAAAPRTM.[A] 1×Dimethyl [N-Term] 2 [32-40] 2.25E+04 2.53E+05    
[A].AAAAAPRTM.[A] 
1×Oxidation [M9]; 1×Dimethyl [N-
Term] 2 [32-40]  3.33E+05    
[A].AAAAPRTMAAPATAVQRLF.[E] 
1×Oxidation [M8]; 1×Dimethyl [N-
Term] 2 [33-51]  1.68E+05    
[A].AAAAPRTMAAPATAVQ.[R] 
1×Oxidation [M8]; 1×Dimethyl [N-
Term] 3 [33-48]  3.92E+06    
[A].AAAAPRTMAAPA.[T] 
1×Oxidation [M8]; 1×Dimethyl [N-
Term] 2 [33-44]  3.42E+05    
[A].AAAPRTMAAPATAVQ.[R] 
1×Oxidation [M7]; 1×Dimethyl [N-
Term] 2 [34-48] 1.61E+04 2.10E+05    
[A].AAPRTMAAPATAVQRLF.[E] 
1×Oxidation [M6]; 1×Dimethyl [N-
Term] 2 [35-51]  6.81E+04    
[A].AAPRTMAAPATAVQ.[R] 
1×Oxidation [M6]; 1×Dimethyl [N-
Term] 2 [35-48]  1.83E+06    
[M].AAPATAVQRLF.[E] 1×Dimethyl [N-Term] 1 [41-51]  6.45E+04    
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[S].VLDSITAADVRLT.[S] 1×Dimethyl [N-Term] 1 [77-89]  1.59E+04 6.67E+04  
[S].VLDSITAADVRL.[T] 1×Dimethyl [N-Term] 1 [77-88]    6.57E+04  
[D].SITAADVRLT.[S] 1×Dimethyl [N-Term] 2 [80-89]     
[F].RRVDPYGTPKITY.[L] 1×Dimethyl [K10] 2 [96-108] 3.20E+05 2.06E+04    
[R].VDPYGTPKITY.[L] 1×Dimethyl [K8] 1 [98-108] 1.46E+05   1.65E+04  
[Y].GTPKITYL.[H] 
1×Dimethyl [K4]; 1×Dimethyl [N-
Term] 7 [102-109] 8.93E+06 2.90E+05 1.64E+05  
[F].SKLLFGAMHIKSY.[D] 
Dimethyl [K]; 1×Dimethyl [N-
Term] 2 [142-154] 5.87E+05 8.79E+03    
[L].LFGAMHIKSY.[D] 
1×Oxidation [M5]; 1×Dimethyl 
[K8] 4 [145-154] 3.12E+06 1.49E+05 4.73E+04  
[L].FGAMHIKSY.[D] 
1×Oxidation [M4]; 1×Dimethyl 
[K7] 2 [146-154] 1.66E+06 4.90E+04   1.31E+04 
[F].GAMHIKSY.[D] 1×Dimethyl [K6] 4 [147-154] 3.17E+07 4.15E+05 1.08E+05 3.30E+03 
[F].GAMHIKSY.[D] 
1×Dimethyl [N-Term]; 1×Formyl 
[K6] 2 [147-154] 5.28E+05      
[AT].MHIKSY.[D] 
1×Oxidation [M1]; 1×Dimethyl 
[K4] 2 [149-154] 8.84E+05 2.04E+04   2.94E+03 




1×Oxidation [M33]; 1×Dimethyl 




1×Oxidation [M33]; 1×Dimethyl 




Dimethyl [K]; 1×Dimethyl [N-




1×Oxidation [M32]; 1×Dimethyl 
[N-Term]; 1×Formyl [K]; 






1×Oxidation [M32]; Dimethyl [K]; 
1×Dimethyl [N-Term] 22 [169-203] 1.03E+07      
[L].QAGPRLAKVKVDGILTAPHETAVLYPED
GGNMH.[C] 
1×Dimethyl [N-Term]; 1×Formyl 
[K]; 1×Dimethyl [K] 13 [169-201] 6.09E+06      
[L].QAGPRLAKVKVDGILTAPHETAVLYPED
GGNMH.[C] 
Dimethyl [K]; 1×Dimethyl [N-
Term] 17 [169-201] 6.09E+06      
[L].QAGPRLAKVKVDGILTAPHETAVLYPED
GGNMH.[C] 
1×Oxidation [M32]; Dimethyl [K]; 












1×Oxidation [M31]; 1×Dimethyl 
[N-Term]; 1×Formyl [K]; 




1×Oxidation [M31]; Dimethyl [K]; 




Dimethyl [K]; 1×Dimethyl [N-




1×Deamidated [N26]; Dimethyl 




1×Oxidation [M27]; 1×Dimethyl 
[N-Term]; 1×Formyl [K]; 




1×Oxidation [M27]; Dimethyl [K]; 






Dimethyl [K]; 1×Dimethyl [N-




1×Oxidation [M27]; Dimethyl [K]; 
1×Dimethyl [N-Term] 3 [174-202] 5.61E+05      
[R].LAKVKVDGILTAPHETAVLYPEDGGNM
H.[C] 
Dimethyl [K]; 1×Dimethyl [N-
Term] 18 [174-201] 2.38E+07   3.44E+03  
[R].LAKVKVDGILTAPHETAVLYPEDGGNM
H.[C] 
1×Oxidation [M27]; Dimethyl [K]; 
1×Dimethyl [N-Term] 19 [174-201] 1.76E+07 4.96E+04    
[R].LAKVKVDGILTAPHETAVLYPED.[G] 
Dimethyl [K]; 1×Dimethyl [N-
Term] 11 [174-196] 2.38E+06      
[R].LAKVKVDGILTAPHETAVLY.[P] 
Dimethyl [K]; 1×Dimethyl [N-
Term] 9 [174-193] 1.75E+06      
[R].LAKVKVDGILTAPHETAVL.[Y] 
Dimethyl [K]; 1×Dimethyl [N-
Term] 9 [174-192] 7.61E+06 3.68E+04    
[R].LAKVKVDGILTAPH.[E] 
Dimethyl [K]; 1×Dimethyl [N-




Dimethyl [K]; 1×Dimethyl [N-
Term] 6 [175-203] 1.08E+06      
[L].AKVKVDGILTAPHETAVLYPEDGGNMH.
[C] 
Dimethyl [K]; 1×Dimethyl [N-
Term] 10 [175-201] 3.97E+06      
[L].AKVKVDGILTAPHETAVLYPEDGGNMH.
[C] 
1×Oxidation [M26]; Dimethyl [K]; 




Dimethyl [K]; 1×Dimethyl [N-




1×Oxidation [M25]; Dimethyl [K]; 
1×Dimethyl [N-Term] 8 [176-203] 3.10E+06 8.24E+03    
[A].KVKVDGILTAPHETAVLYPEDGGNMH.[
C] 
Dimethyl [K]; 1×Dimethyl [N-
Term] 4 [176-201] 5.37E+06      
[A].KVKVDGILTAPHETAVLYPEDGGNMH.[
C] 
1×Oxidation [M25]; Dimethyl [K]; 






1×Dimethyl [N-Term]; 1×Dimethyl 




1×Oxidation [M24]; 1×Dimethyl 
[K2]; 1×Dimethyl [N-Term] 8 [177-203] 2.08E+06     1.86E+04 
[K].VKVDGILTAPHETAVLYPEDGGNMH.[C] 
1×Dimethyl [K2]; 1×Dimethyl [N-
Term] 6 [177-201] 1.94E+06      
[D].GILTAPHETAVLYPEDGGNMHCF.[T] 
1×Carbamidomethyl [C22]; 
1×Dimethyl [N-Term] 1 [181-203] 1.12E+06      
[D].GILTAPHETAVLYPEDGGNMHCF.[T] 
1×Carbamidomethyl [C22]; 
1×Oxidation [M20]; 1×Dimethyl 
[N-Term] 2 [181-203] 1.39E+06      
[Y].LVGSTYMGPKILDHW.[S] 1×Dimethyl [K10] 4 [265-279] 2.51E+06      
[Y].MGPKILDHWSHPQFEK.[-] 
Dimethyl [K]; 1×Dimethyl [N-
Term] 6 [271-286] 4.39E+06 4.85E+04 2.64E+04  
[Y].MGPKILDHWSHPQFEK.[-] 
1×Oxidation [M1]; 2×Dimethyl 
[K4; K16] 6 [271-286] 1.03E+07 1.13E+05    
[Y].MGPKILDHW.[S] 
1×Dimethyl [K4]; 1×Dimethyl [N-
Term] 6 [271-279] 1.24E+08 2.69E+05 3.31E+04 3.76E+03 
[Y].MGPKILDHW.[S] 
1×Acetyl [N-Term]; 1×Dimethyl 









Appendix 11. MS of Maize B and contaminants. Table includes first 12 hits only. Gel in Figure 4.26 Mb, bands labelled 1-5 from the top 
molecular weight band. Bands were digested with chymotrypsin. 
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Elongation factor Tu 2 OS=Escherichia coli O139:H28 







60 kDa chaperonin OS=Escherichia coli (strain K12 / 







Elongation factor Tu 1 OS=Shigella flexneri serotype 5b 







ATP synthase subunit beta OS=Shigella boydii serotype 







Transcription termination factor Rho OS=Shigella 







30S ribosomal protein S1 OS=Escherichia coli (strain 







Elongation factor Tu OS=Pseudomonas fluorescens 








Succinyl-CoA ligase [ADP-forming] subunit beta 
OS=Pseudomonas putida (strain GB-1) GN=sucC PE=3 
SV=1 132.05 1.45E+05 1.37E+05 2.90E+05 3.31E+05   22 7 7 44 
38
8 41.1 6.2 
A7Z
VV7 
Chaperone protein DnaK OS=Escherichia coli O9:H4 







50S ribosomal protein L1 OS=Escherichia coli (strain 
ATCC 8739 / DSM 1576 / Crooks) GN=rplA PE=3 







D-tagatose-1,6-bisphosphate aldolase subunit GatZ 

















Appendix 12. Improving solubility of maize B using lysis conditions. Lysis conditions 
are labelled with a number above. One- regular lysis buffer (2.4.1), 2- regular lysis buffer 
with 400 mM sodium chloride, 3- regular lysis buffer with 125 mM L-arginine and four- 
100 mM Tris pH 7.1 with 300 mM sodium chloride and 0.7% Tween20®. Samples with 
sodium citrate buffer did not run on the gel, perhaps due to the pH of these buffers. 
Number of E. coli cells has not been controlled for in normalising loading. H indicates 
homogenate, S represents supernatant and P indicates pellet. Where maize B is expected 
to run is indicated with a black arrow. The lane labelled M contains molecular weight 
marker. Marker as in Appendix 5.  
 
 
Appendix 13. Maize B expression in Origami®. Equal number of cells as judged by 
OD600, were loaded into each lane. The negative sign indicates sample before induction 
and the numbers following this represents number of hours after induction. Where Maize 
B is predicted to run is indicated with a black arrow. The lane labelled M contains 








Appendix 14. ΔNR expressed in BL21(DE3) pLysS solubility. Loading is kept 
constant for comparison. H indicates homogenate, S represents supernatant and P 
indicates pellet. Where ΔNR is expected to run is indicated with a black arrow. The lane 
labelled M contains molecular weight marker. Marker as in Appendix 5. 
 
 
 Appendix 15. ΔNR expressed in BL21(DE3) pLysS solubility at 37°C. Loading kept 
constant to allow for comparison. H indicates homogenate, S represents supernatant and 
P indicates pellet. Where rice is expected to run is indicated with a black arrow. The lane 







Appendix 16. ΔNR expressed in BL21(DE3) pLysS Strep-tag®  FPLC purification. 
The blue line represents absorbance at 280 nm in mAU (left axis) and the red line 
represents conductivity in mS/cm (right axis). Fractions numbers relate to Appendix 17. 
After sample application, wash buffer was run from 15-60 mL, and elution buffer was 
run from 60-100 mL. A water wash from 100-120 mL was followed by a sodium 




Appendix 17. ΔNR expressed in BL21(DE3) pLysS Strep-tag® FPLC purification 
gel. Lanes labelled with a letter and a number are fraction numbers. Where ΔNR is 
expected to run is indicated with a black arrow. The lane labelled M contains molecular 






Appendix 18. ΔNR expressed in Origami™ (DE3) solubility. Loading was kept 
constant to allow for comparison. H indicates homogenate, S represents supernatant and 
P indicates pellet. Where ΔNR is expected to run is indicated with a black arrow. The 
lane labelled M contains molecular weight marker. Marker as in Appendix 5. 
 
 
Appendix 19. ΔNR expressed in Origami® (DE3) solubility at 37°C. Loading kept 
constant to allow for comparison. H indicates homogenate, S represents supernatant and 
P indicates pellet. Where rice would run is indicated with a black arrow. The lane labelled 








Appendix 20. ΔNR expressed in Origami™ (DE3) Strep-tag® FPLC purification. 
The blue line represents absorbance at 280 nm in mAU (left axis) and the red line 
represents conductivity in mS/cm (right axis). Fractions relate to the samples analysed in 
Appendix 21. After sample application, wash buffer was run from 15-65 mL, and elution 
buffer was run from 65-95 mL. A water wash from 95-115 mL was followed by a sodium 




Appendix 21. ΔNR expressed in Origami™ (DE3) Strep-tag® FPLC purification 
gel. Lanes labelled with a letter and a number are fraction numbers. Where ΔNR is 
expected to run is indicated with a black arrow. The lane labelled M contains molecular 
weight marker. Marker as in Appendix 5. Fractions relate to the chromatogram in 












1  MEKKITGYTT VDISQWHRKE HFEAFQSVAQ CTYNQTVQLD ITAFLKTVKK 
51  NKHKFYPAFI HILARLMNAH PEFRMAMKDG ELVIWDSVHP CYTVFHEQTE 
101  TFSSLWSEYH DDFRQFLHIY SQDVACYGEN LAYFPKGFIE NMFFVSANPW 
151  VSFTSFDLNV ANMDNFFAPV FTMGKYYTQG DKVLMPLAIQ VHHAVCDGFH 
201  VGRMLNELQQ     
Appendix 22. E. coli Chloramphenicol acetyltransferase sequence coverage from 
MS identification. Residues in bold were peptide matched. Sequence coverage is 35%, 
the enzyme used for digestion was chymotrypsin. Molecular weight is 26000 Da. 
 
Sequencing      MPSAGAAAQPAPSPAVQGLFEACREVFGASAGAVPSPAGVERIKSVLDSISAADVSLTRN 60 
Rice_PCO2       MPSAGAAAQPAPSPAVQGLFEACREVFGASAGAVPSPAGVERIKSVLDSISAADVSLTRN 60 
                ************************************************************ 
 
Sequencing      MSYFRRVNSNGIPKITYLHLYECEAFSIGIFCLPPRGVIPLHNHPNMTVFSKLLFGELRV 120 
Rice_PCO2       MSYFRRVNSNGIPKITYLHLYECEAFSIGIFCLPPRGVIPLHNHPNMTVFSKLLFGELRV 120 
                ************************************************************ 
 
Sequencing      KSYDWADASQDSTDAQLQGARLAKVKVDGTLNAPCATSVLYPEDGGNLHCFTAHTACAVL 180 
Rice_PCO2       KSYDWADASQDSTDAQLQGARLAKVKVDGTLNAPCATSVLYPEDGGNLHCFTAHTACAVL 180 
                ************************************************************ 
 
Sequencing      DVLGPPYDDGSGRHCQHYNVSSSAPSAGDSKPLPGDDGYAWLEECEPPDNFHLVGSTYMG 240 
Rice_PCO2       DVLGPPYDDGSGRHCQHYNVSSSAPSAGDSKPLPGDDGYAWLEECEPPDNFHLVGSTYMG 240 
                ************************************************************ 
 
Sequencing      PRIVDNWSHPQFEK 254 
Rice_PCO2       PRIVDNWSHPQFEK 254 
                ************** 
 
Appendix 23. Sequencing of the rice construct. The sequencing results are labelled 
sequencing, and the correct sequence is labelled Rice_PCO2. Sequence match is 100%. 
Clustal Omega was used to produce the alignment. A star is indicative of the same amino 





Appendix 24. Mammalian CDO surface topology with charge distribution. Blue 
represents a positive charge, and red represents a negative charge. PDB accession number 




Appendix 25. MS of higher order structures on non-reducing gel. F1 is the top band (~180 kDa), F2 the middle (~140 kDa) and F3 the bottom 
(~68 kDa). Digestion was with trypsin. Gel the bands are excised from can be found in Figure 5.13. 
Accession Protein  

























(F1) / (F3) 
Abundance Ratio: 
(F2) / (F3) 
Abundance Ratio: 
(F1) / (F2) 
Q9LXG9 PCO1 21 21 188 46.713 41.09 0.986 
B1XDP7 GroEL 22 22 70 1.102 0.685 1.364 




Appendix 26. Molecular weight estimation of PCO1 refolding gel filtration. Line 
equation is y = -0.0013x + 0.0024. Quality of fit, R² = 0.9635.  
 
Calculations 
Rf  of indicated band (grey arrow)= 0.18 
(0.18 – 0.0024)/-0.0013 = x 
x= 138 Da 
138 Da/36 Da(Mr of PCO1)= 3.8 monomers of CDO    
 
Appendix 27.  PCO1 sequence motifs.  
PS00005  PKC_PHOSPHO_SITE (pattern)  Protein 
kinase C phosphorylation site  [occurs frequently] 
16 - 18 
 
27 - 29 
 
42 - 44 
 
64 - 66 
 
PS00006  CK2_PHOSPHO_SITE (pattern)  Casein 
kinase II phosphorylation site  [occurs frequently] 
50 - 53 
 
64 - 67 
 
111 - 114 
 























248 - 251 
 
255 - 258 
 
256 - 259 
 
PS00008  MYRISTYL (pattern)  N-myristoylation 
site  [occurs frequently] 
75 - 80 
 
99 - 104 
 
PS00001  ASN_GLYCOSYLATION (pattern)  N-
glycosylation site  [occurs frequently] 
196 - 199 
 
Headings include a ScanProsite accession number, followed by the type of modification 
then the specific modification. Frequency is also noted.  
Column below contains the amino acid number/s of the modification/s  
 
 
Appendix 28. Maize B spherulites from Crystal Screen HT. Image taken under UV 
light. Spherulites formed in 0.2 M calcium chloride, 0.1 M HEPES pH 7.5 and 28% v/v 






Appendix 29. Maize B spherulites from Crystal Screen HT. Left images taken under 
cross polarised light, whilst right is under UV light. Spherulites formed in 0.2 M calcium 
acetate, 0.1 M sodium cacodylate and 18% w/v PEG 8000. Spherulites were formed with 




Appendix 30. Optimised Maize B spherulites from PEGRx HT with calcium. Image 
taken under UV light. Spherulites formed in 0.1 M calcium chloride, 0.1 M Tris pH 8 






Appendix 31. Large drop Maize B spherulites from PEGRx HT with calcium. Left 
image was taken under UV light and right was taken under cross polarised light. 
Spherulites formed in 0.1 M calcium chloride, 0.1 M citric acid pH 3.5 and 34% v/v PEG 





Appendix 32. Raw kinetic data for refolding experiment. Slope indicative of observed 
velocity in mM/min, and shows substrate depletion. Peptide used was ~30 mM 
pentapeptide (amino acids in order were CGGAI). Enzyme used was PCO1 at a final 
concentration of 5 μM. Data produced using Ellman’s reagent in a 96-well plate format. 





Appendix 33. Raw data for PCO1 dipeptide enzyme titration. Graphs show substrate 
depletion, and slope is indicative of velocity in mM/min. Peptide used was 5 mM 
dipeptide (amino acid were CG). PCO1 concentration is listed above each graph in μM. 




Appendix 34. Raw data for varying substrate concentrations with PCO1. Enzyme 
concentration was 6 μM. Graphs show substrate depletion, and slope is indicative of 
velocity in mM/min. Peptide used was dipeptide (amino acids were CG). Substrate 
concentration is listed above each graph in mM. Data produced using Ellman’s reagent 
in a 96-well plate format.  
